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ABSTRACT	  
Peroxisome	   proliferator-­‐activated	   receptors	   (PPARs)	   are	   ligand-­‐activated	  transcription	   factors	   that	   belong	   to	   the	   nuclear	   hormone	   receptor	  superfamily.	  Three	  PPARs	  (PPARα,	  PPARβ	  and	  PPARγ)	  exist	  in	  mammals,	  and	  all	   are	   activated	   by	   binding	   lipid	  molecules,	   including	   fatty	   acids	   and	   their	  derivatives,	   and	   also	   by	   synthetic	   drug	   ligands.	   Together,	   these	   three	  receptors	  are	  critical	  regulators	  of	  lipid	  and	  energy	  homeostasis	  in	  mammals.	  PPARγ	   is	   a	   central	   factor	   in	   fat	   uptake	   and	   storage	   and	   is	   required	   for	  adipocyte	   differentiation.	   Fish	   are	   now	   known	   to	   have	   homologues	   of	   the	  three	   PPAR	   isotypes,	   although	   in	   many	   species	   there	   is	   more	   than	   one	  representative	   of	   each.	   Piscine	   PPARγ	   is	   of	   particular	   interest	   in	   finfish	  aquaculture,	  since	  under	  aquaculture	  conditions	  fish	  often	  accumulate	  excess	  visceral	  and	  hepatic	  fat.	  This	  can	  affect	  the	  health	  and	  welfare	  of	  the	  fish,	  and	  also	   represents	   an	   economic	   waste	   of	   valuable	   resources	   that	   might	  otherwise	   be	   channelled	   into	   growth.	   However,	   piscine	   PPARγ	   has	   some	  important	   structural	   differences	   to	   the	  mammalian	   counterpart,	   and	   is	   not	  activated	  by	   fatty	  acids	  or	  synthetic	   ligands.	  Although	  presumed	  to	  have	  an	  important	   role	   in	   fat	   accumulation,	   further	   research	   on	   piscine	   PPARγ	   has	  been	  hampered	  by	  this	  failure	  to	  identify	  of	  activating	  compounds.	  	  
The	  aim	  of	  this	  project	  is	  to	  identify	  activators	  for	  piscine	  PPARγ,	  and	  then	  to	  discover	  the	  effects	  of	  PPARγ	  activation	  on	  fish	  lipid	  and	  energy	  metabolism.	  In	  addition,	  given	  the	  variability	  in	  numbers	  of	  PPAR	  genes	  in	  fish	  species,	  the	  PPAR	  complement	  of	  the	  salmon	  genome	  was	  investigated.	  Atlantic	  salmon	  is	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an	   important	   aquaculture	   species	   and	   unlike	   most	   other	   vertebrates,	   was	  found	  to	  contain	  two	  PPARγ	  genes	  with	  distinct	  tissue	  expression	  profiles.	  To	  discover	  activating	  compounds	  for	  fish	  PPARγ,	  total	  lipid	  was	  extracted	  from	  salmon	   liver	   tissue	   and	   fractionated	   into	   different	   lipid	   classes.	   Lipid	  fractions	   obtained	   were	   then	   tested	   in	   a	   high-­‐throughput	   cell-­‐based	  transactivation	   screen	   for	   fish	   PPAR	   activity	   in	   a	   Chinook	   salmon	   embryo	  (CHSE-­‐214)	  cell	  line.	  Two	  polar	  lipid	  fractions	  believed	  to	  contain	  ceramides	  significantly	   increased	   PPARγ-­‐dependent	   transactivation	   of	   a	   luciferase	  reporter	  gene.	  The	  molecular	  species	  in	  two	  of	  these	  fractions	  were	  analysed	  by	   LC-­‐MS,	   confirming	   the	   presence	   of	   various	   ceramide	   and	   sphingolipid	  species.	  Application	  of	  pure	  glucosylceramide	  (GlcCer)	  in	  the	  cell	  transfection	  assay	  resulted	  in	  PPARγ	  activation.	  The	  identification	  of	  activating	  lipids	  for	  piscine	  PPARγ	  will	  enable	  further	  study	  on	  the	  physiological	  functions	  of	  this	  receptor	  in	  fish	  and	  under	  aquaculture	  conditions.	  Ultimately	  this	  knowledge	  could	  lead	  to	  improvements	  in	  finfish	  feed	  formulation	  to	  better	  optimise	  the	  relationship	  between	  lipid	  input,	  fat	  accumulation	  and	  growth.	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Figure	  6-­‐2	  Phylogenetic	   tree	   for	  the	   full-­‐length	  PPARs	  from	  diverse	  species.	  The	   numbers	   represent	   the	   frequencies	   (%)	   with	   which	   the	   tree	   was	  generated	   using	   maximum	   likelihood	   method	   with	   MEGA	   7	   software.	  Receptor	   sequences	   used	   were:	   (1)	   Gallus	   gallus	   (chicken)	   PPARa	  (NP_001001464),	   PPARb	   (NP_990059),	   PPARg	   (NP_001001460);	   (2)	  
Homo	   sapiens	   (human)	   PPARa	   (NP_005027),	   PPARb	   (NP_006229),	  PPARg	   (NP_005028);	   (3)	   Xenopus	   laevis	   (African	   clawed	   frog)	   PPARa	  (P37232),	   PPARb	   (NP_001081310),	   PPARg	   (XP_018095920)	   (4)	   Esox	  
Lucius	   (Northern	   pike)	   PPARa1	   (XP_010882200),	   PPARa2	  (XP_010885449),	   PPARba	   (XP_010891645),	   PPARbb	   (XP_012993730),	  PPARga	   (XP_010872599),	   PPARgb	   (XP_010900626);	   (5)	   Sparus	  aurata	  (gilthead	   seabream)	   PPARa1	   (not	   submitted	   to	   database),	   PPARa2	  (AAT85613),	  PPARb	  (AAT85615),	  PPARg	  (AAT85618);	  (6)	  Pleuronectes	  
platessa	   (European	   plaice)	   PPARa2	   (CAD62447),	   PPARb	   (CAD62448),	  PPARg	   (CAB51618);	   (7)	   Danio	   rerio	   (zebrafish)	   PPARaa	  (NP_001154805),	   PPARab	   (NP_001096037),	   PPARba	   (XP_699900),	  PPARbb	   (NP_571543),	   PPARg	   (NP_571542);	   (8)	   Salmon	   salar	   (Atlantic	  Salmon)	   PPARa1a	   (PPARa,	   NP_001117032),	   PPARa1b	   (PPARaL,	  XP_014025332),	   PPARb1a	   (Q1XE69_SALSA),	   PPARb1b	  (Q1XE68_SALSA),	   PPARb2a	   (NP_001117031),	   PPARb2b	  (XP_014002724),	   PPARg	   (XP_014000887),	   PPARgL	   (not	   submitted	   to	  database).	  ........................................................................................................................	  177	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Figure	  6-­‐3	  Phylogenetic	   tree	   for	   the	   ligand-­‐binding	  domain	  (LBD)	  of	  PPARs	  from	  diverse	  species.	  The	  numbers	  represent	   the	   frequencies	  (%)	  with	  which	   the	   tree	  was	   generated	  using	  maximum	   likelihood	  method	  with	  MEGA	  7	  software.	  the	  tree	  topology	  presented	  was	  replicated	  after	  1,000	  replications.	  Receptor	  sequences	  used	  were:	   (1)	  Gallus	  gallus	   (chicken)	  PPARa	  (NP_001001464),	  PPARb	  (NP_990059),	  PPARg	  (NP_001001460);	  (2)	  Homo	   sapiens	   (human)	   PPARa	   (NP_005027),	   PPARb	   (NP_006229),	  PPARg	   (NP_005028);	   (3)	   Xenopus	   laevis	   (African	   clawed	   frog)	   PPARa	  (P37232),	   PPARb	   (NP_001081310),	   PPARg	   (XP_018095920)	   (4)	   Esox	  
Lucius	   (Northern	   pike)	   PPARa1	   (XP_010882200),	   PPARa2	  (XP_010885449),	   PPARba	   (XP_010891645),	   PPARbb	   (XP_012993730),	  PPARga	   (XP_010872599),	   PPARgb	   (XP_010900626);	   (5)	   Sparus	  aurata	  (gilthead	   seabream)	   PPARa1	   (not	   submitted	   to	   database),	   PPARa2	  (AAT85613),	  PPARb	  (AAT85615),	  PPARg	  (AAT85618);	  (6)	  Pleuronectes	  
platessa	   (European	   plaice)	   PPARa2	   (CAD62447),	   PPARb	   (CAD62448),	  PPARg	   (CAB51618);	   (7)	   Danio	   rerio	   (zebrafish)	   PPARaa	  (NP_001154805),	   PPARab	   (NP_001096037),	   PPARba	   (XP_699900),	  PPARbb	   (NP_571543),	   PPARg	   (NP_571542);	   (8)	   Salmon	   salar	   (Atlantic	  Salmon)	   PPARa1a	   (PPARa,	   NP_001117032),	   PPARa1b	   (PPARaL,	  XP_014025332),	   PPARb1a	   (Q1XE69_SALSA),	   PPARb1b	  (Q1XE68_SALSA),	   PPARb2a	   (NP_001117031),	   PPARb2b	  (XP_014002724),	   PPARg	   (XP_014000887),	   PPARgL	   (not	   submitted	   to	  database).	  ........................................................................................................................	  179	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Figue	   6-­‐4	   Tissue	   expression	   profile	   of	   female	   Atlantic	   salmon	   PPARα	  isotypes.	   Relative	   expression	   of	   each	   PPAR	   was	   normalised	   to	   PPAR	  expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  individual	  salmon	  fish.	  ...............................................................................................	  181	  
Figure	   6-­‐5	   Tissue	   expression	   profile	   of	   female	   Atlantic	   salmon	   PPARγ	  isotypes.	   Relative	   expression	   of	   each	   PPAR	   was	   normalised	   to	   PPAR	  expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  individual	  salmon	  fish.	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  182	  
Figure	   6-­‐6	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   expression	   profile	   of	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   Atlantic	   salmon	   PPARβ1	  isotypes.	   Relative	   expression	   of	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   PPAR	   was	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   to	   PPAR	  expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  individual	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   Asterisk	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   represents	   PPAR	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  which	  differs	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Figure	   6-­‐7	   Tissue	   expression	   profile	   of	   female	   Atlantic	   salmon	   PPARβ2	  isotypes.	   Relative	   expression	   of	   each	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   was	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   PPAR	  expression	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   muscle.	   Data	   are	   the	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   SD	   of	   results	   from	   four	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   Asterisk	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   Gene	   expression	   of	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   Data	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   SD	   of	   results	   from	   four	  individual	   salmon	   fish.	   Asterisk	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LIST	  OF	  ABBREVIATIONS	  
AF	   	   Activation	  Function	   	  
AS	   	   Atlantic	  salmon	  
BHT	   	   Butylated	  hydroxytoluene	  
BLAST	  	   Basic	  Local	  Alignment	  Search	  Tool	  
bPEI	   	   Branched	  polyethylenimine	  
C1P	   	   Ceramide-­‐1-­‐phosphate	  
cDNA	   	   Complementary	  DNA	  
CHOL	   	   Cholesterol	  
CHSE-­‐214	   Chinook	  salmon	  Embryo	  214	  
C:M	   	   Chloroform	  :	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DBD	   	   DNA-­‐binding	  domain	  
DHA	   	   Docosahexaenoic	  acid	  
DPBS	   	   Dulbecco’s	  phosphate	  buffered	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EDTA	   	   Ethylenediaminetetraacetic	  acid	  
EMEM	  	   Eagle’s	  Minimum	  Essential	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EPA	   	   Eicosapentenoic	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FAMEs	  	   Fatty	  acid	  methyl	  esters	  
FBS	   	   Fetal	  bovine	  serum	  
FFA	   	   Free	  fatty	  acids	  
GC	   	   Gas	  chromatography-­‐flame	  ionisation	  detection	  
GlcCer	  	   Glucosylceramide	  
GlcT-­‐1	  	   Glucosylceramide	  synthase	  
HPTLC	  	   High-­‐performance	  thin-­‐layer	  chromatography	  
LB	   	   Luria-­‐Bertani	  
LBD	   	   Ligand-­‐binding	  domain	  
LC-­‐MS	  	   Liquid	  chromatography-­‐mass	  spectrometry	  
LPC	   	   Lysophosphatidylcholine	  
OEA	   	   Oleoylethanolamide	  
OFN	   	   Oxygen-­‐free	  nitrogen	  
PC	   	   Phosphatidylcholine	  
PE	   	   Phosphatidylethanolamine	  
pEGFP	  	   Enhanced	  green	  fluorescent	  protein	  plasmid	  
PPAR	   	   Peroxisome	  Proliferator-­‐Activated	  Receptor	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PPRE	   	   Peroxisome	  Proliferator-­‐Response	  Element	  
PUFA	   	   Poly	  unsaturated	  fatty	  acids	  
qPCR	   	   Quantitative	  polymerase	  chain	  reaction	  
RT-­‐PCR	   Reverse	  Transcription	  Polymerase	  Chain	  Reaction	  
RXR	   	   Retinoid	  X	  receptor	  
S1P	   	   Sphingosine-­‐1-­‐phosphate	  
SE	   	   Sterol	  esters	  
SF	   	   Solvent	  front	  
SM	   	   Sphingomyelin	  
TAE	   	   TRIS/acetate/EDTA	  
TAG	   	   Triacylglycerols	  
TL	   	   Total	  lipid	  
TLC	   	   Thin-­‐layer	  chromatography	  
UAS	   	   Upstream	  Activation	  Sequence	  
UNK1	   	   Unknown	  polar	  lipid	  
UNK2	   	   Unknown	  neutral	  lipid	  
WY-­‐14,643	   4-­‐Chloro-­‐6-­‐(2,3-­‐xylodino)-­‐2-­‐pyrimidinylthioacetic	  acid	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1 General	  Introduction	  
 Current	  status	  of	  aquaculture	  1.1
While	   fish	   production	   continues	   to	   outpace	   the	   global	   growth	   population,	  finfish	   aquaculture	   remains	   as	   one	   of	   the	   fastest-­‐growing	   food	   producing	  sectors	  (FAO,	  2017).	   In	  general,	   the	   larger	  aquaculture	  sector	  now	  provides	  almost	  50	  %	  of	  all	   fish	  and	  seafood	   for	  human	  consumption.	  The	  growth	   in	  finfish	  aquaculture	  is	  to	  a	  large	  extent	  dependent	  on	  the	  use	  of	  artificial	  diets	  and	   feeds	   which	   are	   developed	   and	   formulated	   to	   meet	   the	   essential	  requirements	   that	   include	   amino	   acids,	   fatty	   acids,	   vitamins	   and	   minerals,	  and	  provide	  macronutrients,	  namely,	  protein,	  lipid,	  carbohydrate,	  in	  order	  to	  provide	   energy	   to	   optimize	   growth.	   Hence,	   the	   understanding	   of	   fish	  nutrition,	   including	   lipid	   and	   fatty	   acid	   metabolism	   and	   its	   regulation,	   is	  critical	  in	  order	  to	  satisfy	  the	  requirements	  of	  finfish	  aquaculture	  (Leaver	  et	  
al.,	  2008).	  	  
1.1.1 Use	  of	  lipids	  and	  fatty	  acids	  in	  aquaculture	  feeds	  
Lipids	   and	   fatty	   acids,	   besides,	   proteins,	   are	  major	  macronutrients	   for	   fish	  (Sargent	  et	  al.,	  2002).	  Fish	  do	  not	  utilize	  carbohydrates	  efficiently,	  probably	  because	   they	   are	  not	   large	   components	   of	   their	   diets	   and	   glycogen	  used	   to	  meet	   short-­‐term	   energy	   demands	   is	   a	   product	   of	   gluconeogenesis.	   Dietary	  lipids	   and	   fatty	   acids	   in	   fish	   are	   used	   to	   synthesize	   new	   cell	  membranes/flesh,	   oxidized	   to	   provide	   energy	   or	   are	   stored	   in	   adipose	   or	  other	  tissues	  (Tocher,	  2003).	  Thus,	  it	  is	  important	  that	  the	  lipid	  content	  and	  fatty	   acid	   composition	   of	   feeds	   are	   optimized	   to	   achieve	   high	   growth	   rates	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whilst	   maintaining	   health	   and	   nutritional	   benefits	   of	   fish	   for	   human	  consumption	  (Sargent	  et	  al.,	  2002;	  Tocher,	  2003).	  
Because	  lipids	  are	  high-­‐energy	  nutrients,	  a	  recent	  trend	  in	  finfish	  aquaculture	  feeds	   is	   the	  utilization	  of	  higher	   levels	  of	  dietary	   lipid	   to	  partially	  spare	  (or	  substitute	   for)	   protein	   (Hemre	   and	   Sandnes,	   1999).	   Although	   increasing	  dietary	  lipid	  is	  widely	  accepted	  as	  it	  can	  help	  reduce	  the	  high	  costs	  of	  diets	  by	  partially	  sparing	  protein	  in	  feed,	  its	  effectiveness	  still	  remains	  unclear	  for	  any	  fish	   (Company	   et	   al.,	   1999).	   The	   use	   of	   lipid	   has	   now	   been	   maximized	   in	  dietary	   formulations	   due	   to	   commercial	   pressure	   to	   increase	   growth	   rates,	  and,	  at	  the	  same	  time,	  to	  reduce	  production	  times	  and	  as	  a	  consequence	  can	  lead	   to	  excess	  adiposity	   (or	   fat)	   in	   the	  carcass	   (Hemre	  and	  Sandnes,	  1999).	  	  This	  does	  not	  only	  affect	  the	  fish	  health	  and	  welfare,	  but	  also	  represents	  an	  economic	   waste	   of	   valuable	   feed	   that	   might	   otherwise	   be	   channelled	   into	  overall	  growth.	  	  
 Lipids	  1.2
Lipids	  are	  described	  as	  biological	  substances	  that	  are	  hydrophobic	  in	  nature	  and	  are	  often	  soluble	  in	  organic	  solvents,	  such	  as	  chloroform,	  hydrocarbons	  or	  alcohols,	  represent	  a	  large	  group	  of	  chemically	  heterogeneous	  compounds	  with	  long-­‐chain	  fatty	  acids	  (Smith,	  2000).	  Lipids	  can	  be	  divided	  into	  “simple”	  and	  “complex”	  groups	  based	  on	   their	  molecular	  structure;	   simple	   lipids	  are	  lipids	  that	  yield	  at	  most	  two	  products	  on	  hydrolysis,	  for	  example,	  fatty	  acids,	  sterols	  and	  acylglycerols,	  and	  complex	  lipids	  are	  those	  that	  yield	  one	  or	  more	  products	   on	   hydrolysis,	   such	   as,	   glycerophospholipids	   and	  glycosphingolipids	  (Fahy	  et	  al.,	  2005).	  Lipids	  can	  also	  be	  categorised	  by	  their	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composition,	  for	  example,	  lipids	  that	  contain	  glycerol	  are	  called	  glycerolipids,	  lipids	   containing	   phosphate	   group	   are	   called	   phospholipids,	   lipids	   that	  consist	  of	  carbohydrates	  are	  glycolipids,	  lipids	  with	  sulphur-­‐containing	  group	  are	   named	   sulpholipids,	   lipids	   containing	   sphingosine	   or	   other	   long-­‐chain	  bases	  are	  called	  sphingolipids	  and	  ether	  lipids	  are	  lipids	  with	  long-­‐chain	  alkyl	  moieties	   in	  addition	  to	  having	  ether	  bonds	   to	   fatty	  acids.	  Lipids	  can	  also	  be	  classified	   according	   to	   their	   chemical	   functional	   backbone	   as	   polyketides,	  acylglycerols,	  sphingolipids,	  prenols	  and	  saccharolipids	  (Fahy	  et	  al.,	  2005).	  In	  animals,	  including	  fish,	  lipids	  can	  be	  classified	  into	  two	  groups,	  according	  to	  their	   solubility.	   Neutral	   lipids	   include	   triacylglycerols	   (TAG),	   wax	   esters,	  sterols,	   steryl	   esters	   and	   free	   fatty	   acids	   and	   polar	   lipids	   include	  phosphoglycerides,	  sphingolipids,	  sulpholipids	  and	  glycolipids.	  	  
1.2.1 Polar	  lipids	  or	  phospholipids	  
Phospholipids	   are	   abundant	   in	   all	   biological	   membranes.	   In	   general,	   a	  structure	  of	  a	  phospholipid	  molecule	  consists	  of	  two	  hydrophobic	  fatty	  acid	  “tails”	  and	  a	  hydrophilic	  “head”	  that	  consists	  of	  a	  phosphate	  group	  modified	  by	  an	  alcohol	  and	  a	  platform	  on	  which	  phospholipids	  are	  built,	  for	  example,	  a	  glycerol	   (a	   3-­‐carbon	   alcohol)	   or	   a	   sphingosine	   (a	   more	   complex	   alcohol).	  Phospholipids	  that	  derived	  from	  glycerol	  are	  called	  phosphoglycerides	  (Berg	  
et	  al.,	  2002).	  	   	  





Figure	  1-­‐1	  Schematic	  structure	  of	  phosphoglyceride	  
The	  simplest	  phosphoglyceride,	  phosphatidate	  (diacylglycerol	  3-­‐phosphate),	  is	  formed	  through	  esterification	  between	  the	  C-­‐1	  and	  C-­‐2	  hydroxyl	  groups	  of	  glycerol	   and	   the	   carboxyl	   groups	   of	   the	   two	   fatty	   acid	   chains	   and	  esterification	   between	   the	   C-­‐3	   hydroxyl	   group	   of	   glycerol	   and	   phosphoric	  acid	   (Berg	   et	  al.,	   2002).	   Although	   only	   small	   amounts	   of	   phosphatidate	   are	  present	  in	  membranes,	  it	  is	  an	  intermediate	  key	  molecule	  in	  the	  formation	  of	  the	   other	   phosphoglycerides	   formed	   through	   esterification	   between	   the	  phosphate	   group	   of	   phosphatidate	   and	   the	   hydroxyl	   group	   of	   the	   alcohols,	  such	   as,	   choline,	   serine,	   inositol	   and	   ethanolamine,	   to	   form	  phosphatidylcholine,	   phosphatidylserine,	   phosphatidylinositol	   and	  phosphatidylethanolamine,	  respectively.	  	  
Sphingomyelin	   is	   a	   phospholipid	   that	   is	   also	   found	   in	  membranes,	   derived	  from	  the	  more	  complex	  alcohol,	  sphingosine	  that	  consists	  of	  an	  amino	  alcohol	  with	  a	  long,	  unsaturated	  hydrocarbon	  chain.	  In	  sphingomyelin,	  a	  fatty	  acid	  is	  linked	   through	   an	   amide	   bond	   to	   the	   amino	   group	   of	   the	   sphingosine	  backbone	  (Berg	  et	  al.,	  2002).	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1.2.2 Neutral	  lipids	  
Neutral	  lipids	  are	  compounds	  that	  are	  hydrophobic	  in	  nature	  and	  are	  found	  in	   all	   cells	   with	   critical	   roles	   from	   energy	   storage	   to	   signal	   transduction.	  Neutral	   lipids	   mainly	   include	   triacylglycerols,	   diacylglycerols,	  monoacylglycerols,	   cholesterol	   esters	   and	   cholesterol.	   TAGs	   consist	   of	   a	  glycerol	  moiety	  with	  each	  hydroxyl	  group	  esterified	  to	  a	   fatty	  acid	  (Christie	  and	  Han,	   2010),	  whereas	   diacylglycerols	   and	  monoacylglycerols,	  which	   are	  rarely	   present	   in	   animal	   tissues,	   contain	   two	  moles	   and	   one	   mole	   of	   fatty	  acids	  per	  mole	  of	  glycerol,	  respectively	  (Christie	  and	  Han,	  2010).	  Cholesterol,	  on	   the	  other	  hand,	   is	   the	  main	   sterol	   present	   in	   animal	   tissues	  with	   a	   vital	  role	   in	  maintaining	  membrane	   fluidity	   and	   cholesterol	   esters	   are	   a	   storage	  form	  of	  cholesterol	  found	  in	  lipid	  bodies	  of	  all	  cells.	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 Peroxisome	  proliferator-­‐activated	  receptors	  (PPARs)	  1.3
1.3.1 Origin	  of	  PPARs	  and	  their	  structure	  
Peroxisomes	   are	   small,	   membrane-­‐enclosed	   organelles	   found	   in	   all	  eukaryotic	  cells.	  They	  contain	  a	  variety	  of	  enzymes	  that	  are	  mostly	  involved	  in	   lipid	   homeostasis	   including	   the	   degradation	   of	   fatty	   acids	   and	   their	  derivatives	  through	  β-­‐oxidation	  (Reddy	  and	  Mannaerts,	  1994).	  Peroxisomes	  in	   mice	   respond	   to	   treatment	   with	   certain	   compounds	   called	   peroxisome	  proliferators	  by	  increasing	  in	  size	  and	  number	  and	  it	  was	  discovered	  in	  1990	  that	   these	   peroxisome	   proliferators	   activate	   a	   nuclear	   receptor	   known	   as	  peroxisome	   proliferator-­‐activated	   receptor	   (PPAR,	   later	   PPARα)	   (Issemann	  and	  Green,	  1990).	  	  
Peroxisome	   proliferator-­‐activated	   receptors	   (PPARs)	   are	   ligand-­‐inducible	  transcription	   factors	   that	   belong	   to	   the	   nuclear	   hormone	   receptor	  superfamily	   (Michalik	   and	   Wahli,	   1999).	   The	   isolation	   of	   PPARs	   was	  originally	  performed	  in	  humans,	  rodents	  and	  amphibians,	  and	  they	  have	  now	  been	   identified	   as	   receptors	   that	   are	   critical	   in	   the	   regulation	   of	   lipid	   and	  energy	  homeostasis.	  PPARs	  occur	  in	  three	  different	  isotypes,	  namely,	  PPARα	  (the	   original	   receptor	   responsible	   for	   peroxisome	   proliferation	   in	   mice),	  PPARβ	   (also	   named	   PPARδ	   in	   mouse	   and	   NUC1	   in	   human)	   and	   PPARγ	  (Michalik	  and	  Wahli,	  1999).	  In	  mammals,	  the	  latter	  consists	  of	  two	  different	  proteins,	  γ1	  and	  γ2,	  as	  a	  result	  of	  differential	  splicing	  of	  the	  same	  gene	  (Zhu	  
et	   al.,	   1995).	   Each	   of	   these	   receptors	   has	   a	   specific	   pattern	   of	   tissue	  expression.	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Like	  other	  members	  of	  the	  superfamily,	  PPARs	  have	  six	  structural	  regions	  (A-­‐F)	   in	   four	   functional	   domains,	   A/B,	   C,	   D	   and	   E/F	   (Schoonjans	   et	   al.,	   1996;	  Michalik	  &	  Wahli,	  1999;	  Vamecq	  &	  Latruffe,	  1999).	  These	  receptors	  contain	  two	  activating	  functions,	  that	  is,	  the	  activating	  function	  1	  (AF-­‐1)	  is	   localized	  in	  the	  poorly	  conserved	  A/B	  domain	  whilst	  the	  activating	  function	  2	  (AF-­‐2),	  which	  has	  an	  amphipathic	  α-­‐helical	   ligand-­‐dependent	  activating	   function,	   is	  localized	   in	   the	   C-­‐terminal	   part	   of	   E-­‐domain	   (Schoonjans	   et	  al.,	   1996).	   The	  highly	  conserved	  central	  DNA-­‐binding	  domain	  (C	  domain)	  contains	  about	  66	  amino	   acids	   and	   it	   is	   stabilized	   by	   zinc	   atoms	   that	   bind	   to	   four	   invariant	  cysteine	  residues	  (Figure	  1-­‐2),	  giving	  these	  zinc	  finger-­‐like	  complexes	  an	  α-­‐helical	  structure	  for	  DNA-­‐binding	  (Schoonjans	  et	  al.,	  1996;	  Michalik	  &	  Wahli,	  1999;	   Vamecq	   &	   Latruffe,	   1999).	   The	   DNA	   binding	   domain	   contains	   two	  conserved	  sets	  of	  functionally	  important	  amino	  acids.	  The	  first	  conserved	  set,	  called	  the	  P-­‐box	  is	  composed	  of	  amino	  acids	  (illustrated	  by	  circles	  in	  Figure	  1-­‐2)	  and	  two	  cysteine	  residues,	  and	  it	  determines	  specific	  contacts	  between	  receptor	  and	  DNA.	  As	  for	  the	  second	  conserved	  set,	  the	  D-­‐box,	  is	  composed	  of	  amino	  acids	  residues	  (illustrated	  by	  squares	  in	  Figure	  1-­‐2)	  and	  it	  is	  believed	  to	  be	  involved	  in	  protein-­‐protein	  interactions,	  such	  as	  receptor	  dimerization	  (Schoonjans	  et	  al.,	  1996).	  In	  PPARs,	  the	  D-­‐box	  has	  three	  amino	  acids	  and	  not	  five	   amino	   acids,	   and	   this	   distinguishes	   PPARs	   from	   other	  members	   of	   the	  nuclear	   hormone	   receptor	   family.	   The	  D-­‐domain	   is	   a	   variable	   hinge	   region	  that	   allows	   conformational	   changes	   of	   the	   protein.	   The	   E/F	   domain,	   also	  known	   as	   the	   ligand-­‐binding	   domain	   (LBD),	   is	   a	   multifunctional	   domain.	  Besides	  ligand	  binding,	  it	  is	  also	  responsible	  in	  transducing	  hormonal	  signals	  into	   transcriptional	   activation,	   involved	   in	   nuclear	   localization	   and	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dimerization	  (Schoonjans	  et	  al.,	  1996).	  The	  dimerization	  region	  is	  restricted	  in	  a	  region	  of	  nine	  heptad	  repeats	  (indicated	  by	  black	  stripes	  in	  Figure	  1-­‐2).	  	  
	   	  
Figure	   1-­‐2	   Functional	   domains	   of	   peroxisome	   proliferator-­‐activated	  
receptors	  (PPARs)	  (adopted	  from	  Schoonjans	  et	  al.,	  1996)	  
In	   order	   for	   DNA	   binding	   to	   take	   place,	   PPAR	   is	   required	   to	   form	   a	  heterodimer	   with	   9-­‐cis	   retinoid	   X	   receptor	   (RXR)	   to	   form	   a	   complex,	   by	  interacting	  with	  a	  peroxisome	  proliferator	  responsive	  element	  (PPRE)	  with	  a	  consensus	   sequence	   of	   5’-­‐AACT	   AGGNCA	   A	   AGGTCA-­‐3’,	   located	   in	   the	  promoter	  of	  PPAR	   target	   genes	   (Ijpenberg	  et	  al.,	   1997;	  Michalik	   and	  Wahli,	  1999;	   Vamecq	   and	   Latruffe,	   1999).	   The	   heterodimer	   can	   interact	  with	   and	  become	  activated	  either	  by	  PPAR	  ligands	  or	  by	  RXR	  ligands	  (Hihi	  et	  al.,	  2002)	  and	   this	   in	   turn,	   induces	  conformational	   changes	  allowing	   the	  co-­‐activators	  to	   become	   recruited	   and	   the	   co-­‐repressors	   to	   be	   released,	   consequently	  stimulating	   the	   transcription	   of	   target	   genes	   that	   are	   implicated	   in	   various	  aspects	  of	  lipid	  and	  energy	  metabolism.	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1.3.2 Discovery	  of	  piscine	  PPARs	  and	  their	  structure	  
Whilst	  the	  information	  of	  mammalian	  PPAR	  is	  abundant,	  reports	  for	  PPAR	  in	  teleost	   fish	   are	   very	   limited.	   PPARs	   in	   teleost	   fish	   have	   only	   been	   recently	  discovered	  and	  this	  include	  the	  zebrafish	  (Danio	  rerio)	  (Escriva	  et	  al.,	  1997),	  the	  Atlantic	  salmon	  (Salmo	  salar)	  (Ruyter	  et	  al.,	  1997;	  Andersen	  et	  al.,	  2000),	  the	  plaice	  (Pleuronectes	  platessa)	  (Leaver	  et	  al.,	  1998)	  and	  turbot	  (Scothalmus	  
maximus)	   (Robinson-­‐Rechavi	   et	   al.,	   2001).	   PPARs	   in	   teleost	   were	   initially	  found	   being	   expressed	   in	   the	   liver	   of	   Atlantic	   salmon	   (Ruyter	   et	   al.,	   1997;	  Andersen	  et	  al.,	   2000)	   and	   the	   first	   complete	   sequence	   and	   functional	   data	  for	  the	  three	  PPAR	  isotypes	  was	  reported	  on	  plaice	  and	  sea	  bream	  (Leaver	  et	  
al.,	   2005).	   A	   number	   of	   studies	   have	   been	   carried	   out	   to	   investigate	   the	  structural	   features	   of	   PPARs	   in	   teleost	   fish	   and	   mammals.	   In	   general,	   fish	  PPAR	  genes	  are	  up	  to	  ten	  times	  smaller	  than	  their	  mammalian	  counterparts,	  as	   observed	   in	   plaice	   and	   sea	   bream,	   due	   to	   the	   presence	   of	  much	   smaller	  introns	  (non-­‐coding	  sections	  of	  DNA)	  in	  fish	  genes	  (Leaver	  et	  al.,	  2005).	  	  	  
1.3.2.1 C-­‐Domain	  or	  DNA-­‐binding	  domain	  (DBD)	  
Amino	  acid	  sequences	  in	  PPAR	  proteins	  characterized	  in	  the	  Atlantic	  salmon,	  sea	   bass	   (Dicentrarchus	   labrax),	   sea	   bream	   (Sparus	   aurata)	   and	   plaice	  showed	   ≥90	   %	   sequence	   identity	   with	   the	   correspondent	   sequences	   in	  humans	  within	   the	  core	  of	   the	  C-­‐domain	  or	  DNA-­‐binding	  domain	  (DBD)	   i.e.	  the	  two	  zinc	  fingers	  (Andersen	  et	  al.,	  2000;	  Boukouvala	  et	  al.,	  2004;	  Leaver	  et	  
al.,	  2005).	  Moreover,	  the	  DBD	  of	  salmon	  PPARγ	  shares	  78	  %	  (out	  of	  40	  amino	  acid	   residues)	   sequence	   identity	   with	   rodents	   (Ruyter	   et	   al.,	   1997).	   This	  proves	   that	   the	  DNA-­‐binding	  properties	  of	   the	  DBD	  of	   fish	  and	  mammalian	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PPARs	   are	   conserved,	   indicating	   that	   they	   may	   require	   very	   similar	  promoters	  for	  dependent	  transactivation	  activation	  (Leaver	  et	  al.,	  2005).	  It	  is	  important	   to	   note	   that	   Atlantic	   salmon	   and	   plaice	   PPARγs	   share	   the	  characteristic	   feature	   of	   PPAR,	   having	   three	   amino	   acids	   between	   the	   two	  cysteines	  of	  the	  second	  zinc	  fingers	  in	  the	  DNA	  binding	  domain	  (Ruyter	  et	  al.,	  1997;	  Leaver	  et	  al.,	  1998)	  instead	  of	  five	  amino	  acids,	  as	  observed	  in	  all	  other	  members	  of	  nuclear	   receptor	   superfamily	   (Forman	  and	  Samuels,	  1990).	  On	  the	   other	   hand,	   it	   was	   found	   that	   the	   DBD	   of	   Atlantic	   salmon	   PPARγ	   only	  shares	  53%	  sequence	  identity	  with	  the	  jawless	  lamprey	  (Escriva	  et	  al.,	  1997),	  indicating	  that	  the	  DNA-­‐binding	  properties	  of	  PPARs	  from	  representatives	  of	  ancestral	  fishes	  may	  have	  diverged	  somewhat.	  
1.3.2.2 E/F	  Domain	  or	  ligand-­‐binding	  domain	  (LBD)	  
The	   LBDs	   of	   piscine	   PPARs	   also	   have	   significant	   levels	   of	   identity	   to	  mammalian	   PPARs,	   although	   there	   are	   insertions	   of	   an	   extra	   20-­‐	   and	   25-­‐amino	  acid	  residues	  in	  sea	  bass	  PPARα	  and	  PPARγ,	  respectively	  at	  the	  amino	  terminus	   of	   LBD	   (Boukouvala	   et	   al.,	   2004),	   while	   in	   sea	   bream	   and	   plaice	  PPARα,	   there	   is	   an	   insertion	  of	   an	   extra	   21	   residues	   in	   each	   receptor	   gene	  (Leaver	   et	   al.,	   2005),	   and	   insertions	   of	   an	   extra	   23-­‐	   and	   35-­‐amino	   acid	  residues	  in	  the	  sea	  bass	  and	  plaice	  PPARγ,	  respectively.	  These	  insertions	  may	  have	  resulted	  from	  the	  different	  number	  of	  exons	  encoded	  in	  fish	  and	  human	  PPARα	   and	   PPARγ,	   that	   is	   three	   exons	   in	   sea	   bass	   receptor	   proteins	   as	  opposed	  to	  two	  exons	  in	  humans.	  Thus,	  this	  structure	  is	  believed	  to	  be	  much	  larger	  and	  more	  hydrophilic	  in	  sea	  bream	  and	  plaice	  PPARα	  and	  PPARγ	  than	  in	  its	  mammalian	  counterpart.	  Nevertheless,	  significant	  identity	  (i.e.	  >70	  %)	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between	   sea	   bream/plaice	   and	   human	  PPARα	   and	   PPARγ	  was	   observed	   in	  this	  domain	  (Leaver	  et	  al.,	  2005).	  Moreover,	  the	  LBDs	  of	  sea	  bass	  PPARα	  and	  PPARγ	   isotypes	   share	   67	   %	   and	   66	   %	   identity,	   respectively,	   with	   the	  corresponding	  sequences	  in	  humans	  (Boukouvala	  et	  al.,	  2004)	  and	  part	  of	  D-­‐domain	   and	   the	   LBD	   of	   PPARα	   in	   brown	   trout	   showed	   82	   %	   and	   78	   %	  sequence	   identity	   in	   humans	   and	   rodents,	   respectively	   (Batista-­‐Pinto	   et	  al.,	  2005).	   In	   contrast,	   the	   PPARα	   fragments	   in	   brown	   trout	   showed	   relatively	  higher	  levels	  of	  identity	  with	  corresponding	  sequences	  in	  goldfish	  (Carassius	  
auratus)	  and	  plaice	   (90	  %	  and	  87	  %,	  respectively),	   showing	  PPARα	   gene	   is	  much	   more	   similar	   among	   fish	   species	   in	   comparison	   with	   mammalian	  PPARα,	  as	  the	  number	  of	  amino	  acid	  residues	  in	  the	  deduced	  sequence	  of	  the	  protein	  varies	  only	  by	  one	  between	  fish	  and	  mammalian	  protein.	  It	  was	  also	  revealed	   that	   the	   LBD	  of	   PPARγ	   in	  Atlantic	   salmon	   shares	   63	  %	   and	   78	  %	  sequence	  identity	  with	  human	  and	  rodent	  PPARγs,	  respectively	  (Ruyter	  et	  al.,	  1997;	  Andersen	  et	  al.,	  2000).	  	  
Evidently,	  PPARβ	  gene	  shows	  great	  homogeneity	  among	  fish	  species	  such	  as	  brown	  trout,	  plaice,	  and	  goldfish,	  and	  mammals	  as	  they	  have	  equal	  number	  of	  amino	  acid	  residues	  in	  the	  deduced	  sequence	  of	  the	  protein	  (Batista-­‐Pinto	  et	  
al.,	  2009).	  The	  fragments	  of	  PPARβ	  in	  the	  D-­‐domain	  and	  LBD	  in	  brown	  trout	  showed	  high	  levels	  of	  sequence	  identity	  with	  other	  fish	  species,	  i.e.	  the	  plaice	  (94	  %)	  and	  Atlantic	  salmon	  (84	  %).	  They	  also	  showed	  high	  levels	  of	  sequence	  identity	   with	   the	   correspondent	   PPARβ	   sequences	   of	   humans	   and	   rodents	  (i.e.	  84	  %	  and	  82	  %,	  respectively.	   It	  was	  observed	  that	  although	  the	  LBD	  in	  sea	  bass	  PPARβ	  which	  also	  contains	  three	  exons,	  containing	  equal	  number	  of	  amino	  acid	  residues	  as	  its	  human	  counterpart	  with	  only	  two	  exons,	  thus	  also	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sharing	  relatively	  higher	  identity	  (i.e.	  78	  %)	  with	  human	  PPARβ	  (Boukouvala	  
et	  al.,	  2004).	  	  
1.3.2.3 A/B	  Domain	  
As	   for	   the	   A/B-­‐domain,	   being	   the	   least	   conserved	   region	   in	   PPAR,	   is	  considerably	   longer	   in	   fish	   PPARs	   such	   as	   sea	   bass,	   sea	   bream	   and	   plaice,	  than	   that	   of	   mammalian	   (Boukouvala	   et	   al.,	   2004;	   Leaver	   et	   al.,	   2005),	  indicating	   that	   this	   domain	   has	   the	   lowest	   identity	   with	   its	   human	  counterpart.	  It	  was	  observed	  that	  PPARs	  in	  the	  fish	  species	  and	  mammals	  are	  of	   negative	   net	   charge.	   The	   A/B	   domain	   of	   mammalian	   PPARβ	   is	   only	   42	  amino	  acid	  residues	  long	  and	  is	  negatively	  charged	  due	  to	  the	  presence	  of	  13	  glutamate	  residues.	  42	  %	  of	  the	  residues	  and	  the	  net	  charged	  of	  this	  domain	  is	  maintained	  in	  sea	  bream	  PPARβ,	  whereas	  39	  %	  of	  the	  residues	  is	  found	  in	  plaice	   PPARβ	   and	   the	   net	   charge	   is	   less	   negative	   (Leaver	   et	   al.,	   2005),	  indicating	  that	  teleost	  and	  mammalian	  PPARs	  have	  low	  similarity	  and	  this	  is	  also	   true	   for	   salmon	   PPARγ	   (Andersen	   et	   al.,	   2000).	   This	   gives	   an	   overall	  amino	  acid	  sequence	  identity	  of	  43-­‐48	  %	  to	  mammalian	  PPARγ.	  
1.3.2.4 D-­‐Domain	  
The	  D-­‐domains	  in	  sea	  bream/plaice	  and	  mammalian	  PPARβ	  and	  PPARγ	  have	  the	  same	  number	  of	  amino	  acid	  residues	  i.e.	  68	  and	  67	  amino	  acids	  residues,	  respectively,	   and,	   are	   highly	   conserved,	   whereas	   PPARα	   in	   sea	   bream	   and	  plaice	   possess	   a	   D-­‐domain	   that	   is	   shorter	   by	   one	   residue	   when	   compared	  with	   mammals	   (i.e.	   67	   versus	   68	   amino	   acids)	   (Leaver	   et	   al.,	   2005).	  Interestingly,	   according	   to	   Batista-­‐Pinto	   et	  al.	   (2005),	   the	   D-­‐domain	   of	   fish	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PPARγ	  shows	  high	  variability,	  not	  only	  in	  sequence,	  but	  also	  in	  length.	  PPARγ	  in	  brown	  trout	  was	  observed	  to	  share	  97	  %	  sequence	  identity	  with	  PPARγ	  in	  Atlantic	   salmon,	   while	   sharing	   only	   46	   %	   with	   plaice	   and	   <52	   %	   with	  mammals.	   The	   lower	   identity	   between	   the	   salmonids	   and	   plaice	   PPARγs	   is	  due	   to	   the	   large	   insertion	  of	   amino	  acid	   residues	   in	   the	  D-­‐domain	   in	  plaice	  PPARγ	   that	   is	   absent	   in	   the	   salmonids,	   while	   the	   PPARγ	   of	   the	   salmonids	  have	  a	  10	  amino	  acid	  segment	  that	  is	  not	  present	  in	  mammals	  (Batista-­‐Pinto	  
et	  al.,	  2005).	  	  
1.3.3 Tissue-­‐specific	  distribution	  of	  piscine	  PPARs	  
Recently,	  attention	  has	  been	  paid	  on	  the	  distribution	  patterns	  and	  expression	  of	   PPARs	   in	   tissues	   and	   cells	   of	   different	   organs	   in	   the	   Atlantic	   salmon	  (Ruyter	  et	  al.,	  1997;	  Andersen	  et	  al.,	  2000),	  the	  zebrafish	  (Ibabe	  et	  al.,	  2002;	  2005),	  gray	  mullet	  (Mugil	  cephalus)	  (Ibabe	  et	  al.,	  2004),	  sea	  bass	  (Boukouvala	  
et	  al.,	  2004),	  sea	  bream,	  plaice	  (Leaver	  et	  al.,	  2005)	  and	  brown	  trout	  (Salmo	  
trutta	   f	  fario)	  (Batista-­‐Pinto	  et	  al.,	  2005).	  Ibabe	  et	  al.	  (2002)	  had	  carried	  out	  the	   first	   analysis	   on	   the	   tissue	   and	   cellular	   distribution	   of	   fish	   PPAR	   on	  zebrafish	   that	   was	   achieved	   by	   performing	   western	   blots	   and	  immunohistochemistry	   using	   commercially	   available	   antibodies	   against	  PPARα,	  PPARβ	  and	  PPARγ.	  Similar	  analyses	  were	  done	  with	  sea	  bass	  and	  sea	  bream	  using	  RNase	  protection	  assay	   (Boukouvala	  et	  al.,	  2004;	  Leaver	  et	  al.,	  2005),	  brown	   trout	  by	  conducting	  both	  semi-­‐quantitative	  RT-­‐PCR	  and	  real-­‐time	   RT-­‐PCR	   (Batista-­‐Pinto,	   2009)	   and	   the	   plaice	   by	   Northern	   blotting	  (Leaver	   et	   al.,	   2005).	   These	   analyses	   of	   tissue	   distribution	   of	   the	   PPAR	  isotypes	  are	  crucial	  towards	  understanding	  of	  their	  physiological	  roles.	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1.3.3.1 PPARβ 	  
In	   mammals,	   a	   single	   gene	   for	   PPARβ	   encodes	   a	   transcription	   factor.	  However,	   teleosts	   have	   varying	   numbers	   of	   PPARβ	   genes,	   from	   one	   in	   the	  pufferfishes,	   Takifugu	   rubripes	   and	   Tetraodon	   nigroviridis,	   plaice	   and	   sea	  bream	   (Leaver	   et	  al.,	   2005),	   and	   two	   in	   zebrafish	   (Robinson-­‐Rechavi	   et	  al.,	  2001).	   More	   recently,	   the	   sequencing	   of	   Atlantic	   salmon	   genome	   revealed	  that	   there	   are	   four	   PPARβ	   genes	   termed	   termed	   ssPPARβ1A,	   ssPPARβ1B,	  ssPPARβ2A	   and	   ssPPARβ2B,	   and	   at	   least	   two	   are	   functional	   PPARβ	   genes	  (Leaver	   et	   al.,	   2007).	   The	   presence	   of	   these	   four	   PPARβ	   genes	   in	   Atlantic	  salmon	   supports	   theory	   that	   salmonids	   may	   be	   derived	   from	   a	   relatively	  recent	   autotetraploidization	   event	   (Allendorf	   and	   Thorgaad,	   1984;	  Alexandrou	  et	  al.,	   2013)	   and	   that	   a	   previous	   genome	  duplication	  may	  have	  occurred	   in	   early	   evolution	   of	   ray-­‐finned	   fishes	   (Taylor	   et	   al.,	   2003).	   This	  event	  is	  supported	  by	  the	  recent	  comparative	  syntenic	  analyses	  of	  zebrafish	  and	  pufferfish	   genomes	   suggesting	   that	   genes	  may	  have	  been	   lost	   or	   being	  retained	   through	   the	   divergence	   of	   different	   lineages	   of	   fish,	   resulting	   in	  different	  gene	  numbers	  between	  these	  species	  (Woods	  et	  al.,	  2005).	  	  
Like	   its	   mammalian	   homolog,	   PPARβ	   being	   the	   most	   ubiquitous	   isotype,	  showed	  the	  strongest	  overall	  expression	  and	  is	  present	  in	  almost	  all	  tissues.	  Its	   widespread	   distribution	   was	   seen	   in	   fish	   species	   including	   sea	   bass	  (Boukouvala	   et	   al.,	   2004),	   zebrafish	   (Ibabe	   et	   al.,	   2002),	   sea	   bream,	   plaice	  (Leaver	   et	   al.,	   2005)	   and	   brown	   trout	   (Batista-­‐Pinto	   et	   al.,	   2005).	   This	  subtype	   is	   more	   expressed	   in	   the	   liver	   of	   these	   fishes.	   However,	   the	   two	  functional	  Atlantic	  salmon	  PPARβ	  subtypes	  were	  expressed	  differently,	  with	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PPARβ1A	  expressed	  more	  in	  liver	  and	  PPARβ2A	  in	  gill	  (Leaver	  et	  al.,	  2007).	  Nevertheless,	  this	  subtype	  showed	  the	  strongest	  overall	  expression	  in	  almost	  all	  tissues	  when	  compared	  to	  that	  of	  PPARα	  and	  PPARγ.	  
Because	  of	   its	  great	  homogeneity	  among	  species	  and	  abundance,	  the	  role	  of	  PPARβ	   is	   less	   well	   understood.	   However,	   various	   studies	   suggest	   that	   this	  receptor	   plays	   a	   general	   role	   in	   controlling	   lipid	   homeostasis	   in	   mammals	  (Wagner	   and	  Wagner,	   2010).	   It	   has	  been	   shown	   that	  PPARβ	   activates	   fatty	  acid	   oxidation	   in	   adipose	   tissues	   (Peters	   et	   al.,	   2000)	   and	   that	   it	   plays	   an	  important	  role	   in	  β-­‐oxidation	  as	   it	  directly	  controls	   lipid	  utilization	  through	  up-­‐regulation	   of	   genes	   and	   energy	   uncoupling	   in	   the	   skeletal	   muscle	   cells	  (Dressel	  et	  al.,	  2003).	  Besides	  functioning	  as	  a	  regulator	  in	  lipid	  metabolism,	  this	   receptor	   has	   significant	   roles	   in	   controlling	   cellular	   proliferation	   and	  differentiation	  (Burdick	  et	  al.,	  2006).	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1.3.3.2 PPARα 	  
PPARα	   is	   encoded	   by	   a	   single	   gene	   in	  mammals	   and	   this	   isotype	   is	   highly	  expressed	  in	  tissues	  that	  catabolize	  large	  amounts	  of	  fatty	  acids,	  such	  as	  liver,	  kidney,	  heart,	  skeletal	  muscle	  and	  adipose	  tissue	  (Lemberger	  et	  al.,	  1996).	  On	  the	   other	   hand,	   it	   was	   suggested	   that	   fish	   PPARs	   may	   exhibit	   two	   PPARα	  subtypes,	  termed	  PPARα1	  and	  PPARα2.	  The	  PPARα	  subtype	  cDNAs	  that	  have	  been	   characterized	   from	  sea	  bream,	   sea	  bass	   and	  plaice	   (Boukouvala	  et	  al.,	  2004;	  Leaver	  et	  al.,	  2005),	  appear	  to	  have	  high	  identity	  to	  mammalian	  PPARα.	  These	  proteins	  have	  been	  termed	  PPARα2	  in	  sea	  bream	  and	  plaice	  and	  they	  are	   highly	   expressed	   in	   liver	   and	   heart,	   showing	   that	   they	   are	   structurally	  and	  functionally	  similar	  to	  the	  mammalian	  PPARα	  (Leaver	  et	  al.,	  2005).	  As	  for	  PPARα1,	   this	   subtype	   was	   found	   closely	   related	   to	   PPARα	   present	   in	  genomes	   of	   pufferfish	   and	   zebrafish	   (Maglich	   et	   al.,	   2003).	   Although	   its	  functional	  characteristics	  are	  not	  yet	  known,	  there	  was	  a	  PPARα	  cDNA	  from	  Atlantic	  salmon	  that	  is	  evidently	  a	  homologue	  of	  the	  uncharacterised	  PPARα1	  from	   pufferfish	   and	   zebrafish	   (Leaver	   et	   al.,	   2005).	   It	   was	   suggested	   that	  since	  these	  two	  conserved	  PPARα	  subtypes	  are	  found	  in	  zebrafish,	  pufferfish	  (Leaver	   et	   al.,	   2005)	   sea	   bream,	   sea	   bass,	   and	   possibly	   salmonids,	   it	   is	  possible	   that	   the	   rest	   of	   teleost	   fish	   possess	   them	   too,	   phylogenetically	  (Leaver	   et	   al.	   2008).	   Thus,	   this	   would	   further	   imply	   that	   PPARα1	   and	  PPARα2	   (and	   mammalian	   PPARα)	   have	   different	   functions,	   though	   this	  hypothesis	  needs	  to	  be	  further	  justified.	  
In	  zebrafish,	  PPARα	  was	  expressed	  in	  liver	  with	  higher	  intensity	  than	  PPARβ	  (Ibabe	  et	  al,	  2002).	  This	  is	  in	  agreement	  with	  the	  expression	  intensity	  in	  gray	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mullet	  liver	  that	  PPARα	  was	  the	  strongly	  expressed	  isotype	  compared	  to	  the	  other	   two	   isotypes	   (Ibabe	   et	   al.,	   2004).	   	   PPARα	   was	   also	   mainly	   found	   in	  kidney,	   intestine	   and	   pancreas	   of	   zebrafish,	  while	   in	   sea	   bream,	   plaice	   and	  brown	  trout,	  PPARα	  is	  more	  expressed	  in	  heart	  and	  liver	  (Leaver	  et	  al.,	  2005;	  Batista-­‐Pinto	   et	   al.,	   2005).	   Interestingly,	   although	   this	   isotype	   is	   more	  expressed	  in	  the	  liver	  of	  brown	  trout,	  it	  is	  expressed	  much	  weaker	  compared	  to	  its	  expression	  in	  mammals	  (Batista-­‐Pinto	  et	  al.,	  2005).	   	   In	  sea	  bass,	  while	  the	   highest	   expression	   PPARα	   is	   detected	   in	   the	   red	  muscle	   and	   liver,	   this	  isotype	   is	   weakly	   expressed	   in	   intestine	   and	   spleen	   and	   none	   is	   found	   in	  kidney	  and	  adipose	  tissue	  (Boukouvala	  et	  al.,	  2004).	  	  
PPARα	   and	   PPARβ	   likely	   have	   similar	   functions	   to	   those	   interpreted	   in	  mammals.	   Like	   PPARβ,	   PPARα	   directly	   controls	   the	   expression	   of	   key	  enzymes	   that	   regulate	   mitochondrial	   and	   peroxisomal	   fatty	   acid	   oxidation	  (Mandard	   et	  al.,	   2004).	   It	   is	   hypothesised	   that	   PPARα	   is	   responsible	   in	   the	  conversion	   and	  use	   of	   energy	   storage	   as	   its	  main	   function	   is	   to	   control	   the	  reversible	  induction	  of	  β-­‐oxidation	  in	  specific	  tissues,	  especially	  in	  liver	  as	  a	  response	   to	   changing	   energy	   requirements	   and	   nutritional	   status.	   It	   was	  shown	   that	   mice	   that	   lack	   PPARα	   are	   not	   able	   to	   up-­‐regulate	   hepatic	   β-­‐oxidation	   in	   response	   to	   starving	   (Kersten	   et	  al.,	   1999;	   Leone	   et	  al.,	   1999).	  Starvation	  stimulates	   lipolysis	   in	   the	  adipose	   tissue	  and	  releases	   fatty	  acids	  available,	  resulting	  in	  the	  development	  of	  fatty	  livers	  in	  mice	  lacking	  PPARα.	  Besides	   this,	   PPARα	   is	   also	   involved	   in	   amino	   acid	   metabolism,	  gluconeogenesis	  and	  inflammation	  (Mandard	  et	  al.,	  2004).	  
	  	   43	  
1.3.3.3 PPARγ 	  
Mammals	  have	  a	  single	  gene	  encoding	  PPARγ	  that	  is	  alternatively	  spliced	  to	  give	   two	  proteins,	   PPARγ1	   and	  PPARγ2,	   each	   carrying	  different	  N-­‐terminal	  sequence	  (Tontonoz	  et	  al.,	  1994).	  PPARγ1	  is	  highly	  expressed	  in	  gut	  where	  as	  PPARγ2	  is	  abundant	  in	  adipose	  tissues	  compared	  to	  the	  other	  tissues	  (Escher	  
et	  al.,	   2001).	  While	  mammalian	  PPARγ	   has	   two	   transcripts	   coding	  different	  proteins	   (Zhu	   et	  al.,	   1995;	   Tsukahara,	   2013),	  most	   teleost	   fishes	   only	   have	  one	   transcript	   (Maglich	   et	   al.,	   2003;	   Boukouvala	   et	   al.,	   2004;	   Ibabe	   et	   al.,	  2005,	   2004,	   2002;	   Leaver	  et	  al.,	   2005;	  Batisto-­‐Pinto	  et	  al.,	   2005;	  Tsai	  et	  al.,	  2008;	   Oku	   and	   Umino,	   2008;	   Cho	   et	   al.,	   2009;	   Kondo	   et	   al.,	   2010,	   2007;	  Agawa	  et	  al.,	  2012;	  He	  et	  al.,	  2012;	  Li	  et	  al.,	  2012)	  
PPARγ,	  being	   the	   first	  PPAR	   isotype	   to	  be	   identified	   in	  Atlantic	   salmon	  and	  plaice	   (Ruyter	   et	   al.,	   1997;	   Leaver	   et	   al.,	   1998),	   exhibits	   restricted	   tissue	  distribution.	  This	  is	  in	  agreement	  with	  the	  tissue	  distribution	  analysis	  in	  sea	  bass	   in	   which	   PPARγ	   is	   abundantly	   expressed	   in	   adipose	   tissue	   and	   gills,	  some	  in	  red	  muscle	  and	  intestine	  and	  only	  very	  small	  amounts	  are	  found	  in	  the	  liver	  (Boukouvala	  et	  al.,	  2004).	  In	  the	  previous	  study	  done	  by	  Ibabe	  et	  al.	  (2002),	   because	   adipose	   tissue	   was	   not	   present	   in	   the	   preparation	   in	   the	  zebrafish	   examined,	   the	   expression	   of	   PPARγ	   could	   not	   be	   justified	   in	   this	  species,	   however,	   the	   anaylsis	   has	   shown	   that	   this	   subtype	   is	   weakly	  expressed	   in	   other	   tissues,	   such	   as	   pancreatic	   cells,	   muscle	   and	   serous	  membrane	   of	   intestine	   and	   gonads	   of	   zebrafish.	   In	   contrast,	   in	   the	   liver	   of	  gray	   mullet	   M.	   cephalus,	   highest	   expression	   was	   observed	   in	  melanomacrophages	  (Ibabe	  et	  al.,	  2004).	  Similar	  observations	  were	  found	  in	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brown	  trout,	  where	  by	  the	  strongest	  PPARγ	  expression	  was	  detected	  in	  trunk	  kidney	  where	  melanomacrophages	  were	  particularly	  abundant,	   and	  a	  weak	  expression	   found	   in	   liver	  where	   they	  were	   least	   found	   (Batista-­‐Pinto	  et	  al.,	  2005).	  	  
One	  of	  PPARγ	  major	  roles	  is	  that	  it	  acts	  as	  a	  lipid	  regulator	  and	  is	  believed	  to	  play	  an	   important	  role	   in	   the	  accumulation	  of	   fat,	  particularly	   in	  adipocytes	  and	  lipid-­‐accumulating	  macrophages	  (Fajas	  et	  al.,	  2001;	  Rosen	  et	  al.,	  1999).	  It	  is	   known	   to	   regulate	   the	   differentiation	   of	   adipocytes	   by	   detecting	   the	  availability	  of	  lipid	  and	  responding	  by	  adapting	  appropriate	  gene	  expression	  programs	  (Escher	  et	  al.,	  2001).	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1.3.4 PPAR	  activation	  
1.3.4.1 Endogenous	  (natural)	  ligands	  
Based	  on	  the	  reports	  that	  known	  ligands	  of	  PPAR	  shared	  similar	  amphipathic	  structure	  to	  fatty	  acids	  and	  that	  high-­‐fat	  diets	  and	  some	  fatty	  acid	  analogues	  induced	  the	  peroxisomal	  β-­‐oxidation	  of	  fatty	  acids,	  Keller	  et	  al.	  (1993),	  for	  the	  first	   time,	   successfully	   demonstrated	   that	   fatty	   acids	   were	   endogenous	  activators	  of	  Xenopus	  laevis	  PPARα	  (xPPARα).	  Transfection	  experiments	  with	  xPPARα	   and	   RXRβ	   and	   in	   the	   presence	   of	   fatty	   acids,	   indeed,	   have	   shown	  cooperative	  activation	  of	  the	  acyl	  CoA	  oxidase	  promoter	  through	  the	  binding	  of	   PPARα-­‐RXRβ	   heterodimers	   to	   the	   peroxisome-­‐proliferator	   response	  element	  (PPRE)	  of	  the	  promoter	  (Keller	  et	  al.,	  1993).	  Because	  both	  PPAR	  and	  RXR	  ligands	  can	  regulate	  the	  expression	  of	  PPRE-­‐containing	  target	  genes	  via	  the	   activation	   of	   the	   heterodimer,	   it	   was	   further	   demonstrated	   that	   the	  activation	  of	  PPAR-­‐RXRβ	  heterodimer	  by	  fatty	  acids	  was	  indeed	  through	  the	  direct	   interaction	   of	   fatty	   acids	   and	   PPARs	   and	   not	   due	   to	   the	   interaction	  between	  fatty	  acids	  and	  the	  RXR	  heterodimer	  partner	  (Kliewer	  et	  al.,	  1997).	  Fatty	  acids	  are	  also	  observed	  to	  be	  activators	  of	  native	  PPARα	  in	  fish	  species,	  for	  example,	  Japanese	  medaka	  (Oryzias	  latipes)	  (Kondo	  et	  al.,	  2010),	  gilthead	  sea	   bream	   and	   European	   plaice	   (Leaver	   et	   al.,	   2005).	   Furthermore,	   cell	  transient	  transfection	  experiments	  using	  fish	  cells	  co-­‐transfected	  with	  Gal4-­‐constructs	   of	   PPARα	   and	   PPARβ	   demonstrated	   that	   these	   receptors	   are	  activated	   by	   fatty	   acids	   (Colliar	   et	   al.,	   2011).	   In	   addition	   to	   fatty	   acids,	  transactivation	   assays	   and	   gel	   retardation	   studies	   have	   shown	   that	  derivatives	   of	   fatty	   acid	   metabolism	   such	   as	   eicosanoids	   are	   endogenous	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ligands	   for	   mammalian	   PPARs	   (Kliewer	   et	   al.,	   1997).	   Derivatives	   of	  arachidonic	   acid,	   including	  20-­‐hydroxyeicosatetraenoic	   acid	   (20-­‐HETE)	  and	  several	   epoxyeicosatrienoic	   acids	   (EETs)	   and	   dihyroxyeicosatrienoic	   acids	  (DHETs)	   are	   activators	   of	   PPARα	   and	   PPARγ,	   as	   shown	   in	   transactivation	  assays	  (Ng	  et	  al.,	  2007).	  Like	  PPARα,	  fatty	  acids	  have	  been	  shown	  to	  activate	  mammalian	  PPARβ	   (Xu	  et	  al.,	   1999),	   although	   the	  extent	  of	   its	   activation	   is	  less	   than	  that	  of	  PPARα	   (Krey	  et	  al.,	  1997).	  Evidently,	  piscine	  native	  PPARβ	  and	  Gal4-­‐construct	  of	  PPARβ	  have	  also	  shown	  significant	  activation	  by	  some	  fatty	   acids	   in	   cell	   transactivation	   assays	   (Leaver	   et	   al.,	   2005;	   Colliar,	   et	   al.,	  2011).	  Also	  similar	  to	  PPARα,	  fatty	  acids	  including	  eicosanoid,	  15-­‐deoxy-­‐D12,	  14-­‐prostaglandin	   J2	   (15d-­‐J2)	   have	   been	   identified	   as	   potential	   specific	  endogenous	   agonists	   of	   PPARγ	   (Forman	   et	   al.,	   1995;	   Kliewer	   et	   al.,	   1995).	  However,	  none	  of	   the	   fatty	   acids	   that	   activate	  mammalian	  PPARγ	   is	   able	   to	  activate	  piscine	  PPARγ.	  
1.3.4.2 Synthetic	  ligands	  
The	   hypolipidemic	   drug,	   clofibrate,	   was	   identified	   as	   the	   first	   activating	  compound	  for	  PPARα	  (Issemann	  and	  Green,	  1990).	  Since	  then	  several	  other	  members	   of	   the	   fibrate	   class	   of	   drugs,	   including	   the	   PPARα-­‐specifc	   ligand	  WY-­‐14,643,	  have	  been	  developed	  as	  ligands	  of	  PPARα	  (Willson	  et	  al.,	  2000).	  Several	   fibrates	   have	   been	   tested	   in	   transactivation	   assays	   using	   murine	  PPARs	   and	   revealed	   that	   ciprofibrate,	   gemfibrozil	   and	   clofibrate	   strongly	  activate	  PPARα,	  weakly	  activate	  PPARγ	  and	  did	  not	  activate	  PPARβ	  (Forman	  
et	   al.,	   1997).	   These	   compounds	   were	   also	   tested	   in	   amphibian	   and	   fish.	  Bezafibrate	   and	   ciprofibrate	   activate	   PPARβ	   and	   PPARγ	   of	   Xenopus,	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respectively	   (Krey	   et	   al.,	   1997),	   and	   fibrate	   treatment	   was	   observed	   to	  increase	  the	  activity	   	  of	   the	  target	  gene	  acyl-­‐CoA	  oxidase	   in	  Atlantic	  salmon	  hepatocytes	   (Ruyter	   et	  al.,	   1997)	   and	   rainbow	   trout	   (Oncorhynchus	  mykiss)	  (Donohue	   et	   al.,	   1993).	   Moreover,	   gemfibrozil	   and	   ciprofibrate	   were	  demonstrated	   to	   activate	   Gal4-­‐PPARα	   and	   bezafibrate	   activate	   Gal4-­‐PPARβ	  in	  cell	  transient	  transfection	  experiments	  using	  fish	  cells	  (Colliar	  et	  al.,	  2011).	  Several	   PPARβ	   subtype-­‐specific	   synthetic	   ligands	   have	   been	   identified,	   for	  example,	   GW501516	   (Oliver	   et	   al.,	   2001)	   and	   this	   compound	   has	   been	  reported	   to	  activate	  PPARβ	   in	   fish	   (Leaver	  et	  al.,	   2007;	  Colliar	  et	  al.,	   2011).	  Thiazolidinedione	   (TZD)	   class	   of	   compounds,	   which	   include	   troglitazone,	  pioglitazone,	  rosiglitazone	  and	  ciglitazone,	  have	  been	  identified	  as	  potentially	  useful	   drugs	   based	   on	   their	   ability	   to	   activate	   rodent	   and	   human	  PPARγ	   in	  transient	   transfection	   assays	   (Lehmann	   et	   al.,	   1995;	   Lambe	   and	   Tugwood,	  1996).	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1.3.4.3 Transcriptional	  activation	  
PPARs	  target	   transcription	  of	  specific	  genes	  by	  binding	   to	  specific	  elements	  in	  gene	  promoter	  regions.	  Liganded	  PPARs	  activate	  transcription	  by	  binding	  co-­‐activator	  proteins	  and/or	  releasing	  co-­‐repressor	  proteins	  (Viswakarma	  et	  
al.,	  2010).	  Binding	  of	   ligand	  to	  PPAR	  causes	  a	  conformational	  change	   in	   the	  LBD	  region	  of	   the	  protein	   that	   leads	   to	  dissociation	  of	   co-­‐repressor	  protein	  and	   recruitment	   of	   co-­‐activator	   (McInerney	   et	   al.,	   1998).	   Both	   co-­‐activator	  and	  co-­‐repressor	  proteins	  belong	  to	  families	  of	  transcriptional	  activators	  that	  have	   broad	   specificity	   with	   regard	   to	   interaction	   with	   DNA	   binding	  transcription	   factors,	   and	   act	   to	   integrate	   transcriptional	   responses	   within	  cells	  (Rosenfeld	  et	  al.,	  2006).	  Thus,	  the	  activity	  of	  PPARs	  within	  particular	  cell	  types	   is	   not	   just	   dependent	   on	   the	   PPAR	   expressed,	   but	   also	   on	   the	  complement	  of	  co-­‐activators	  and	  co-­‐repressors.	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 Cell	  culture	  1.4
In	  the	  growing	  aquaculture	  industry,	  cell	  cultures	  from	  a	  wide	  variety	  of	  fish	  species,	  including	  Atlantic	  salmon,	  Artic	  charr,	  European	  whitefish,	  common	  carp,	  goldfish	  and	  zebrafish,	  have	  been	  developed	  with	  the	  aim	  to	  contribute	  towards	  increasing	  and/or	  improving	  fish	  production	  (Freshney,	  2010).	  In	  in	  
vitro	   studies,	   compared	   to	   in	   vivo,	   cell	   cultures	   are	   used	   as	   simple	   and	  manipulable	  analogs	  of	  animals,	  in	  order	  to	  reduce	  the	  number	  of	  sacrificed	  animals	  (Segner,	  1998).	  These	  systems	  have	  several	  significant	  advantages	  as	  the	   basic	   characteristics	   of	   the	   more	   complex	   in	   vivo	   condition	   can	   be	  retained	   and	   experimental	   conditions	   can	  be	   controlled	   (Baksi	   and	  Frazier,	  1990).	   	  The	  physical	  and	  chemical	  conditions	  surrounding	  the	  cells,	  such	  as	  temperature,	  pH,	  pCO2	  and	  ionic	  concentration,	  can	  be	  controlled	  over	  wide	  ranges	   to	   reveal	   fundamental	   mechanisms.	   Moreover,	   biological	   factors	  influencing	   cellular	   responses	   that	   cannot	   be	  measured	   individually	   and	   in	  combinations	  in	   in	  vivo	  studies,	  can	  be	  carried	  out	  using	   in	  vitro	   techniques.	  These	   systems	   also	   help	   in	   reducing	   variability	   between	   experiments,	   not	  only	   by	   controlling	   the	   environmental	   conditions,	   but	   also,	   the	   internal	  factors	   as	   these	   systems	   allow	   the	   incorporation	   of	   positive	   and	   negative	  control	   chemicals	   into	   the	   desired	   experimental	   design	   to	   calibrate	   the	  system	   for	   different	   experiments.	   Other	   advantages	   include	   the	   ability	   of	  repeating	   experiments,	  more	   time	   efficient	   and	   importantly,	   because	  of	   the	  use	  of	  small	  quantities	  of	  test	  chemicals,	  these	  systems	  are	  often	  cheaper	  and	  less	  toxic	  waste	  are	  disposed	  at	  the	  end	  of	  experiments.	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A	  number	  of	   studies	  have	  been	   carried	  out	   using	   in	  vitro	   techniques	   in	   the	  investigation	   of	   peroxisome	   proliferation,	   ligand	   binding	   and	   activation	   of	  PPARs	  and	  changes	  in	  expression	  of	  PPARs	  (Ibabe	  et	  al.,	  2005;	  Colliar	  et	  al.,	  2011).	   In	   this	   study,	   permanent	   cell	   lines	   of	   Chinook	   salmon	   embryo	   214	  (CHSE-­‐214)	  were	   used	   for	   in	   vitro	   investigations.	   Although	   permanent	   cell	  lines	   often	   have	   lost	   functional,	   structural	   or	   metabolic	   properties	   of	   the	  originating	   tissues	   or	   cells	   in	   comparison	   to	   primary	   cell	   cultures	   having	  many	  of	   in	  vivo	   features	  retained,	  cell	   lines	  can	  be	   in	  convenience	   in	  supply	  and	  propagated	  indefinitely	  in	  culture	  (Baksi	  &	  Frazier,	  1990;	  Segner,	  1998).	  These	   immortalized	  cultured	  cells	   can	  be	   transfected	  much	  more	  readily	   to	  higher	   efficiency	   as	   some	   parts	   of	   the	   cellular	   processes	   may	   have	   been	  altered	  during	  the	  process	  of	  transforming	  cells	  towards	  making	  them	  more	  amendable	  to	  culture	  conditions	  and	  thus,	  making	  them	  more	  susceptible	  to	  transfection	  (Hsu	  &	  Uludağ,	  2012).	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 Thesis	  aims	  and	  objectives	  1.5
There	   is	   strong	  evidence	   that	  PPARs	  play	  critical	   roles	   in	   lipid	  homeostasis	  based	  on	   the	   information	  gathered	  on	   the	   tissue	  distribution	  of	  PPARs	  and	  the	   identification	   of	   PPAR	   target	   genes.	   Although	   PPARα	   and	   PPARβ	   may	  have	  similar	   functions	   to	   those	  described	   in	  mammals	  (Leaver	  et	  al.,	  2005),	  the	  role	  of	  PPARγ	  in	  fish	  still	  remain	  unclear.	  Because	  mammalian	  PPARγ	  has	  a	   critical	   role	   in	   determining	   lipid	   uptake	   and	   storage,	   it	   is	   of	   particular	  interest	  in	  finfish	  aquaculture	  as	  farmed	  fish	  often	  accumulate	  excess	  visceral	  and	  hepatic	  fat	  especially	  when	  fed	  plant	  seed	  oil-­‐based	  diets.	  This	  can	  affect	  the	  health	  and	  welfare	  of	  the	  fish,	  and	  also	  represents	  an	  economic	  waste	  of	  valuable	   feed	   that	   might	   otherwise	   be	   channelled	   into	   growth.	   Thus,	   this	  research	  may	  become	  relevant	  to	   feed	  formulation	  because	  at	  present	  most	  fish	   feed	   formulation	   is	   based	   on	   trial	   and	   error	   using	   ingredients	   that	   are	  either	   available	   locally	   or	   are	   economically	   feasible.	   By	   understanding	   the	  differences	  between	  the	  activities	  of	  fish	  and	  mammalian	  PPARγ	  and	  the	  role	  PPARγ	   in	   fish	   physiology,	   new	   diets	   can	   be	   designed	   with	   optimized	  quantities	   and	   qualities	   of	   lipid	   components	   from	   a	   variety	   of	   available	  ingredients.	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The	  specific	  aims	  of	  this	  project	  were:	  
1. To	   optimise	   the	   transfection	   of	   plasmid	  DNA	   into	   an	   established	  fish	   cell	   line	   using	   a	   transfection	   reagent,	   branched	  polyethylenimine	   (bPEI),	   and	   range	   of	   DNA	   to	   reagent	   ratios	  (Chapter	  3)	  2. To	   prepare	   expression	   plasmid	   construct	   in	   which	   the	   ligand-­‐binding	  domain	  of	  European	  plaice	  PPARγ	   is	   ligated	  downstream	  of	  the	  Gal4	  DNA-­‐binding	  domain	  (Chapter	  3)	  3. To	  extract	   the	   total	   lipid	   from	   liver	   tissues	  of	   farmed	   fish,	  and	   to	  fractionate	  the	  lipid	  into	  lipid	  classes	  and	  test	  them	  with	  the	  Gal4-­‐PPARγ	   LBD	   expression	   construct	   in	   a	   series	   of	   luciferase	   assays	  (Chapter	  4)	  4. To	   identify	  molecular	   components	  within	   the	   lipid	   fractions	   that	  interact	  with	  plaice	  PPAR	  ligand-­‐binding	  domain	  (Chapter	  4)	  5. To	   evaluate	   the	   transcriptional	   responses	   of	   potential	   molecular	  components	   identified	   in	  (4)	  on	  the	  cellular	  transactivation	  assay	  developed	  previously	  (Chapter	  5)	  6. To	   determine	   the	   tissue	   expression	   pattern	   of	   PPARs	   in	   Atlantic	  salmon	   (Salmon	   salar)	   and	   to	   construct	   phylogenetic	   trees	  comparing	  PPARs	   from	  different	   vertebrate	   species	   to	  determine	  whether	   or	   not	   the	   genetic	   divergence	   of	   Atlantic	   salmon	   PPARs	  exhibit	  functional	  divergence	  (Chapter	  6)	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2 General	  materials	  and	  methods	  
 Preparation	  of	  media	  and	  buffers	  2.1
2.1.1 Preparation	  of	  50x	  TRIS/acetate/EDTA	  (TAE)	  buffer	  	  
A	  50	   x	   stock	   solution	   of	   TAE	  buffer	  was	   prepare	   using	   121	   g	  Tris	   base	   (2-­‐amino-­‐2-­‐hydroxymethyl-­‐propane-­‐1,3-­‐diol),	   50	   ml	   0.5M	   Na2EDTA	   (pH8.0)	  and	  28.5	  ml	  glacial	  acetic	  acid	  (100%	  acetic	  acid).	  First,	  50	  ml	  0.5M	  Na2EDTA	  was	  prepared	  by	  dissolving	  9.3	  g	  of	  EDTA	  in	  50	  ml	  of	  MilliQ	  water	  (Millipore)	  before	   this	   was	   stirred	   vigorously	   using	   a	   magnetic	   stirrer	   and	   the	   pH	  adjusted	  to	  8.0	  with	  sodium	  hydroxide	  (NaOH).	  Subsequently,	  121	  g	  Tris	  base	  was	  measured	   into	  500	  ml	  beaker	  containing	  about	  350	  ml	  of	  MilliQ	  water,	  stirred	  and	  the	  previously	  prepared	  Na2EDTA	  and	  28.5	  ml	  glacial	  acetic	  acid	  were	  added	   to	   the	  mixture,	   stirred	  and	  MilliQ	  added	   to	  bring	  volume	  up	   to	  500	  ml.	  
2.1.2 Preparation	  of	  Luria-­‐Bertani	  (LB)	  broth	  
A	  400	  ml	   of	   LB	  broth	  was	   prepared	  by	   dissolving	   8	   g	   of	   LB	  medium	   (USB,	  Ohio,	   USA)	   in	   400	   ml	   of	   MilliQ	   water	   in	   a	   500	   ml	   bottle	   before	   it	   was	  autoclaved	  and	  stored	  at	  room	  temperature.	  
2.1.3 Preparation	  of	  antibiotic	  ampicillin	  solution	  
Ampicillin	   solution	   (50	   mg/ml)	   was	   prepared	   by	   dissolving	   250	   mg	   of	  ampicillin	   in	  5	  ml	  MilliQ	  before	   the	   solution	  was	  divided	   into	  1	  ml	  aliquots	  and	  stored	  at	  -­‐20	  °C.	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2.1.4 Preparation	  of	  Luria-­‐Bertani	  (LB)	  agar	  with	  ampicillin	  
LB	  agar	  was	  prepared	  by	  dissolving	  12.8	  g	  LB	  agar	  (USB,	  Ohio,	  USA)	  in	  400	  ml	   MilliQ	   in	   a	   500	   ml	   bottle	   and	   mixed	   before	   this	   was	   autoclaved	   and	  allowed	  to	  cool	  to	  50	  °C	  and	  stored	  at	  room	  temperature.	  To	  prepare	  the	  agar	  in	  plates,	  this	  was	  microwaved	  to	  melt	  the	  solid	  agar,	  and	  to	  50	  ml	  of	  molten	  LB	   agar,	   100	  µl	   of	   50	  mg/ml	   ampicillin	   solution	  was	   added.	   The	   agar	  was	  gently	  mixed	  and	  poured	  into	  two	  100mm	  Petri	  dishes.	  Plates	  were	  allowed	  to	  set,	  and	  if	  not	  used	  immediately,	  stored	  at	  4	  °C.	  
 Preparation	  of	  pure	  plasmid	  DNA	  	  2.2
2.2.1 Transformation	  of	  plasmid	  DNA	  into	  Escherichia	  coli	  (E.	  
coli)	  	  
This	  method	  involves	  the	  insertion	  of	  a	  foreign	  plasmid	  DNA	  into	  the	  bacteria	  using	   the	   traditional	   heat	   shock	  method.	   0.5	  µl	   of	   plasmid	  DNA	  was	   added	  into	   micro-­‐tube	   containing	   competent	   E.	   coli	   Top	   10	   cells,	   previously	  prepared	   using	   the	  method	   employed	   by	   Inoue	   et	  al.	   (1990),	   and	   this	  was	  incubated	   in	   ice	   for	  30	  min.	  This	  mixture	  of	   chemically	   competent	  bacteria	  and	  DNA	  was	   then	  placed	   in	   a	  water	  bath	   at	  42	   °C	   for	  1	  min	  before	   it	  was	  placed	  back	  in	  ice	  to	  chill	  for	  1-­‐2	  min.	  900	  µl	  of	  LB	  media	  was	  added	  to	  and	  the	  transformed	  cells	  were	   incubated	  at	  37	  °C	  for	  1	  hour	  with	  agitation.	  On	  LB	  agar	  plate	  containing	  ampicillin,	  50	  µl	  of	  the	  mixture	  was	  plated	  and	  this	  was	  incubated	  at	  37	  °C	  overnight.	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2.2.2 Inoculation	  of	  bacterial	  cells	  containing	  plasmid	  DNA	  
A	  starter	  culture	  was	  prepared	  by	  inoculating	  4	  ml	  of	  LB	  medium	  (containing	  ampicillin)	  with	  a	  single	  colony	  picked	  from	  the	  agar	  plate	  prepared	  earlier.	  This	   was	   incubated	   at	   37	   °C	   for	   about	   8	   hours,	   shaking	   at	   250	   rpm.	   The	  inoculation	  of	  a	  large	  overnight	  culture	  was	  prepared	  by	  diluting	  the	  starter	  culture	   1/1000	   into	   300	  ml	   of	   LB	  medium	   (containing	   ampicillin)	   and	   this	  was	  incubated	  further	  37	  °C	  for	  12-­‐16	  hours,	  shaking	  at	  250	  rpm.	  
2.2.3 Purification	  of	  plasmid	  DNA	  	  
The	   following	   day,	   plasmid	   DNA	   was	   isolated	   from	   the	   overnight	   culture	  using	   using	   Nucleobond®	   Xtra	   kit	   (Macharey-­‐Nagel),	   following	   the	  manufacturer’s	  instructions.	  Briefly,	  the	  bacteria	  were	  harvested	  from	  the	  LB	  culture	  by	  centrifugation	  at	  5,100	  x	  g	   for	  25min	  at	  4°C	  and	  the	  supernatant	  was	  carefully	  decanted.	  The	  pellet	  of	  bacterial	  cells	  was	  re-­‐suspended	  in	  12	  ml	   Resuspension	   Buffer	   RES	   (containing	   RNase	   A)	   by	   vortexing	   the	   cells,	  making	  sure	  that	  no	  clumps	  remain	  in	  the	  suspension	  for	  efficient	  cell	   lysis.	  To	  the	  suspension,	  12	  ml	  of	  Lysis	  Buffer	  LYS	  was	  added	  and	  was	  mixed	  gently	  by	  inverting	  the	  tube	  5	  times.	  At	  the	  stage,	  vortexing	  would	  have	  sheared	  and	  released	   contamination	   chromosomal	   DNA	   from	   cellular	   debris	   into	   the	  suspension.	  The	  mixture	  was	  left	  to	  incubate	  at	  room	  temperature	  (18-­‐25	  °C)	  for	  5	  min.	  To	  the	  suspension	  mixture,	  12	  ml	  of	  Neutralization	  Buffer	  NEU	  was	  added	  and	  was	   lysate	  was	   immediately	  mixed,	   gently	  by	   inverting	   the	   tube	  until	   a	   homogenous	   suspension	   containing	   an	   off-­‐white	   flocculate	   was	  formed.	  The	   lysate	  was	  centrifuged	  at	  5,100	  x	  g	   at	  4	   °C	   for	  10	  min	  and	   the	  supernatant	  was	   then	   applied	   to	   the	   previously	   equilibrated	  Nucleobond®	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Xtra	  Column	  Filter	  (with	  25	  ml	  of	  Equilibration	  Buffer	  EQU).	  This	  clarification	  step	  was	  extremely	  important	  to	  ensure	  that	  the	  column	  was	  not	  clogged	  by	  any	  residual	  precipitate.	  When	  the	  column	  was	  emptied	  by	  gravity	  flow,	  the	  Nucleobond®	   Xtra	   Column	   Filter	   and	   Nucleobond®	   Xtra	   Column	   were	  washed	  with	   15	  ml	   Equilibration	   Buffer	   EQU.	   The	   filter	  was	   then	   removed	  before	  the	  column	  was	  washed	  with	  25	  ml	  Wash	  Buffer	  WASH.	  The	  plasmid	  DNA	  was	  eluted	  with	  15	  ml	  Elution	  Buffer	  ELU	  and	  the	  eluate	  was	  collected	  in	   a	   50	   ml	   centrifuge	   tube.	   The	   eluted	   plasmid	   DNA	   was	   precipitated	   by	  adding	  10.5	  ml	  of	  room-­‐temperature	  isopropanol,	  centrifuged	  at	  5,100	  x	  g	  at	  10	  °C	  for	  25	  min.	  The	  supernatant	  was	  carefully	  decanted	  before	  4	  ml	  room	  temperature	  70	  %	  ethanol	  was	  added	   to	   the	  pellet.	  This	  was	  centrifuged	  at	  5,100	   x	   g	   at	   room	   temperature	   (18-­‐25	   °C)	   for	   5	   min.	   The	   ethanol	   was	  carefully	  removed	  from	  the	  tube	  using	  a	  pipette	  tip	  and	  was	  allowed	  to	  dry	  at	  room	   temperature	   (18-­‐25	   °C)	   for	   25	  min.	   The	   pellet	  was	   then	   dissolved	   in	  200	   µl	   of	   10	   mM	   Tris-­‐Cl	   pH8.0	   and	   the	   concentration	   of	   the	   DNA	   was	  measured	  using	  the	  Nanodrop	  ND1000	  spectrophotometer.	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2.2.4 Determination	   of	   plasmid	   integrity	   by	   Agarose	   Gel	  
Electrophoresis	  
2.2.4.1 Preparation	  of	  samples	  for	  Restriction	  Digestion	  	  
In	   this	   case,	   a	   Master	   mix	   was	   prepared	   depending	   on	   the	   number	   of	  plasmids	   and	   this	   consisted	   of	   all	   the	   reaction	   components	   except	   plasmid	  DNA.	   In	   a	   Master	   mix,	   1	   µl	   NEB	   buffer	   was	   used	   to	   optimize	   the	   enzyme	  activity,	  0.25	  µl	  each	  of	   two	  selected	  restriction	  enzymes,	  BamHI	  and	  Kpn1,	  were	   used	   to	   cut	   the	   DNA	   and	   7	   µl	   of	   deionised	   water	   was	   added.	   In	   a	  microtube,	   9	  µl	   of	  Master	  mix	  was	   prepared	   and	   1	  µl	   of	   plasmid	  DNA	  was	  added.	   This	  was	  mixed	   gently	   by	   pipetting	   up	   and	   down.	   The	  mixture	  was	  incubated	  at	  37	  °C	  for	  1	  hour	  and	  into	  each	  tube,	  2	  µl	  of	  6	  x	  loading	  dye	  was	  added	  and	  this	  was	  mixed	  by	  vortexing.	  
2.2.4.2 Preparation	  of	  Agarose	  Gel	  
Agarose	  gel	  electrophoresis	  is	  the	  easiest	  and	  commonest	  way	  of	  separating	  and	  analysing	  DNA.	  On	  a	  weighing	  boat,	  0.25	  g	  of	  agarose	  was	  weighed	  out	  and	  was	  decanted	   into	  250	  ml	   conical	   flask,	   into	  which	  25	  ml	  of	  0.5	  X	  TAE	  buffer	  was	  added.	  A	  25	  ml	  conical	  flask	  (inverted)	  was	  used	  as	  a	  lid	  and	  this	  was	  microwaved	   for	  1	  min,	  gently	  swirling	   that	   flask	  at	  regular	   intervals	   to	  help	  it	  dissolve.	  This	  was	  left	  to	  cool	  for	  5-­‐10	  min	  until	  it	  reaches	  about	  60	  °C	  (just	   hand	   hot).	   To	   the	   flask,	   0.25	   µl	   of	   ethidium	   bromide	   (5	   mg/ml)	   was	  added	   and	   mixed	   by	   gentle	   swirling.	   A	   6	   cm	   x	   7	   cm	   gel	   casting	   tray	   was	  prepared	  by	  sealing	  the	  ends	  of	  the	  tray	  using	  masking	  tape	  and	  the	  required	  comb	  was	  placed	   into	   the	  position	   in	   the	   tray.	  The	  agarose	  gel	  was	  poured	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slowly	  into	  the	  casting	  tray	  and	  was	  left	  to	  set	  for	  1	  hour.	  The	  tape	  was	  then	  removed	  from	  the	  tray	  and	  was	  placed	  in	  the	  electrophoresis	  tank,	  into	  which	  about	  250	  ml	  of	  0.5	  X	  TAE	  buffer	  was	  poured	  to	  submerge	  the	  gel	  to	  2-­‐5	  mm	  depth,	   herein	   referred	   to	   as	   the	   running	   buffer.	   The	   gel	   was	   allowed	   to	  equilibrate	  in	  the	  buffer	  for	  5-­‐10	  min.	  
2.2.4.3 Loading	  the	  gel	  
Using	  a	  fresh	  pipette	  tip	  for	  each	  sample,	  1	  µl	  of	  sample	  was	  loaded	  alongside	  a	  1	  kb	  Hyper	  Ladder	  molecular	  weight	  marker	  (Fementas).	  The	  samples	  were	  run	  at	  70	  V	   for	  45	  min	   and	   the	  progress	  of	   the	   gel	   by	   the	   loading	  dye	  was	  monitored	  and	  stopped	  when	   the	  dye	  had	  run	  approximately	  ¾	  of	   the	  way	  through	  the	  gel.	  The	  gel	  was	  then	  placed	  on	  the	  Syngene	  Transilluminator	  to	  observe	  DNA	  bands,	  indicating	  successful	  digestion.	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3 Development	  of	  a	  luciferase	  reporter	  assay	  and	  the	  
optimisation	   of	   transfection	   methods	   using	  
branched	   polyethylenimine	   (bPEI)	   transfection	  
reagent	  	  
 Introduction	  3.1
3.1.1 Development	  of	  a	  reporter	  gene	  construct	  
Peroxisome	  proliferator	  activated	  receptors	  (PPARs)	  are	  factors	  that	  activate	  transcription	  by	  interacting	  with	  peroxisome	  proliferator	  element	  (PPRE)	  of	  a	   target	   gene,	   and	   function	   as	   heterodimers	   with	   9-­‐cis	   retinoid	   X	   receptor	  (RXR).	  Gearing	  et	  al.	  (1993)	  had	  shown	  that	  endogenous	  PPARs	  expressed	  in	  rat	   cells,	   upon	   purification,	  were	   found	   to	   have	   lost	   their	   ability	   to	   bind	   to	  PPREs	  from	  acyl-­‐CoA	  oxidase	  gene,	  and	  the	  binding	  was	  however	  restored	  by	  the	  addition	  of	  in	  vitro-­‐translated	  RXRα.	  It	  was	  also	  observed	  that	  activation	  of	   the	   reporter	   gene	   depended	   on	   the	   interaction	   between	   PPAR	   and	  RXR,	  and	   this	   activation	  was	   limited	   to	   the	   levels	   of	   RXR.	   The	   formation	   of	   this	  heterodimeric	   complex	   with	   RXR	   brings	   about	   challenges	   particularly	   in	  determining	  activating	  compounds	  of	  PPARs	  as	  simultaneous	  exposure	  of	  the	  complex	   to	   clofibric	   acid,	   an	   activator	   of	   PPARα,	   and	   9-­‐cis	   retinoic	   acid,	   a	  ligand	  of	  RXRα,	  resulted	  in	  the	  expression	  of	  acyl-­‐CoA	  oxidase	  gene	  (Kliewer	  
et	  al.,	   1992).	   This	   showed	   that	   the	   PPAR-­‐activated	   pathways	   in	   cells	   could	  also	  be	   influenced	  by	  the	  activation	  of	  RXR	  and	  that	  PPARs	  require	  RXR	  for	  proper	  functioning.	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Thus,	   the	   identification	   of	   compounds	   that	   interact	   with	   PPARs	   can	   be	  hindered	   by	   the	   interference	   of	   compound	   that	   interact	  with	   the	   RXR.	   The	  removal	  of	  RXR,	  however,	   is	  not	  an	  option,	  as	  PPARs	  cannot	   function	   in	  the	  absence	  of	  RXR.	  Therefore,	   in	  order	   to	  overcome	   this,	   a	   fusion	  protein	   that	  consists	   of	   the	   Gal4	   DNA-­‐binding	   domain	   and	   the	   PPAR	   ligand-­‐binding	  domain	   was	   developed	   for	   use	   in	   as	   reporter	   gene	   assay.	   Thus,	   the	  transcription	   of	   the	   reporter	   gene	   was	   depended	   on	   the	   activity	   of	   the	  activation	  function	  2	  (AF-­‐2)	  located	  within	  the	  PPAR	  ligand-­‐binding	  domain,	  without	   having	   to	   form	   a	   heterodimer	   complex.	   Binding	   of	   this	   ligand-­‐dependent	   domain	   by	   an	   activating	   compound	   would	   enable	   the	  determination	   of	   PPAR	   activators	   and	   repressors	   with	   no	   interference	   or	  influence	  from	  the	  RXR.	  
3.1.1.1 The	  Gal4-­‐PPAR/UAS	  assay	  system	  
Gal4	   is	   a	   yeast	   transcriptional	   activator	   protein	   that	   binds	   to	   its	   specific	  recognition	  sequence,	  known	  as	  the	  upstream	  activation	  sequence	  (UAS)	  and	  activates	   transcription	   of	   target	   genes.	   Several	   studies	   have	   shown	   that	   he	  Gal4-­‐UAS	   system	  has	  been	  demonstrated	   to	  be	   functional	  not	   only	   in	   yeast	  but	   also	   in	   various	   animal	   cells	   (Fischer	   et	   al.,	   1988;	   Scheer	   and	   Campos-­‐Ortega,	   1999;	   Hartley	   et	   al.,	   2002).	   The	   use	   of	   this	   system	   in	   vitro	   was	  developed	   by	  Kakidani	   and	   Ptashne	   (1988)	   to	   study	   the	   activation	   of	   gene	  expression	   in	   mammalian	   cells	   by	   Gal4	   protein	   when	   the	   DNA-­‐binding	  domain	  was	  inserted	  upstream	  of	  the	  mouse	  mammary	  tumor	  virus	  (MMTV)	  promoter.	  Similar	  system	  was	  adapted	  by	  Webster	  et	  al.	  (1988)	  to	  study	  the	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activation	   of	   gene	   expression	   of	   a	   promoter	   region	   controlled	   by	   an	  oestrogen-­‐responsive	  enhancer	  in	  human	  HeLa	  cells.	  	  
The	   development	   of	   the	   Gal4	   transient	   assay	   provides	   several	   advantages	  and	   these	   include	   high	   throughput	   transactivation	   screen	   for	   fish	   PPAR	  activity,	  allowing	  the	  specific	  responses	  to	  be	  tested	  and	  the	  ability	  to	  define	  dose	   in	   a	   constant	   or	   controlled	   physio-­‐chemical	   environment,	  without	   the	  interference	  of	  other	  receptors,	  hormones,	  signalling	  pathways	  and	  other	   in	  
vivo	  complexities.	  The	  Gal4-­‐UAS	  system	  is	  a	  powerful	  technique	  for	  studying	  gene	  expression,	  thus	  in	  this	  project,	  taking	  advantage	  of	  the	  functionality	  of	  the	  Gal4	  DNA-­‐binding	  domain	  as	  a	  fusion	  protein	  with	  an	  activation	  function-­‐containing	   protein,	   Gal4-­‐PPARγ,	   was	   generated	   for	   use	   in	   fish	   cell	   line	   to	  identify	  activators	  and	  repressors	  of	  PPARγ.	  	  
Two	  plasmid	  constructs	  were	  used	  in	  the	  Gal4-­‐UAS	  system.	  The	  first	  plasmid	  construct	   is	   fusion	  protein	  consisted	  of	  amino	  acids	  1-­‐147	  of	   the	  Gal4	  gene,	  encoding	  the	  DNA-­‐binding	  domain	  (Gal4-­‐DBD).	  The	  Gal4-­‐DBD	  was	  fused	  in-­‐frame	  to	   the	  PPAR	   ligand-­‐binding	  domain	  (PPAR-­‐LBD),	  with	   the	  expression	  of	   the	   whole	   construct	   being	   driven	   by	   the	   cytomegalovirus	   (CMV)	  immediate	   early	   promoter	   (Figure	   3-­‐1A).	   The	   second	   plasmid	   construct	  consisted	   of	   five	   Gal4	   UAS	   sequences	   upstream	   of	   a	   TATA	   box,	   which	  was	  upstream	  of	  the	  reporter	  gene,	  firefly	  luciferase	  (Figure	  3-­‐1B).	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Figure	   3-­‐1	   Schematic	   diagram	   of	   the	   two	   constructs	   in	   the	   Gal4-­‐UAS	  
system.	   A:	   The	   Gal4-­‐PPAR	   construct	   consisted	   of	   PPAR-­‐LBD	   cloned	  
downstream	  of	  the	  Gal4-­‐DBD,	  whose	  expression	  was	  driven	  by	  the	  CMV	  
promoter.	   B:	   The	   Gal4UAS-­‐luc	   construct	   consisted	   of	   5	   Gal4UAS	  
sequences	   upstream	   of	   a	   TATA	   box,	   which	   was	   upstream	   of	   a	   firefly	  
luciferase	  enzyme	  	  
The	  PPAR-­‐LBD	  contains	  a	  crucial	  ligand-­‐induced	  helical	  component,	  helix	  12,	  that	  re-­‐conforms	  to	  subsequently	  release	  the	  co-­‐repressor	  proteins	  to	  allow	  the	   binding	   of	   co-­‐activator	   proteins,	   and	   thereby	   activates	   transcription	   of	  the	  AF-­‐2	  (Moras	  and	  Gronemeyer,	  1998).	   	  The	   interaction	  between	  the	   two	  plasmid	  constructs	   involves	   the	  binding	  of	   the	  Gal4UAS	  sequences	  with	   the	  Gal4-­‐DBD,	  forming	  a	  complex,	  which	  remains	  transcriptionally	  inactive	  until	  binding	  of	  a	  ligand	  to	  the	  ligand-­‐binding	  domain	  of	  the	  PPAR.	  This	  interaction	  leads	   to	   a	   conformational	   change	   in	   the	  Gal4-­‐PPAR	   construct,	   releasing	   the	  co-­‐repressor	  proteins	  and	  subsequently	  recruitment	  of	  co-­‐activator	  proteins.	  As	   a	   result,	   AF-­‐2	   becomes	   activated	   and	   this	   ultimately	   an	   increase	   the	  luciferase	  expression	  (Moras	  and	  Gronemeyer,	  1998).	  This	  whole	  process	  can	  be	  seen	  in	  Figure	  3-­‐2.	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Figure	  3-­‐2	  Schematic	   illustration	  of	   the	  Gal4-­‐UAS	  assay	  system.	  A:	  The	  
interaction	  between	  the	  two	  plasmid	  constructs	  involves	  the	  binding	  of	  
the	   Gal4UAS	   sequences	  with	   the	   Gal4-­‐DBD,	   forming	   a	   complex,	   which	  
remains	   transcriptionally	   inactive	  due	   to	   the	  association	  of	  PPAR-­‐LBD	  
with	   co-­‐repressor	   proteins.	   B:	   Binding	   of	   ligand	   to	   the	   ligand-­‐binding	  
domain	  of	  PPAR	   leading	   to	  a	   conformational	   change	   in	   the	  Gal4-­‐PPAR	  
construct,	   releasing	   the	   co-­‐repressor	   proteins	   and	   subsequently,	  
recruitment	   of	   co-­‐activator	   proteins.	   AF-­‐2	   becomes	   activated	   and	   this	  
ultimately	   results	   in	   an	   increase	   in	   the	   transcription	   of	   the	   firefly	  
luciferase	  reporter	  enzyme.	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3.1.1.2 Luciferase	  genes	  as	  reporter	  proteins	  
Luciferase	   reporter	   genes	   are	   commonly	   used	   in	   molecular	   and	   cell	  applications	   to	  monitor	   changes	   in	   transcriptional	   rate	   as	   bioluminescence	  that	   is	   instantaneous,	   sensitive	  and	  quantitative	   (van	  Lune	  and	  Bruggeman,	  2006).	   Firefly	   (Phonitus	   pyralis)	   luciferase	   is	   a	   monomeric	   61	   kDa	   protein	  that	  yields	  a	  greenish	  yellow	  light	  at	  560	  nm,	  whereas	  Renilla	   luciferase	  is	  a	  36	  kDa	  protein	  isolated	  from	  the	  sea	  pansy	  (Renilla	  reniformis)	  that	  produces	  a	  blue	  light	  at	  480	  nm.	  	  The	  different	  light	  outputs,	  as	  well	  as,	  substrate	  and	  co-­‐factor	  requirements	  are	   the	  characteristics	   that	  enable	   these	  enzymes	  to	  be	   used	   in	   the	   same	   assay	   system.	   This	   project	   made	   use	   of	   “homemade”	  luciferase	   assay	   buffers	   in	   a	   dual	   luciferase	   reporter	   assay	   in	   analysing	   the	  expression	   of	   the	   reporter	   genes,	   firefly	   luciferase	   and	   Renilla	   luciferase	  enzymes.	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3.1.2 Transfection	  
Transfection	  is	  a	  non-­‐viral	  delivery	  method	  of	  gene	  transfer	  and	  this	  involves	  an	   introduction	   of	   foreign	   nucleic	   acids	   into	   eukaryotic	   cells	   (Kim	   and	  Eberwine,	   2010).	   Viral-­‐mediated	   transfection,	   called	   transduction,	   involves	  the	   use	   of	   viral	   vectors	   derived	   from	   natural,	   usually	   partially	   disabled	  viruses	   such	  as	  adenovirus	  and	   retrovirus.	  Although	  viruses	  are	  efficient	   in	  transducing	   cells,	   their	   immunogenicity,	   cytotoxicity,	   limited	   gene-­‐carrying	  capacity,	  potential	  pathogenicity	  and	  small-­‐scale	  production	  have	  made	  non-­‐viral	  delivery	  systems	  an	  attractive	  alternative	  (Li	  and	  Huang,	  2000;	  Thomas,	  
et	  al.,	  2003).	  	  
Over	   the	   years,	   the	   development	   of	   the	   non-­‐viral	   delivery	   systems	   has	  significantly	   improved	   and	   their	   application	   has	   been	   made	   a	   preferable	  option,	  depending	  on	   cell	   type,	   cellular	   context	   (in	  vivo	   or	   in	  vitro),	   desired	  efficiency	  as	  well	  as	  cost	  and	  time.	  There	  are	  two	  non-­‐viral	  methods	  of	  gene	  delivery:	  physical	  and	  chemical	  methods.	  
3.1.2.1 Physical	  methods	  of	  transfection	  
Physical	  methods	  enable	  the	  direct	  transfer	  of	  plasmid	  DNA,	  through	  the	  cell	  membrane,	   into	   cytoplasm	   or	   nucleus	   by	   physical	   or	   mechanical	   means,	  which	   may	   (or	   may	   not)	   cause	   temporary	   micro-­‐disruption	   to	   the	   cell	  membrane	  (Li	  and	  Huang,	  2000;	  Wells,	  2004).	  Some	  of	  the	  physical	  methods	  are	  described	  briefly	  below.	  
	  	   66	  
3.1.2.1.1 Electroporation	  
A	   frequently	   used	   physical	   method	   of	   gene	   transfer	   is	   known	   as	  electroporation	  and	  this	  involves	  an	  application	  of	  a	  series	  of	  electric	  pulses	  to	   overcome	   the	   barrier	   the	   cell	   membranes.	   The	   electric	   field	   creates	   a	  potential	   difference	   across	   the	   membrane	   subsequently	   inducing	   the	  formation	  of	  temporary	  hydrophilic	  pores	  in	  the	  cell	  membrane	  for	  plasmid	  DNA	   to	   pass	   through.	   The	   first	   successful	   gene	   transfer	   by	   electroporation	  was	   documented	   by	   Neumann	   et	   al.	   (1982),	   involving	   the	   transfection	   of	  circular	  plasmid	  DNA	  containing	   the	  herpes	   simplex	   thymidine	  kinase	   (TK)	  gene	   into	   TK-­‐deficient	   mouse	   L	   cells.	   Since	   then,	   several	   studies	   have	  reported	   that	  electroporation	  can	  be	  done	   in	  vitro	   and	   in	  vivo	   involving	   the	  delivery	  of	  various	  molecules	   into	  eukaryotic	   cells,	   including	   ions	   (Saulis	  et	  
al.,	   2007),	   dyes	   (Mir	   et	   al.,	   1988;	   Dinchuk	   et	   al.,	   1992)	   oligonucleotides	  (Spiller	   et	   al.,	   1998)	   and	   even	   anti-­‐cancer	   drugs	   in	   patients	   (Sersa	   et	   al.,	  2000).	  
3.1.2.1.2 Microinjection	  
Microinjection	   is	   another	   physical	   method	   of	   transfection	   and	   it	   is	   mainly	  used	   to	  manipulate	   single	   cells	   by	   injection	   of	  DNA,	  mRNA	  and	  proteins.	   It	  was	  recently	  reported	  by	  Michaelis	  et.	  al.	   (2014)	   that	   in	  vivo	  microinjection	  was	   used	   to	   successfully	   transfect	   testicular	   mouse	   cells	   with	   a	   reporter	  vector	   pEGFP-­‐C1	   and	   this	   was	   illustrated	   by	   the	   green	   fluorescence	  expressed	   by	   the	   vector.	   Although	   this	   method	   is	   highly	   effective,	   it	   is	  however	  very	  time-­‐consuming	  and	  is	  not	  suitable	  to	  transfect	  a	  large	  number	  of	  cells.	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3.1.2.1.3 Particle	  bombardment	  or	  gene	  gun	  
Similarly,	   the	   particle	   bombardment,	   or	   gene	   gun,	   method,	   involves	   the	  acceleration	   of	   DNA-­‐coated	   gold	   particles	   using	   a	   high-­‐voltage	   electric	  discharge	   device,	   enabling	   efficient	   penetration	   of	   target	   organs,	   tissues	   or	  single	   cells	   (Yang	   et	   al.,	   1990).	   Although	   this	   method	   causes	   minimum	  damage	  to	  the	  cells,	  the	  start-­‐up	  cost	  is	  however	  very	  expensive.	  
3.1.2.2 Chemical	  methods	  of	  transfection	  
Chemical	   methods	   of	   transfection	   involves	   the	   interaction	   of	   negatively	  charged	  nucleic	  acids	  with	  positively	  charged	  carrier	  molecules	  (also	  known	  as	  transfection	  reagents),	  and	  this	  enables	  the	  positively	  charged	  nucleic	  acid	  chemical	   complexes	   to	   interact	   with	   negatively	   charged	   cell	   membranes	  consequently	   introducing	   the	   gene	   into	   the	   cell	   by	   endocytosis	   or	  phagocytosis,	   although	   the	   exact	   uptake	  mechanism	   is	   still	   unknown	   (Kim	  and	   Eberwine,	   2010).	   These	   transfection	   reagents	   are	   cationic	   organic	  polymers,	  calcium	  phosphate	  or	  cationic	  lipids.	  
3.1.2.2.1 Cationic	  polymers	  
Diethylaminoethyl-­‐dextran	   (DEAE-­‐D)	   was	   the	   first	   non-­‐viral	   transfection	  method	   proved	   by	   Vaheri	   and	   Pagano	   (1965).	   It	   was	   well-­‐known	   for	   its	  simplicity	   and	   low	   costs,	   however,	   but	   is	   limited	   by	   low	   efficiency	   and	  reproducibility,	  and	  high	   toxicity.	  Over	   the	  recent	  years,	  various	  alternative	  cationic	   polymers	   with	   multiple	   functionalities	   have	   been	   documented	   to	  potentially	   achieve	  efficient	  gene	   transfection	   (Lin	  and	  Lou,	  2012).	  Cationic	  polymers	   that	   have	   been	   frequently	   studied	   in	   gene	   delivery	   include	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chitosan,	  PAMAM	  (polyamidoamine)	  dendrimer,	  and	  PEI	  (polyethylenimine).	  These	   polymers	   have	   the	   ability	   to	   self-­‐assemble	   with	   negatively-­‐charged	  DNA	   to	   form	   polymer/DNA	   complexes	   (polyplexes)	   and	   induce	   detectable	  gene	  transfection	  efficiency	  in	  vitro.	  PEIs	  with	  molecular	  weights	  above	  2	  kDa	  and	  dendrimers	  were	  reported	  to	  be	  very	  efficient	  in	  gene	  transfer	  (Remy	  et	  
al.,	  1998).	  
3.1.2.2.2 Calcium-­‐phosphate	  
The	  calcium-­‐phosphate	  co-­‐precipitation	  method	  was	  first	  verified	  by	  Graham	  and	   van	   der	   Eb	   in	   1973	   and	   it	   was	   reported	   that	   adenovirus	   5	   DNA	   was	  successfully	  transfected	  into	  human	  KB	  cells.	  In	  principal,	  DNA	  is	  mixed	  with	  calcium	  chloride	  before	  this	  is	  added	  to	  a	  buffered	  saline/phosphate	  solution	  to	  form	  a	  precipitate.	  This	  consequently	  allows	  the	  DNA	  to	  be	  taken	  up	  by	  the	  cells,	  presumably	  by	  endocytosis	  or	  phagocytosis.	  Since	  then,	  this	  method	  has	  become	  one	  of	  the	  major	  methods	  for	  DNA	  transfer	  into	  mammalian	  cell	  lines	  (Loyter,	  et	  al.,	  1982;	  Chen	  and	  Okayama,	  1987;	  Jordan	  et	  al.,	  1996;	  Jordan	  et	  
al.,	  1998)	  as	  the	  reagents	  are	  inexpensive	  and	  easily	  obtainable.	  This	  method,	  however,	  has	   low	  reproducibility	  and	  low	  transfection	  efficiencies,	  although	  recently,	   improvements	   have	   been	   made	   in	   increasing	   the	   transfection	  efficiency,	   for	   example	   by	   mixing	   ethidium	   monoazide	   and	   fluorescent	  peptide	   nucleic	   acid	   (PNA)	   labelling	   with	   the	   plasmid	   DNA	   (Batard,	   et	   al.,	  2001).	   Results	   have	   revealed,	   for	   the	   first	   time,	   up	   to	   100,000	   plasmid	  molecules	   were	   successfully	   transfected	   into	   Chinese	   hamster	   ovary	   cells	  (CHO).	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3.1.2.2.3 Cationic	  lipids	  
A	   successful	   in	   vitro	   transfection	   with	   cationic	   lipid	   was	   first	   reported	   by	  Felgner	  et	  al.	   in	  1987	  and	   this	   experiment	  made	  use	  of	   a	   synthetic	   cationic	  lipid,	   N-­‐[1-­‐(2,3-­‐dioleyloxy)propyl]-­‐N,	   N,	   N-­‐trimethylammonium	   chloride	  (DOTMA).	   In	   principal,	   small	   unilamellar	   liposome	   vesicles	   of	   the	   synthetic	  cationic	  lipid	  interact	  with	  DNA	  to	  form	  lipid-­‐DNA	  complexes.	  The	  synthetic	  lipid	   consequently	   facilitates	   the	   fusion	   of	   the	   complex	   with	   the	   cell	  membrane,	   resulting	   in	   the	  uptake	  of	  DNA	   into	   the	   cell.	   This	  method	  has	   a	  main	  advantage	  of	  successful	  delivery	  of	  DNA	  of	  all	  sizes	  into	  a	  wide	  range	  of	  cell	  types	  with	  high	  efficiency,	  but	  can	  exhibit	  high	  toxicity	  to	  cells.	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3.1.3 Transfection	  of	  fish	  cell	  lines	  
Several	   studies	  have	  reported	  successful	   transfection	  of	   fish	  cell	   lines	  using	  the	   application	   of	   various	   methods	   described	   above	   including	  electroporation	   (Schiøtz	  et	  al.,	   2011),	   cationic	   lipids	   (Romøren	  et	  al.,	   2004)	  and	  cationic	  polymers	  (Bearzotti	  et	  al.,	  1992;	  Leaver	  et	  al.,	  2005;	  Colliar	  et	  al.,	  2011).	  Because	  transfection	  efficiencies	  vary	  greatly	  among	  cell	   lines	  due	  to	  the	  differences	  in	  cell	  physiology	  and	  metabolic	  requirement	  that	  determines	  the	   uptake	   pathway,	   it	   is	   imperative	   that	   the	   transfection	   conditions	   are	  optimised	  for	   individual	  cell	   line	  (Hsu	  and	  Uludağ,	  2012),	  depending	  on	  the	  transfection	   reagent	   of	   choice.	   Having	   said	   this,	   the	   DNA	   concentration,	  reagent	  concentration	  and	  the	  ratio	  of	  reagent	  to	  DNA	  must	  be	  determined	  to	  ensure	  optimal	  binding	  affinity	  between	  reagent-­‐DNA	  complex	  and,	  effective	  release,	  consequently	  leading	  to	  successful	  transfection	  of	  cells.	  
This	  chapter	  focuses	  on:	  
1) The	   isolation	   of	   ligand-­‐binding	   domain	   (LBD)	   of	   plaice	  (Pleuronectes	  platessa)	  from	  full	  receptors	  and	  clone	  the	  sequences	  encoding	   the	   LBD	   into	   the	   pBIND	   plasmid	   by	   polymerase	   chain	  reaction	   (PCR),	   to	   create	   Gal4-­‐PPARγLBD	   construct	   (herein	  referred	  to	  as	  Gal4-­‐PPARγ).	  2) Identifying	   the	   most	   suitable	   cell	   line	   by	   measuring	   the	  transfection	  efficiencies	  of	  two	  cell	  lines:	  Atlantic	  salmon	  (AS)	  and	  Chinook	  salmon	  embryo	  214	  (CHSE-­‐214)	  cell	   lines,	  with	   the	  help	  of	   a	   transfection	   reagent,	   a	   cationic	   polymer,	   25-­‐kDa	   branched	  polythethylenimine	  (bPEI).	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3) Assessment	   of	   a	   variety	   of	   reagent	   to	   DNA	   ratios	   through	   the	  measurement	   of	   luciferase	   enzyme	   activity	   in	   identifying	   the	  optimal	  conditions	  for	  use	  in	  subsequent	  experiments	  using	  three	  plasmids:	   Gal4-­‐PPARαLBD	   construct	   (herein	   referred	   to	   as	   Gal4-­‐PPARα),	   a	   reporter	   gene	   construct,	   Gal4UAS-­‐luciferase	   plasmid	  (pGL4.31[luc2P/Gal4UAS/hygro])	  and	  an	  internal	  control	  plasmid,	  
Renilla	  luciferase	  plasmid	  (pGL4.75[hRluc/CMV]).	  	  4) The	   measurement	   of	   luciferase	   enzyme	   activity	   from	   CHSE-­‐214	  cells	   transfected	   with	   Gal4-­‐PPARα	   and	   Gal4-­‐PPARγ	   and	  subsequently	   treated	   with	   their	   known	   PPAR	   agonists	   in	  mammals,	  WY-­‐14,643	  and	  rosiglitazone,	  respectively,	  and	  selected	  fatty	  acids.	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 Materials	  and	  methods	  3.2
3.2.1 Construction	  of	  Gal4-­‐PPARγ 	  expression	  plasmid	  
3.2.1.1 PCR	  amplification	  of	  PPARγ 	  ligand-­‐binding	  domain	  
Sequences	  of	  cDNA	  encoding	  for	  PPARγ	  isotype	  has	  previously	  been	  isolated	  from	   plaice	   (Pleuronectes	   platessa)	   and	   cloned	   into	   pcDNA3	   vector	  (Invitrogen)	   (Leaver	   et	   al.,	   2005).	   The	   tissue	   distribution	   and	   activation	  profile	   of	   plaice	   PPARs	   have	   been	   characterised	   previously	   and	   they	   are	  therefore	   a	   suitable	   starting	   point	   for	   the	   development	   of	   cellular	  transfection	   systems.	   The	   plaice	   PPARα	   and	   PPARβ	   Gal4	   constructs	   have	  previously	   been	   produced	   (Colliar	   et	   al.,	   2011).	   The	   cDNA	   sequences	  encoding	   ligand-­‐binding	   domain	   of	   plaice	   PPARγ	   (amino	   acids	   196	   to	   532)	  was	  amplified	  by	  polymerase	  chain	   reaction	   (PCR)	  and	  cloned	  downstream	  and	   in-­‐frame	   with	   Gal4	   DNA-­‐binding	   domain	   (DBD)	   of	   the	   pBIND	   cloning	  vector.	  	  
A	  pair	  of	  primers	  was	  designed	   from	  the	  predicted	  coding	  regions	  of	  plaice	  PPAR	   gene	   around	   the	   nucleotide	   sequences	   corresponding	   to	   the	   amino	  acids	  above.	  The	  forward	  and	  reverse	  primer	  sequences	  for	  PPARγ	  were	  5’-­‐	  TTG	  GAT	  CCG	  CAT	  GTC	  ACA	  CAA	  CGC	  TAT	  TCG	  TTT	  T	   -­‐3’	  and	  5’-­‐	  AAG	  GTA	  CCC	  TCT	  AAT	  ACA	  AGT	  CCT	  TCA	  TGA	  TC	  -­‐3’,	  respectively.	  Within	  the	  forward	  and	   reverse	   primers	   were	   recognition	   sequences	   for	   restriction	   enzymes	  BamHI	  (5’	  –GGATCC-­‐	  3’)	  and	  Kpn1	  (5’	  –GGTACC-­‐	  3’),	  respectively,	  at	  their	  5’	  ends	   underlined	   above.	   The	   selection	   of	   these	   enzymes	   were	   due	   to	   the	  presence	  of	  their	  recognition	  sequences	  within	  the	  multiple	  cloning	  region	  of	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the	  pBIND	  plasmid	   into	  which	   the	  PPAR	   ligand-­‐binding	   regions	  were	   to	  be	  cloned	   but	   absent	   in	   the	   ligand-­‐binding	   domain	   of	   plaice	   PPARγ.	   These	  restriction	   enzyme	   recognition	   sequences	   were	   to	   be	   incorporated	   into	  primers	   and	   were	   then	   incorporated	   into	   the	   amplified	   products,	  subsequently	   the	   directional	   cloning	   of	   the	   ligand-­‐binding	   domain	   into	   the	  pBIND	  cloning	  vector,	  downstream	  of	  and	  in-­‐frame	  with	  the	  Gal4-­‐DBD.	  	  
Two	   PCR	   reactions	   were	   prepared	   in	   50	   µl	   volumes	   in	   PCR	   tubes,	   each	  containing	   5	   ng	   DNA	   template	   (ppcDNA3-­‐PPARγ-­‐1	   or	   ppcDNA3-­‐PPARγ-­‐2),	  250	  nM	  each	  of	   forward	   and	   reverse	  primer	   and	  25	  µl	   2	   x	  My	  Taq	  HS	  mix	  (Promega).	  Both	  reaction	  tubes	  were	  cycled	  in	  a	  thermal	  cycler	  (Biometra	  T	  gradient)	  using	  the	  following	  conditions:	  one	  minute	  at	  95	  ᵒC	  to	  activate	  the	  enzyme	   and	   break	   the	   DNA	   strand	   (initial	   denaturation),	   followed	   by	   20	  seconds	  at	  95	  ᵒC	  to	  allow	  denaturation,	  20	  seconds	  at	  55	  ᵒC	  to	  allow	  primers	  to	  anneal	  to	  DNA	  strands	  and	  one	  minute	  at	  72	  ᵒC,	  an	  optimum	  temperature	  at	   which	   1	   kb	   fragment	   could	   be	   generated	   (extension).	   The	   denaturation,	  annealing	  and	  extension	  steps	  were	  repeated	  35	  x	  to	  get	  235	  copies.	  
3.2.1.2 Precipitation	  and	  restriction	  digestion	  of	  DNA	  
PCR	  products	  were	  precipitated	  out	  of	  enzymatic	  reactions	  using	  ethanol.	  To	  each	   PCR	   reaction	   1/10	   volume	   of	   3	   M	   sodium	   acetate	   (Sigma)	   and	   2.5	  volumes	   of	   95	   %	   ethanol	   were	   added.	   This	   was	   mixed	   thoroughly	   before	  incubating	   the	   reaction	   on	   ice	   (4	   ᵒC)	   for	   about	   5	   minutes,	   to	   allow	   the	  formation	  of	  precipitate.	  Each	  reaction	  was	  centrifuged	  at	  15,000	  x	  g	  for	  10	  minutes.	   The	   supernatant	  was	   carefully	   discarded	   and	   the	   DNA	   pellet	   was	  washed	  with	  200	  µl	  70	  %	  ethanol	  before	  each	  reaction	  tubes	  was	  centrifuged	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again	  for	  5	  minutes.	  The	  supernatant	  was	  removed	  from	  each	  tube	  and	  was	  left	   to	   dry	   at	   room	   temperature	   for	   15	  minutes	   to	   remove	   excess	   ethanol,	  leaving	  behind	  a	  pellet	  of	  purified	  DNA.	  
Each	   DNA	   pellet	   was	   re-­‐suspended	   in	   20	   µl	   volumes	   digestion	   reactions	  containing	   final	   concentrations	   of	   1	   x	   multicore	   buffer	   (Promega),	   5	   units	  BamH1	  restriction	  enzyme	  (Invitrogen)	  and	  5	  units	  Kpn1	  restriction	  enzyme	  (Invitrogen).	  pBIND	  vector	  (1	  µg;	  Promega)	  was	  digested	  in	  the	  same	  way	  in	  50	  µl	  volume,	  	  but	  whilst	  the	  digested	  reactions	  were	  incubated	  at	  37	  ᵒC	  for	  an	  hour,	  the	  digested	  pBIND	  vector	  was	  incubated	  at	  37	  ᵒC	  for	  3	  hours.	  The	  digested	   reactions	   were	   heated	   at	   75	   ᵒC	   for	   15	   minutes	   to	   inactivate	  restriction	  nucleases.	  Purified	  DNAs	  were	  obtained	  from	  the	  final	  2	  digested	  reactions	   and	   a	   digested	   pBIND	   vector	   using	   QIAquick	   spin	   columns	   in	   a	  microcentrifuge,	   following	   the	   manufacturer’s	   instructions	   in	   the	   QIAquick	  PCR	   purification	   kit	   protocol.	   The	   final	   products	   from	   this	   procedure	  obtained	  were	  purified	  DNAs,	  each	  eluted	  in	  30	  µl	  MilliQ	  water.	  A	  sample	  of	  each	   purified	   DNA	   was	   loaded	   onto	   a	   1x	   TAE,	   1	   %	   agarose,	   0.5	   µg/ml	  ethidium	  bromide	  gel	  and	  electrophoresed	  at	  75	  V	  for	  45	  minutes	  alongside	  a	  1	  kb	  Hyper	  Ladder	  molecular	  weight	  marker	  (Fementas).	  Ethidium	  bromide-­‐stained	  DNA	  was	  visualised	  by	  exposure	  of	  the	  gel	  to	  UV	  light.	  	  
3.2.1.3 Ligation	  of	  digested	  PCR	  products	  into	  digested	  pBIND	  vector	  
The	   amplified	   and	   digested	   ligand-­‐binding	   domains	  were	   each	   ligated	   into	  pBIND	   vector	   in	   a	   20	   µl	   reaction	   volume,	   each	   containing	   an	   appropriate	  molar	  range	  of	  vector	  to	  insert	  of	  1:3	  that	  adds	  up	  to	  no	  more	  than	  100	  ng	  of	  DNA	  (volume	  was	  adjusted	  to	  14	  µl	  with	  MilliQ	  water),	  1	  µl	  QS	  ligase	  and	  5	  µl	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of	  4	  x	  QS	  buffer.	  The	  ligation	  reactions	  were	  incubated	  at	  room	  temperature	  for	  5	  minutes.	  
3.2.1.4 Transformation	  of	  pBIND	  PPARγ-­‐LBD	  into	  Top10	  E.	  Coli	  
Ligated	  DNA	  was	  transformed	  into	  Top10	  chemo-­‐competent	  E.	  coli	  cells.	  100	  µl	   of	   E.	   coli	   cells	   were	   thawed	   on	   ice	   and	   5	   µl	   of	   each	   ligation	   reaction	  containing	  plasmid	  was	  added.	  These	  were	   incubated	  on	   ice	   for	  30	  minutes	  before	  the	  cells	  were	  transform	  by	  heat	  shock	  in	  a	  waterbath	  at	  42ᵒC	  for	  one	  minute.	  Into	  each	  tube	  of	  transformed	  cells,	  0.9	  ml	  of	  sterilised	  Luria-­‐Bertani	  (LB)	   broth	   was	   added	   and	   incubated	   at	   37	   ᵒC	   for	   one	   hour.	   100µl	   of	  transformants	   were	   spread	   on	   selective	   LB	   agar	   plates	   (100	   µg/ml	  ampicillin).	  Plates	  were	  incubated	  at	  37ᵒC	  overnight.	  The	  colonies	  from	  each	  plate	  were	  inoculated	  into	  4	  ml	  cultures	  (LB	  media,	  supplemented	  with	  100	  
µg	   ampicillin)	   and	   these	   were	   incubated	   overnight	   at	   37ᵒC	   with	   agitation	  (~150	  rpm).	  Purification	  of	  plasmid	  DNA	  from	  cultures	  was	  done	  using	   the	  ISOLATE	  II	  Plasmid	  Mini	  Kit,	  following	  manufacturer’s	  instructions.	  	  DNA	  was	  eluted	  from	  columns	  using	  70	  µl	  MilliQ	  water.	  
A	  restriction	  digest	  was	  performed	  on	  a	  sample	  of	  each	  eluate	  as	  described	  in	  Section	  2.2.4.1.	  Each	  purified	  DNA	  was	   loaded	  onto	  a	  1	  x	  TAE,	  1	  %	  agarose,	  0.5	  µg/ml	  ethidium	  bromide	  gel	  and	  electrophoresed	  at	  75	  V	  for	  45	  minutes	  alongside	   a	   1	   kb	   Hyper	   Ladder	   molecular	   weight	   marker	   (Fementas)	   to	  confirm	   the	   insertion	   of	   DNA	   fragments	   into	   the	   pBIND	   vector.	   Ethidium	  bromide-­‐stained	   DNA	   was	   visualised	   by	   exposure	   of	   the	   gel	   to	   UV	   light.	  Successful	  cloning	  was	  indicated	  by	  the	  presence	  of	  at	  least	  one	  DNA	  band	  at	  6	   kb	   pBIND	   vector	   and	   another	   band	   about	   1000	  bp	  PPARγ	   ligand-­‐binding	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domain	  insert	  before	  the	  plasmids	  were	  sent	  for	  sequencing	  to	  confirm	  this,	  using	  the	  selection	  of	  sequences	  in	  Table	  3-­‐1.	  	  
	  
Table	  3-­‐1	  Primer	   (sequences)	  used	   in	   the	   sequencing	  of	  pBIND	  vector	  
containing	  ligand-­‐binding	  domain	  of	  PPARγ 	  
	  	   	  
Name	  of	  Sequencing	  Primer	   Primer	  sequence	  (5’	  to	  3’)	  
pBINDseqF	   CTC	  TAA	  CAT	  TGA	  GAC	  AGC	  
pBINDseqR	   GGT	  TTG	  TCC	  AAA	  CTC	  ATC	  
PPARγ	  LBDseqR	   CCT	  CAG	  ATC	  TGC	  TGC	  TTC	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3.2.2 	  Cell	  culture	  
3.2.2.1 Brief	  description	  of	  cell	  lines	  
The	   established	   cell	   lines	   of	   AS	   and	   CHSE-­‐214	   were	   obtained	   from	   the	  Laboratory	   of	   Disease	   and	   Virology,	   Institute	   of	   Aquaculture,	   School	   of	  Natural	   Sciences,	  University	   of	   Stirling,	   Stirling	   (UK).	   The	  AS	   cell	   line	  has	   a	  monolayer	   culture	   of	   fibroblast-­‐like	   cells	   originally	   derived	   from	   a	   trypsin	  digest	   of	   heart,	   liver,	   kidney	   and	   spleen	   tissue	   of	   young	   Atlantic	   salmon	  (Salmon	  salar)	  (Nicholson	  and	  Byrne,	  1973).	  Likewise,	  the	  monolayer	  culture	  of	  CHSE-­‐214	  has	  fibroblast-­‐like	  morphology	  and	  this	  established	  cell	  line	  was	  initiated	  from	  Chinook	  salmon	  (Oncorhynchus	  tshawytscha)	  embryo	  (Lannan	  
et	  al.,	  1984).	  	  
3.2.2.2 Routine	  culture	  of	  cells	  
Cells	   were	   grown	   in	   25	   cm2	   tissue	   culture	   flasks	   (Sarstedt	   AG	   &	   Co.	  Laboratories,	  Nümbrecht,	   Germany)	   in	   the	   complete	  media,	   containing	  5ml	  Eagle’s	  Minimum	  Essential	  Medium	  (EMEM;	  Gibco)	  supplemented	  with	  10%	  (v/v)	  fetal	  bovine	  serum	  (FBS),	  1	  x	  non-­‐essential	  amino	  acids	  (NEAA)	  and	  2	  mM	  L-­‐glutamine,	  incubated	  at	  22	  °C	  in	  an	  atmosphere	  of	  4	  %	  carbon	  dioxide	  CO2	   (the	   lids	   of	   flasks	   were	   left	   slightly	   loose).	   All	   media	   were	   prepared	  under	   sterile	   conditions,	   kept	   at	   room	   temperature	   (20-­‐22	   °C)	   and	  supplemented	   weekly	   with	   200	   μM	   L-­‐glutamine.	   Cells	   were	   passaged	   1:3	  once	   per	   week	   before	   reaching	   full	   confluence	   and	   the	   growth	   of	   the	  monolayers	  were	  observed	  under	  the	  inverted	  microscope	  (Olympus	  IMT-­‐2).	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All	  experiments	  were	  performed	  on	  cultures	  at	  80-­‐85	  %	  confluence	  when	  the	  cells	  were	  still	  actively	  growing.	  
3.2.2.3 Harvesting	  of	  cells	  
Cells	  were	  harvested	  from	  the	  25	  cm2	  tissue	  culture	  flasks	  for	  the	  purpose	  of	  passaging,	  seeding	  and	  cell	  counting.	  The	  medium	  was	  removed	  from	  flasks	  by	   decanting	   and	   the	   cells	   were	   washed	   twice	   with	   Dulbecco’s	   phosphate	  buffered	  saline	  (DPBS;	  Gibco).	  Cells	  were	  harvested	  by	  adding	  1	  ml	  of	  0.05	  %	  trypsin/ethylenediaminetetraacetic	  acid	  (EDTA),	  with	  incubation	  for	  2	  min	  at	  room	   temperature.	   When	   the	   monolayer	   became	   opaque,	   excess	  trypsin/EDTA	  was	  decanted	  and	  the	  cells	  were	  dislodged	  by	  sharply	  tapping	  the	  side	  of	  flasks	  with	  the	  palm	  of	  the	  hand.	  Cells	  were	  then	  re-­‐suspended	  in	  an	  appropriate	  volume	  of	   the	  complete	  media	  by	  pipetting	  up	  and	  down	  to	  ensure	  a	  homogenous	  cell	   suspension	   for	   further	  procedures	  depending	  on	  the	  purpose	  mentioned	  earlier.	  
3.2.2.4 Counting	  and	  seeding	  of	  cells	  
Prior	  to	  seeding	  of	  cells,	  a	  cell	  count	  using	  the	  trypan	  blue	  exclusion	  method,	  was	  used	   to	   assess	   cell	   viability.	   Trypan	  blue	   solution	  was	  used	   to	   identify	  living	  and	  dead	  cells	  and	  with	  this	  solution,	  dead	  cells	  are	  permeable	  to	  take	  up	   the	  dye	  and	  are	  stained	  blue	  while	   the	  viable	  cells	   remain	  colourless	  do	  not	  take	  up	  impermeable	  dyes.	  Harvested	  cells	  were	  re-­‐suspended	  in	  3ml	  of	  fresh	  medium	   followed	  by	  gentle	  pipetting	   to	  ensure	  homogeneity.	  The	  cell	  suspension	   was	   then	   transferred	   to	   a	   fresh	   Bijoux	   sample	   container	   from	  which	  100	  μl	  was	  aliquoted	  and	  mixed	  with	  an	  equal	  volume	  of	  0.4	  %	  trypan	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blue	   solution.	   A	   standard	   Neubauer	   chamber	   haemocytometer	   (improved	  Neubauer	   B.S.	   748	   Depth	   0.1	   mm	   or	   1/400	   mm2)	   was	   used	   and	   a	   special	  haemocytometer	   coverslip	  20	  x	  26	  x	  0.4	  mm	  was	  pressed	  onto	   the	   slide	   to	  ensure	  good	  adherence	  between	  the	  coverslip	  and	  the	  haemocytometer	  and	  both	   chambers	   filled	   by	   capillary	   action	   with	   the	   stained	   cell	   suspension.	  Looking	   through	   the	   microscope	   under	   a	   low	   power	   objective,	   the	   viable,	  colourless	  cells	  within	   the	  1	  mm2	  square	  of	   the	  central	  portion	  of	   the	  ruled	  pattern	   were	   counted	   and	   the	   cell	   numbers	   were	   averaged	   over	   the	   two	  chambers.	  To	  calculate	   the	  number	  of	   cells	  per	  ml	   suspension,	   this	  average	  was	   multiplied	   by	   1000	   and	   again	   multiplied	   by	   the	   volume	   of	   cell	  suspension	  to	  give	  the	  total	  number	  of	  cells.	  To	  achieve	  a	  cell	  density	  of,	  the	  cell	  suspension	  was	  diluted	  with	  complete	  media	  to	  achieve	  a	  cell	  density	  of	  2.0	  x	  105	  cells/ml	  and	  to	  the	  wells	  of	  24-­‐well	  assay	  plates	  (Corning),	  1ml	  of	  cell	  suspension	  was	  seeded,	  incubated	  overnight	  at	  22	  °C	  in	  an	  atmosphere	  of	  4	  %	  CO2,	  ready	  for	  transfection	  the	  following	  day.	  	  
3.2.2.5 Freezing	  and	  preservation	  of	  cells	  
Cells	  were	  preserved	   for	   future	  use	   and	   subsequent	   experiments	   to	   ensure	  that	  all	  transfections	  were	  performed	  on	  cells	  with	  similar	  passage	  numbers.	  As	  described	  in	  Section	  3.2.2.3,	  cells	  harvested	  from	  a	  25	  cm2	  tissue	  culture	  flask	  were	   re-­‐suspended	   in	   3	  ml	   of	   growth	  medium	  by	   gently	   pipetting	   up	  and	  down.	  This	  cell	  suspension	  was	  collected	  in	  a	  universal	  container	  and	  a	  viable	   cell	   count	   was	   performed	   as	   described	   in	   Section	   3.2.2.4.	   Cryovials	  were	   used	   to	   store	   the	   cells	   and	   each	   cryovial	   was	   prepared	   with	   the	  following	  details:	   cell	   line,	  passage	  number,	  date	  of	   freezing	  and	  number	  of	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cells	   per	   ampoule.	   The	   total	   volume	   was	   calculated	   and	   adjusted	   using	  freezing	   medium	   (growth	   media	   +	   10%	   dimethyl	   sulphoxide,	   DMSO)	   to	  produce	  a	  solution	  containing	  3	  x	  106	  cells	  per	  ml	  per	  cryovial.	  All	  cryovials	  were	   placed	   in	   -­‐20	   °C	   freezer,	   upright	   in	   a	   polystyrene	   box	   to	   avoid	   cell	  suspension	  freezing	  into	  lid,	  for	  1	  hour	  before	  they	  were	  being	  transferred	  to	  the	   -­‐70	   °C	   freezer	   for	   an	   additional	   2	   hours.	   Cryovials	  were	   then	   removed	  from	   the	  box,	   placed	   in	   labelled	   canes	   and	   immediately	   immersed	   in	   liquid	  nitrogen	  (-­‐196	  °C).	  
3.2.3 Optimisation	  1:	  Transfection	  of	  cell	  lines	  
AS	  and	  CHSE-­‐214	  cells	  were	  harvested	  and	  seeded	  into	  24-­‐well	  assay	  plates	  (Corning)	  24	  hours	  prior	  to	  transfection,	  as	  explained	  in	  Sections	  3.2.2.3	  and	  3.2.2.4.	  The	  cells	  were	  incubated	  overnight	  at	  22	  °C	  in	  an	  atmosphere	  of	  4	  %	  CO2.	  	  
3.2.3.1 Transfection	  of	  cell	  lines	  with	  plasmid	  DNA	  using	  bPEI	  reagent	  
According	  to	  Hsu	  and	  Uludağ	  (2012),	   the	  use	  of	  branched	  polyethylenimine	  (bPEI)	  reagent	  has	  been	  optimised	  for	  transfection	  of	  a	  variety	  of	  mammalian	  cells.	   In	   this	  project,	   optimisation	  was	   required	   for	   the	   transfection	  of	  DNA	  into	   fish	   cell	   lines	   by	   altering	   the	   ratio	   of	   bPEI	   reagent	   to	   DNA.	   The	  recommended	  ratio	  of	  bPEI	  (µg)	  to	  DNA	  (µg),	  2.5:1	  (Hsu	  and	  Uludağ,	  2012)	  was	   used	   as	   a	   starting	   point	   in	   the	   transfection	   of	   the	   cells	   and	   that	   half,	  double	  and	  quadruple	  the	  recommended	  ratio	  were	  also	  tested.	  	  
In	   this	   first	  part	  optimisation	  experiment,	  plaice	  Gal4-­‐PPARα	  was	  used	  as	  a	  positive	  control	  and	  the	  transfection	  efficiencies	  were	  assessed	  by	  measuring	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the	  levels	  of	  a	  constitutively	  expressed	  Renilla	  luciferase	  gene.	  A	  total	  of	  four	  transfection	  mixtures	  with	  bPEI:DNA	  (µg:µg)	   	   ratio	  of	  1.25:1,	  2.5:1,	  5:1	  and	  10:1	  were	   prepared	   using	   two-­‐part	  mixing	   in	   salt-­‐free	   buffer	  method	   (Hsu	  and	  Uludağ,	  2012),	  to	  a	  volume	  enough	  for	  triplicates	  for	  both	  cell	  lines.	  Each	  transfection	  mix	  contained	  1	  µg	  of	  pDNA	  in	  equal	  amount	  (ratio	  1:1:1):	  Gal4-­‐PPARα,	   a	   plasmid	   containing	   the	   firefly	   luciferase	   reporter	   gene	  pGL4.31[luc2P/Gal4UAS/hygro],	   used	   to	   report	   transcriptional	   activation,	  and	   a	   plasmid	   containing	   the	   Renilla	   luciferase	   gene	   pGL4.75[hRluc/CMV],	  used	   as	   an	   indicator	   of	   transfection	   efficiency.	   These	   plasmids	   were	   used	  because	  this	  combination	  reflects	  the	  experimental	  used	  in	  subsequent	  PPAR	  assays.	  
Pure	  bPEI	  (Sigma)	  stock	  solution	  was	  prepared	  by	  dissolving	  the	  powder	  in	  MilliQ	  water	  to	  a	  concentration	  of	  5	  mg/ml,	  sterile	  filtered	  through	  0.22	  µm	  membrane	  and	  stored	  at	  4	  °C.	  For	  transfection	  experiments,	  diluted	  bPEI	  of	  1	  mg/ml	  was	  used.	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Table	  3-­‐2	  The	  four	  transfection	  mixes	  prepared	  using	  two-­‐part	  mixing	  
in	   salt-­‐free	   buffer	   method	   with	   bPEI	   transfection	   reagent,	   each	  
containing	   the	   Gal-­‐PPARα ,	   pGL4.31[luc2P/Gal4UAS/hygro]	   and	  
pGL4.75[hRluc/CMV]	   at	   a	   ratio	   of	   1:1:1	   and	  different	   amounts	   of	   bPEI	  
reagent.	   bPEI	   reagent	  was	   added	   before	   each	   of	   the	   four	   transfection	  
mixes	  was	  split	  between	  3	  wells	  containing	  AS	  cells.	  
A	   total	   of	   1	   µg	   plasmid	   DNA	   containing	   Gal-­‐PPARα	   plasmid,	  pGL4.31[luc2P/Gal4UAS/hygro]	   and	   pGL4.75[hRluc/CMV]	   in	   a	   1:1:1	   ratio,	  respectively,	  was	  diluted	  with	  EMEM	  (containing	  no	  FBS	  or	  antibiotics),	  to	  a	  final	   concentration	   of	   0.02	  µg/ml.	   In	   separate	   tubes,	   EMEM	   (containing	   no	  FBS	  or	  antibiotics)	  was	  combined	  with	  1	  mg/ml	  bPEI	  reagent	  (Table	  3-­‐2)	  and	  incubated	  at	  room	  temperature	  for	  5	  min.	  The	  diluted	  DNA	  solution	  was	  then	  added	   to	   the	   diluted	   polymer	   solution	   vortex	   mixed	   for	   5	   s	   before	   being	  incubated	  at	   room	  temperature	   for	  25	  min	   to	  allow	   for	  a	   complex	  between	  the	  bPEI	  reagent	  and	  DNA	  to	  form.	  This	  polyplex	  solution	  was	  then	  diluted	  in	  400	   µl	   EMEM	   (containing	   no	   FBS	   or	   antibiotics)	   and	   was	   left	   at	   room	  temperature	  for	  an	  additional	  5	  min.	  	  The	  cell	  culture	  medium	  was	  removed	  
DNA	  Ratio	  (1μg)	   1:1:1	  
Gal4-­‐PPARα	  (ng)	   333.3	   333.3	   333.3	   333.3	  
pGL4.31[luc2P/Gal4UAS/hygro]	  (ng)	   333.3	   333.3	   333.3	   333.3	  
pGL4.75[hRluc/CMV]	  (ng)	   333.3	   333.3	   333.3	   333.3	  
bPEI:DNA	  (μg:μg)	   1.25:1	   2.5:1	   5:1	   10:1	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from	   each	   well	   of	   the	   24-­‐well	   plate	   by	   aspiration	   and	   500	   µl	   of	   diluted	  polyplex	  transfection	  mixture	  was	  then	  added	  to	  the	  each	  well.	  The	  plate	  was	  gently	   agitated	   before	   it	   was	   centrifuged	   at	   210	   x	   g	   for	   5	   min	   at	   room	  temperature,	  forcing	  the	  complexes	  onto	  the	  cell	  surface	  at	  the	  bottom	  of	  the	  plate	  in	  a	  microplate	  adaptor	  rotor.	  The	  plate	  was	  then	  gently	  removed	  from	  the	   centrifuge,	   being	   careful	   not	   to	   disturb	   the	   medium	   and	   incubated	  overnight	   at	   22	   °C	   in	   an	   atmosphere	   of	   4	   %	   CO2.	   The	   following	   day,	   the	  transfection	   mixture	   was	   removed	   from	   each	   well	   by	   aspiration	   and	   was	  replaced	  with	   1ml	   complete	  media	   and	   incubated	   overnight	   at	   22	   °C	   in	   an	  atmosphere	  of	  4	  %	  CO2.	  The	  aim	  of	  this	  experiment	  was	  to	  identify	  the	  most	  suitable	  and	  effective	  cell	  line	  for	  transfection	  using	  bPEI	  reagent.	  
3.2.3.1.1 Measurement	  of	  Firefly	  (Photinus	  pyralis)	  luciferase	  
After	   24	   hr	   incubation,	   the	   cell	   media	   were	   removed	   from	   the	   plate	   by	  aspiration	   and	   blotted	   on	   paper	   to	   remove	   any	   excess	   media.	   The	   cells	   in	  each	  well	  were	  washed	  using	  1	  x	  DPBS,	  twice.	  Cells	  were	  then	  lysed	  in	  1	  ml	  of	  1	   x	   passive	   lysis	   buffer	   (Promega)	   for	   10	  min,	   shaking.	   The	   cell	   lysate	  was	  then	  used	  in	  a	  dual	  luciferase	  assay	  system	  in	  which	  75	  µl	  of	  cell	  lysate	  from	  each	  well	  was	  transferred	  to	  a	  black	  96-­‐well	  plate	  (Corning).	  Into	  each	  well,	  equal	  volume	  of	  a	  2	  x	  concentrated	  volume	  of	  “homemade”	  firefly	  luciferase	  buffer	  was	  added	  to	  wells	  and	  the	  final	  composition	  of	  the	  homemade	  buffer	  in	   wells	   was	   15	  mM	   potassium	   phosphate	   (KxPO4,	   pH	   8.0),	   25	   mM	   glycyl-­‐glycine	   (pH	   8.0),	   1	   mM	   dithiothreitol	   (DTT,	   Sigma),	   15	   mM	   magnesium	  chloride	  (MgCl2),	  1	  mM	  adenosine	  triphosphate	  (ATP),	  100	  µM	  coenzyme	  A	  (CoA,	  Sigma)	  and	  150	  µM	  luciferin	  (Promega).	  The	  contents	  of	  the	  wells	  were	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pipetted	  up	  and	  down	  to	  mix	  and	  was	  incubated	  for	  2	  min	  before	  luciferase	  activity	   was	   measured	   on	   the	   Wallac	   1420	   Victor	   2	   multilabel	   counter	  (Perkin	  Elmer).	  	  
3.2.3.1.2 Measurement	  of	  Renilla	  (Renilla	  reniformis)	  luciferase	  
Following	  measurement	  of	  firefly	  luciferase,	  75	  µl	  volume	  of	  3x	  concentrated	  “homemade”	   Renilla	   luciferase	   buffer	   was	   added.	   The	   final	   composition	   of	  this	  reagent	  was	  575	  mM	  sodium	  chloride	  (NaCl),	  100	  mM	  sodium	  phosphate	  (NaPO4,	   pH	   5.1),	   2	   mM	   Ethylenediaminetetraacetic	   acid	   (EDTA),	   1	   mM	  sodium	   azide	   (NaN3),	   0.33	   mg/ml	   BSA	   (Sigma)	   and	   1	   µM	   coelenterazine	  (Promega).	   The	   contents	  were	   again	   pipetted	   up	   and	  down	   to	  mix	   and	   a	   2	  min	  incubation	  given.	  Renilla	  luciferase	  activity	  was	  measured	  on	  the	  Wallac	  1420	  Victor	  2	  multilabel	  counter	  (Perkin	  Elmer).	  
Both	   firefly	   and	   Renilla	   luciferase	   activities	   were	   assayed	   in	   order	   to	  accurately	  reflect	  the	  conditions	  for	  subsequent	  PPAR	  assays.	  
3.2.3.1.3 Data	  analysis	  
For	   this	   experiment,	   the	  Renilla	   luciferase	   values	  were	   averaged	   and	   these	  values	  would	  represent	   the	   transfection	  efficiencies	  of	  various	  bPEI	   to	  DNA	  ratios	  on	   transfected	  AS	  and	  CHSE-­‐214	  cells.	  The	   results	   are	  based	  only	  on	  graphical	  trends.	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3.2.3.2 Transfection	  of	  AS	  cells	  with	  different	  amount	  of	  DNA	  
Renilla	   luciferase	   enzymes	  were	   expressed	   relatively	   higher	   in	   AS	   cell	   line	  than	   in	  CHSE-­‐214	   cell	   line	   at	  bPEI:DNA	   ratio	  of	  2.5:1	   (Figure	  2-­‐1).	  Another	  optimisation	   experiment	   was	   carried	   out	   by	   varying	   the	   amount	   of	   DNA	  plasmids	   in	   the	   0.1	   mg/ml	   DNA	   mix	   containing	   Gal4-­‐PPARα,	  pGL4.31[luc2P/Gal4UAS/hygro]	   and	  pGL4.75[hRluc/CMV]	   	   i.e.	   1:1:1,	   1:1:0.5	  and	  1:1:0.2,	  respectively	  and	  at	  a	  constant	  ratio	  of	  bPEI:DNA	  2.5:1.	  	  
In	   this	   experiment,	   transfected	   cells	   were	   subsequently	   treated	   with	   4-­‐Chloro-­‐6-­‐(2,3-­‐xylodino)-­‐2-­‐pyrimidinylthioacetic	   acid	   (WY-­‐14,643;	   Sigma),	   a	  compound	  previously	  identified	  as	  a	  ligand,	  reported	  to	  activate	  mammalian	  and	   piscine	   PPARα.	   A	   2.5	  mM	   stock	   solution	   of	  WY-­‐14,643	   compound	  was	  prepared	   in	   ethanol	   absolute	   and	   10	   µl	   was	   diluted	   into	   1	   ml	   complete	  EMEM,	  giving	  a	  final	  concentration	  of	  25	  µM.	  A	  control	  treatment	  of	  ethanol	  vehicle	   was	   also	   prepared,	   in	   which	   ethanol	   was	   diluted	   into	   EMEM	   at	   a	  concentration	  of	  5	  µl/ml.	  This	  experiment	  aimed	  to	  determine	  the	  activation	  of	   Gal4-­‐PPARα	   by	  WY-­‐14,643	   by	   measuring	   the	   firefly	   luciferase	   signal	   at	  various	   amounts	   of	   DNA,	   in	   order	   to	   confirm	   that	   the	   PPAR	   assay	  worked	  under	  the	  transfection	  and	  luciferase	  assay	  conditions	  used.	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Table	  3-­‐3	  The	  three	  transfection	  mixes	  prepared	  using	  two-­‐part	  mixing	  
in	   salt-­‐free	   buffer	   method	   with	   bPEI	   transfection	   reagent,	   each	  
containing	   DNA	   mix	   of	   Gal4-­‐PPARα ,	   pGL4.31[luc2P/Gal4UAS/hygro]	  
and	   pGL4.75[hRluc/CMV]	   at	   different	   ratio	   1:1:1,	   1:1:0.5	   and	   1:1:0.2,	  
respectively.	   bPEI	   reagent	   was	   added	   before	   	   each	   of	   the	   three	  
transfection	  mixes	  was	  split	  between	  3	  wells	  containing	  AS	  cells.	  
	  	   	  
bPEI:DNA	  (μg:µg)	   2.5:1	  
DNA	  Ratio	  (1	  µg	  or	  0.1	  mg/ml)	   1:1:1	   1:1:0.5	   1:1:0.2	  
Gal4-­‐PPARα	  (ng)	   333.3	   400.0	   450.0	  
pGL4.31[luc2P/Gal4UAS/hygro](ng)	   333.3	   400.0	   450.0	  
pGL4.75[hRluc/CMV]	  (ng)	  	   333.3	   200.0	   100.0	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3.2.3.3 Transfection	  of	  AS	  and	  CHSE-­‐214	  cells	  with	  pEGFP	  
The	  AS	   cell	   line	   showed	   instability	   in	   cell	   growth	   after	   a	   few	  passages	   and	  that	   the	   firefly	   luciferase	   activities	   were	   observed	   to	   have	   decreased	   at	  higher	   passage	  numbers	  when	   the	   transfected	   cells	  were	   treated	  with	  WY-­‐14,643	  (Figure	  3-­‐6).	  Thus,	  both	  AS	  and	  CHSE-­‐214	  cell	  lines	  were	  once	  again	  tested	   for	   optimisation	   but	   this	   time,	   enhanced	   green	   fluorescent	   protein	  plasmid	   (pEGFP)	   was	   transfected	   into	   the	   cells.	   This	   experiment	   was	   to	  determine	  the	  transfection	  efficiency	  by	  visually	  observing	  the	  expression	  of	  this	   plasmid	   in	   the	   transfected	   cells	   under	   a	   fluorescent	   microscope	  (Olympus).	  	  Six	  transfection	  mixes	  were	  prepared	  using	  a	  constant	  amount	  of	  pEGFP,	  0.1	  mg/ml	  (or	  1	  µg),	  and	  the	  bPEI:DNA	  (μg:μg)	  ratio	  set	  ups	  were	  1:1,	  2.5:1,	  4:1	  and	  doubling	  the	  amount	  of	  bPEI	  and	  DNA	  to	  the	  three	  ratios.	  These	  were	   added	   to	   the	   cells	   and	   were	   incubated	   overnight	   at	   22	   °C	   in	   an	  atmosphere	  of	  4	  %	  CO2.	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3.2.4 Optimisation	  2:	  Transfection	  using	  CHSE-­‐214	  cell	  line	  
3.2.4.1 Transfection	  of	  CHSE-­‐214	  with	  plasmid	  DNA	  using	  bPEI	  
Transfected	  pEGFP	  was	  highly	  expressed	  in	  CHSE-­‐214	  cells	  when	  the	  amount	  of	  bPEI:DNA	  ratio	  of	  2.5:1	  was	  doubled	  (Figure	  3-­‐8).	  This	  was	  further	  tested	  in	  another	  optimisation	  experiment	  in	  the	  dual	  luciferase	  assay	  by	  measuring	  the	  expression	  of	  firefly	  and	  Renilla	  luciferase	  enzymes.	  	  
	  
Table	  3-­‐4	  The	  six	  transfection	  mixes	  prepared	  using	  two-­‐part	  mixing	  in	  
salt-­‐free	  buffer	  method	  with	  bPEI	  transfection	  reagent,	  each	  containing	  
the	   Gal4-­‐PPARα ,	   pGL4.31[luc2P/Gal4UAS/hygro]	   and	  
pGL4.75[hRluc/CMV]	   at	   ratio	   of	   1:1:0.5,	   respectively.	   The	   bPEI:DNA	  
ratio	  set	  ups	  were	  1:1,	  2.5:1,	  4:1,	  and	  doubling	  the	  amount	  of	  bPEI	  and	  
DNA	  to	  the	  three	  ratios.	  bPEI	  reagent	  was	  added	  before	  each	  of	  the	  six	  
transfection	  mixes	  was	  split	  between	  3	  wells	  containing	  CHSE-­‐214	  cells.	  
DNA	  Ratio(1μg)	   1:1:0.5	   2	  x	  (1:1:0.5)	  
Gal4-­‐PPARα(ng)	   400.0	   400.0	   400.0	   800.0	   800.0	   800.0	  
pGL4.31[luc2P/Gal4UAS/hygro]	  (ng)	   400.0	   400.0	   400.0	   800.0	   800.0	   800.0	  
pGL4.75[hRluc/CMV](ng)	   200.0	   200.0	   200.0	   400.0	   400.0	   400.0	  
bPEI:DNA	  (μg:μg)	   1:1	   2.5:1	   4:1	   2	  x	  (1:1)	   2	  x	  (2.5:1)	   2	  x	  (4:1)	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3.2.5 Treatment	   of	   transfected	   CHSE-­‐214	   cells	   with	   PPAR	  
ligands	  and	  fatty	  acids	  
The	   selected	   PPAR	   activators	   were	   4-­‐Chloro-­‐6-­‐(2,3-­‐xylodino)-­‐2-­‐pyrimidinylthioacetic	   acid	   (WY-­‐14,643)	   and	   rosiglitazone	   that	   had	   been	  previously	  reported	  to	  activate	  piscine	  PPARα	  (Leaver	  et	  al.,	  2005;	  Colliar,	  et	  
al.,	   2011)	   and	  mammalian	   PPARγ	   respectively.	   Concentration	   of	  Wy-­‐14643	  (Sigma)	   was	   prepared	   at	   2.5	   mM	   stock	   concentration	   in	   ethanol	   and	  rosiglitazone	   at	   5	  mM.	   Selected	   fatty	   acids	   were	   prepared	   at	   10	  mM	  were	  docosahexaenoic	   acid	   (22:6;	   DHA),	   eicosapentenoic	   acid	   (20-­‐5;	   EPA)	   and	  oleoylethanolamide	  (OEA).	  
In	   bijoux	   tubes,	   each	   compound	   was	   diluted	   into	   complete	   EMEM	   at	   a	  concentration	  of	  10	  µl	  per	  ml,	  to	  give	  final	  assay	  concentrations	  of	  25	  µM	  Wy-­‐14643,	   50	   µM	   rosiglitazone	   and	   100	   µM	   fatty	   acids,	   enough	   to	   produce	  triplicates	  with	   each	   compound.	  An	   ethanol	   vehicle	  was	   also	  prepared	   as	   a	  control	   treatment	   at	   a	   concentration	   of	   10	   µl	   ethanol	   absolute	   per	   ml	   of	  EMEM.	   The	   diluted	   treatment	   compounds	   were	   mixed	   thoroughly	   before	  being	  added	  to	  transfected	  cells.	  Transfection	  mixes	  were	  removed	  from	  each	  well	  of	  the	  24-­‐well	  assay	  plate	  by	  aspiration	  and	  the	  cells	  were	  washed	  once	  with	   DPBS,	   after	   which	   1	   ml	   of	   treatment	   compounds	   was	   added	   to	   cells.	  Cells	  were	   subsequently	   incubated	  with	   treatment	   compounds	  overnight	  at	  22	  °C	  in	  an	  atmosphere	  of	  4	  %	  CO2	  before	  assaying	  for	  luciferase	  activity.	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3.2.5.1 Data	  normalisation	  and	  statistical	  analysis	  
Firefly	  and	  Renilla	   luminescence	  readings	   from	  three	  wells	   transfected	  cells	  in	  which	  no	  DNA	  had	  been	  transfected	  were	  taken	  as	  background	  levels.	  The	  background	  levels	  for	  the	  firefly	  and	  Renilla	  values	  were	  each	  averaged	  and	  subtracted	   from	   firefly	   and	  Renilla	   luciferase	   values	   from	   transfected	   cells,	  respectively.	   To	   account	   for	   differences	   in	   transfection	   efficiency	   between	  wells	   on	   an	   assay	   plate,	   the	   ratio	   of	   firefly	   to	   Renilla	   luminescence	   was	  calculated	   and	   the	   mean	   of	   replicate	   wells	   was	   obtained.	   To	   test	   for	  statistically	   significant	   differences	   between	   ethanol	   control	   treatment	   and	  treatment	   with	   PPAR	   agonists	   and	   fatty	   acids,	   T-­‐test	   was	   carried	   out	   and	  results	   were	   considered	   statistically	   significant	   when	   the	   probability	   value	  (P)	  was	  less	  than	  0.05	  (P<0.05).	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 Results	  3.3
3.3.1 Construction	  of	  Gal4-­‐PPARγ 	  expression	  plasmid	  
3.3.1.1 Amplification	  of	  PPARγ 	  ligand-­‐binding	  domain	  	  
The	   cDNA	   encoding	   the	   LBD	   of	   PPARγ	   were	   amplified	   by	   the	   polymerase	  chain	  reaction	  (PCR),	  using	  the	  primer	  pairs	  designed	  to	  the	  5’	  and	  3’	  of	  the	  ligand-­‐binding	  domain	  of	  PPARγ,	  yielding	  an	  expected	  DNA	  fragment	  of	  1014	  base	  pairs.	  This	  expected	  size	  of	  the	  PCR	  product	  was	  revealed	  in	  the	  agarose	  gel	  reflected	  the	  size	  for	  the	  PPARγ	  ligand-­‐binding	  domain.	  
3.3.1.2 Cloning	  of	  PCR-­‐amplified	  DNA	  fragment	  into	  the	  pBIND	  vector	  
Following	   transformation	   of	   ligation	   product	   that	   was	   formed	   from	   DNA	  fragment	   being	   cloned	   in	   pBIND	   vector	   using	   restriction	   digestion	   and	  ligation	  reaction,	   into	  Top10	  E.	  coli	  cells,	  a	  total	  of	  23	  colonies	  were	  formed	  on	  the	  agar	  plate.	  Following	  purification	  of	  plasmid	  DNA,	  a	  restriction	  digest	  was	  performed	  on	  a	  sample	  of	  each	  plasmid	  to	  confirm	  which,	   if	  any,	  of	  the	  purified	  plasmids	  contained	  the	   ligand-­‐binding	  domain	  of	  PPARγ.	   In	  5	  of	  23	  samples,	   two	   bands	  were	   visible	   following	   restriction	   digestions	   and	   these	  corresponded	   to	   the	   expected	   size	   of	   the	   PPARγ-­‐LBD	   insert	   of	   about	   1000	  base	   pairs	   and	   the	   pBIND	   vector	   of	   about	   6	   kb	   size,	   indicating	   successful	  cloning.	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3.3.1.3 Sequencing	  of	  the	  pBIND-­‐PPARγ 	  LBD	  plasmid	  
Successful	  cloning	  was	  indicated	  by	  the	  production	  of	  two	  DNA	  fragments	  as	  a	  result	  of	  restriction	  digestion.	  Each	  of	  the	  five	  purified	  plasmids	  prepared	  in	  Section	   3.2.1.4,	   was	   sequenced	   to	   confirm	   (i)	   that	   the	   insert	   in	   the	   pBIND	  vector	   was	   the	   ligand-­‐binding	   domain	   of	   PPARγ	   and	   (ii)	   that	   the	   ligand-­‐binding	   sequence	   and	   the	   Gal4	   DNA-­‐binding	   domain	   of	   the	   pBIND	   vector	  were	  in	  the	  same	  continuous	  reading	  frame.	  Using	  the	  software	  SeqManPRO,	  The	   raw	   sequencing	   files	   for	   each	   plasmid	   were	   assembled	   to	   a	   single	  continuous	   contig	   for	   PPARγ	   and	   were	   compared	   to	   the	   PPARγ	   sequences	  from	  plaice	  already	  available	  in	  the	  database,	  confirming	  that	  one	  out	  of	  five	  purified	   plasmids	   had	   identical	   sequences	   and	   that	   the	   Gal4	   DNA-­‐binding	  domain	  and	  PPARγ-­‐LBD	  were	  in	  a	  continuous,	  single	  frame	  (Figure	  3-­‐3).	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Figure	   3-­‐3	   Nucleotide	   and	   deduced	   amino	   acid	   sequences	   of	   Gal4-­‐
PPARγ 	  contigs	  assembled	  using	  SeqManPRO	  software.	  The	  first	  and	  stop	  
codons	  of	  PPAR	  ligand-­‐binding	  domains	  are	  boxed	  in	  blue.	  The	  BamH1	  
(GGATCC)	   and	   Kpn1	   (GGTACC)	   enzyme	   recognition	   sites	   are	   boxed	   in	  
red.	  
3.3.2 Transfection	  efficiency	  of	  bPEI	  reagent	  	  
Branched	  polyethylenimine	  (bPEI)	  was	  one	  of	   the	   first	  cationic	  polymers	  to	  be	   used	   as	   transfection	   reagent.	   Its	   transfection	   ability	   depends	   on	   the	  interaction	  between	  the	  positive	  charges	  of	  amine	  groups	  and	  the	  negatively	  charged	  phosphate	  backbone	  of	  DNA	  and	  its	  transfection	  efficiency	  depends	  on	   the	   overall	   net	   charge	   of	   the	   bPEI/DNA	   complex	  when	   bPEI	   condenses	  DNA,	  which	  consequently	  affects	  the	  binding	  ability	  of	  these	  complexes	  to	  the	  cell	  surfaces	  and	  DNA	  dissociation	  into	  the	  cell	  cytoplasm	  (Akinc	  et	  al.,	  2005;	  Hsu	  and	  Uludağ,	  2012).	  	  
In	   practical,	   the	   overall	   net	   charge	   of	   the	   complexes	   is	   dependent	   on	   the	  amounts	   of	   the	   reagent	   and	   the	  DNA,	   thus,	   in	   order	   to	  determine	   the	  most	  suitable	   cell	   line,	   different	   bPEI	   to	   DNA	   ratios	   were	   used	   to	   measure	   the	  transfection	   efficiencies	   and	   these	   were	   determined	   by	   measuring	   the	  luciferase	   signal	   from	   the	   constitutively	   expressed	   Renilla	   luciferase	   gene,	  present	   on	   the	   transfected	   internal	   control	   plasmid	   pGL4.75[hRluc/CMV]	  (Figure	   3-­‐4).	   Maximum	  Renilla	   luciferase	   signal,	   40.5-­‐fold	   over	   the	   control	  (mock	  transfected	  wells	  in	  which	  no	  DNA	  was	  transfected),	  was	  observed	  at	  bPEI	  to	  DNA	  ratio	  of	  2.5:1,	  when	  plasmid	  DNA	  was	  transfected	  into	  AS	  cells.	  However,	   the	   efficiency	  decreased	   to	  4.4-­‐fold	   and	  0.95-­‐fold	   at	   bPEI	   to	  DNA	  ratios	  of	  5.0:1	  and	  10.0:1,	  respectively.	  On	  the	  other	  hand,	  the	  efficiency	  with	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which	   plasmid	   DNA	   was	   transfected	   into	   CHSE-­‐214	   cells	   saw	   the	   highest	  
Renilla	  luciferase	  signal,	  4.8-­‐fold	  over	  the	  control	  at	  1.25:1	  bPEI	  to	  DNA	  ratio,	  and	  this	  decreased	  with	  increasing	  bPEI	  to	  DNA	  ratio,	  to	  2.0-­‐fold,	  1.5-­‐fold	  and	  0.95-­‐fold	  at	  bPEI	  to	  DNA	  ratios	  of	  2.5:1,	  5.0:1	  and	  10.0:1,	  respectively.	  	  
	  
	  
Figure	   3-­‐4	   The	  mean	   transfection	   efficiencies	   (+	   SD)	   at	   four	   different	  
bPEI	   reagent	   to	   DNA	   ratios	   (µg	   to	   µg),	   containing	   equal	   amounts	   of	  
plasmid	   DNA	   i.e.	   Gal4-­‐PPARα ,	   pGL4.31[luc2P/Gal4UAS/hygro]	   and	  
pGL4.75[hRluc/CMV].	   Different	   ratios	   of	   bPEI:DNA	   were	   used	   to	  
transfect	   AS	   and	   CHSE-­‐214	   before	   they	   were	   assayed	   for	   Renilla	  
luciferase	  signal,	  used	  as	  a	  measurement	  of	  transfection	  efficiency.	  
The	   results	   have	   indicated	   that	   the	   AS	   cells	   had	   the	   highest	   transfection	  efficiency	  at	  bPEI:DNA	  ratio	  of	  2.5:1,	  thus	  AS	  cell	  line	  and	  this	  optimised	  ratio	  were	   subsequently	   used	   to	   determine	   the	   effect	   of	   altering	   the	   amounts	   of	  plasmids	   transfected	   into	   the	   AS	   cells	   while	   maintaining	   a	   constant	   final	  concentration	  of	  0.1	  mg/ml	  DNA	  mix	  and	  the	  optimised	  amount	  of	  2.5	  µl	  bPEI	  (Figure	  3-­‐5).	   In	   this	  experiment,	   the	  PPARα	   agonist,	  WY-­‐14,643	  compound,	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was	  used	  to	  measure	  the	  firefly	  luciferase	  activity	  to	  determine	  Gal4-­‐PPARα	  activation.	  The	  highest	  firefly	  luciferase	  signal	  was	  observed	  at	  DNA	  ratio	  of	  1:1:0.5,	   containing	   DNA	   mix	   of	   400	   ng	   Gal4-­‐PPARα,	   400	   ng	  pGL4.31[luc2P/Gal4UAS/hygro]	   and	   200	   ng	   pGL4.75[hRluc/CMV],	  with	   9.4-­‐fold	  increase	  over	  the	  ethanol	  control	  vehicle.	  
	  
	  
Figure	   3-­‐5	   The	   mean	   firefly	   luciferase	   signals	   (+	   SD)	   measured	   from	  
transfected	  AS	  cells	  at	  2.5:1,	  bPEI	  to	  DNA	  ratio,	  with	  different	  amounts	  
of	   plasmid	   DNAs,	   Gal4-­‐PPARα ,	   pGL4.31[luc2P/Gal4UAS/hygro]	   and	  
pGL4.75[hRluc/CMV],	   respectively	   	   and	   treated	   with	   95	   %	   ethanol	  
vehicle	  and	  PPARα 	  agonist,	  WY-­‐14,643	  compound.	  


















	  	   97	  
3.3.3 Re-­‐optimisation	  of	  AS	  and	  CHSE-­‐214	  cell	  lines	  
The	   AS	   cell	   line	   had	   shown	   instability	   in	   reproducibility	   when	   the	   same	  transfection	   experiment	   was	   repeated	   using	   a	   higher	   passage	   number	   i.e.	  p121	   (labelled	   ‘new’	   in	   Figure	   3-­‐6).	   When	   the	   transfected	   AS	   cells	   were	  treated	  with	  the	  PPARα	  agonist,	  WY-­‐14,643	  compound,	  the	  firefly	  luciferase	  signals	   were	   significantly	   lower	   compared	   to	   that	   of	   the	   activity	   signals	  observed	   in	   the	   previous	   experiment,	   using	   AS	   cells	   with	   a	   lower	   passage	  number,	   p99	   (labelled	   ‘old’	   in	   Figure	   3-­‐6).	   Thus,	   re-­‐assessment	   of	   the	  efficiency	   of	   bPEI	   to	   transfect	   AS	   and	   CHSE-­‐214	   cell	   lines	   were	   again	  conducted	   using	   enhanced	   green	   fluorescent	   protein	   plasmid	   (pEGFP)	   to	  determine	   the	   quality	   of	   the	   cells	   and	   the	   efficiency	   of	   the	   transfection	  reagent.	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Figure	  3-­‐6	  The	  mean	  firefly	  luciferase	  signals	  (+	  SD)	  from	  the	  previous	  
transfection	   experiment	   (labelled	   "old",	   from	   Figure	   3-­‐2),	   plotted	  
against	   the	   latest	   firefly	   luciferase	   signals	   measured	   from	   the	   same	  
experiment	   (labelled	   "new").	   AS	   cells	   were	   transfected	   with	   different	  
amounts	  of	  plasmid	  DNAs,	  Gal4-­‐PPARα ,	  pGL4.31[luc2P/Gal4UAS/hygro]	  
and	  pGL4.75[hRluc/CMV],	  at	  2.5:1,	  bPEI	  to	  DNA	  ratio,	  and	  treated	  with	  
95	  %	  ethanol	  vehicle	  and	  PPARα 	  agonist,	  WY-­‐14,643	  compound.	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3.3.3.1 Transfection	  of	  cell	  lines	  with	  pEGFP	  
The	  effect	  of	  transfecting	  1	  µg	  pEGFP	  into	  AS	  and	  CHSE-­‐214	  cell	   lines	  using	  different	  amounts	  of	  bPEI	  was	  investigated	  to	  determine	  the	  efficiency	  of	  the	  transfection	   reagent.	   The	   expression	   of	   the	   transfected	   plasmid	   DNA	   was	  visually	  observed	  under	  an	  inverted	  fluorescent	  microscope	  equipped	  with	  a	  digital	   camera	   and	   successful	   transfections	   of	   cells	   are	   indicated	   by	   green	  fluorescence.	  Results	  have	  shown	  that	  the	  green	  fluorescence	  AS	  cells.	  In	  the	  microscope	  images	  (Figure	  3-­‐7),	  no	  fluorescence	  was	  observed	  when	  the	  AS	  cells	  were	  transfected	  with	  1:1,	  bPEI	  to	  DNA	  ratio,	  not	  even	  when	  the	  amount	  was	   doubled.	   Although	   the	   number	   of	   green	   AS	   cells	   increased	   when	   the	  amounts	   of	   bPEI	   and	  DNA	  were	   increased,	   the	  number	  of	   transfected	   cells,	  thus,	   transfection	   efficiency,	   was	   however,	   insignificant	   compared	   to	   the	  successful	   transfection	   of	   CHSE-­‐214	   cells	   observed	   (Figure	   3-­‐8).	   CHSE-­‐214	  cells	   treated	   with	   twice	   the	   amount	   of	   bPEI	   to	   DNA	   ratio,	   i.e.	   2	   x	   2.5:1,	  showed	   the	   most	   numerous	   and	   brightest	   green	   fluorescent	   spots	   (Figure	  3-­‐8(D))	  and	  this	  was	  in	  accordance	  with	  the	  increased	  transfection	  efficiency	  expressed	   by	   Renilla	   luciferase	   gene	   by	   1268-­‐fold	   over	   the	   control	   (mock	  transfected	   wells	   in	   which	   no	   DNA	   was	   transfected)	   (Figure	   3-­‐9).	   Renilla	  luciferase	   signals	  were	   observed	   to	   be	   about	   5	   times	   lower	  when	   the	   cells	  were	  treated	  with	  the	  recommended	  ratio	  of	  2.5:1.	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Figure	   3-­‐7	   Morphology	   of	   “new”	   AS	   cells	   (at	   passage	   number	   121)	  
transfected	   with	   pEGFP	   overnight.	   Cells	   were	   transfected	   with	   the	  
following	  bPEI:DNA	  ratios:	  (A)	  1:1	  (B)	  2	  x	  1:1	  (C)	  2.5:1	  (D)	  2	  x	  2.5:1	  (E)	  
4:1	  (F)	  2	  x	  4:1.	  Bar	  is	  approximately	  100	  µm.	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Figure	   3-­‐8	   Morphology	   of	   CHSE-­‐214	   cells	   transfected	   with	   pEGFP	  
overnight.	  Cells	  were	  transfected	  with	  the	  following	  bPEI:DNA	  ratio:	  (A)	  
1:1	   (B)	   2	   x	   1:1	   (C)	   2.5:1	   (D)	   2	   x	   2.5:1	   (E)	   4:1	   (F)	   2	   x	   4:1.	   Bar	   is	  
approximately	  100	  µm.	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Figure	  3-­‐9	  The	  mean	   transfection	  efficiencies	   (+	  SD)	  at	   three	  different	  
bPEI	  reagent	  to	  DNA	  ratios	  (µg	  to	  µg).	  Different	  ratios	  of	  bPEI:DNA	  were	  
used	   to	   transfect	   CHSE-­‐214	   before	   they	   were	   assayed	   for	   Renilla	  
luciferase	  signal,	  used	  as	  measurement	  of	  transfection	  efficiency.	  
When	   various	   amounts	   of	   bPEI	   to	   DNA	   ratio	   were	   transfected,	   cells	  transfected	  with	  the	  ratio	  1:1	  showed	  an	  efficiency	  of	  100-­‐fold	  over	  control	  and	   this	   increased	   by	   11	   times	   when	   the	   ratio	   was	   doubled.	   Transfection	  efficiencies	   at	   4:1,	   bPEI	   to	   DNA	   ratio	   were	   also	   about	   100-­‐fold	   over	   the	  control,	   even	   when	   the	   ratio	   was	   doubled.	   Therefore,	   in	   the	   future	  transfections,	  the	  more	  stable	  CHSE-­‐214	  cells	  were	  chosen	  as	  the	  suitable	  cell	  line	   and	   doubling	   the	   amount	   of	   bPEI	   to	  DNA	   ratio,	   2.5:1,	  was	   used	   as	   the	  optimised	  ratio	  for	  future	  transfections.	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3.3.4 Transactivation	   of	   Gal4-­‐PPAR	   with	   PPAR	   ligands	   and	  
fatty	  acids	  
CHSE-­‐214	  cells	  transfected	  with	  Gal4-­‐PPARα	  and	  subsequently	  exposed	  to	  25	  
µM	  Wy-­‐14,643	  showed	   the	  highest	   luciferase	  activity	  which	  was	  about	  6.7-­‐fold	  over	  the	  ethanol	  control	  vehicle	  (Figure	  3-­‐10).	  This	  increase	  of	  induction	  in	   reporter	   gene	   expression	   by	   the	   PPARα	   specific	   synthetic	   ligand,	   WY-­‐14,643,	   has	   been	   previously	   shown	   in	   transient	   transfection	   assays	   using	  native	   full-­‐length	   PPARα	   from	   European	   plaice	   (Leaver	   et	   al.,	   2005)	   and	  plaice	  Gal4-­‐PPARα	  (Colliar	  et	  al.,	  2011).	  In	  contrast,	  transfection	  of	  the	  Gal4-­‐PPARγ	   construct	   and	   subsequent	   treatment	   with	   the	   compound	  rosiglitazone,	   a	   mammalian	   PPARγ	   agonist,	   failed	   to	   induce	   an	   induction	  reporter	   signal.	   In	   CHSE-­‐214	   cells	   transfected	   with	   the	   Gal4-­‐PPARα	  construct,	  all	  the	  tested	  fatty	  acids	  at	  100	  µM,	  significantly	  induced	  reporter	  gene	   expression,	   with	   increase	   induction	   of	   2.3-­‐fold,	   2.0-­‐fold	   and	   2.7-­‐fold	  over	   the	   ethanol	   control	   vehicle	   when	   exposed	   to	   docosahexaenoic	   acid	  (22:6;	   DHA),	   eicosapentenoic	   acid	   (20-­‐5;	   EPA)	   and	   oleoylethanolamide	  (OEA),	   respectively.	   However,	   none	   of	   the	   fatty	   acids	   tested	   were	   able	   to	  significantly	  activate	  transcription	  from	  Gal4-­‐PPARγ.	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Figure	  3-­‐10	  Transactivation	  of	  Gal4-­‐PPARα 	  and	  Gal4-­‐PPARγ 	  in	  response	  
to	   PPAR	   activators	   and	   fatty	   acids.	   CHSE-­‐214	   cells	   were	   transiently	  
transfected	   with	   Gal4-­‐PPARα 	   firefly	   luciferase	   reporter	   plasmid	  
pGL4.31	  and	  an	  internal	  Renilla	   luciferase	  reporter	  used	  to	  correct	  for	  
transfection	   efficiencies	   pGL4.75.	   Post-­‐transfection	   cells	   were	   treated	  
with	   25	   µM	  Wy-­‐14,643,	   50	   µM	   rosiglitazone	   and	   100	   µM	   fatty	   acids.	  
Data	   are	   the	   mean	   (+	   SD)	   in	   which	   each	   treatment	   was	   applied	   in	  
triplicates,	   expressed	   as	   the	   fold	   increase	   over	   ethanol	   control	   of	  
normalised	   firefly	   luciferase	   activity.	   Asterisks	   (*)	   indicate	   activities	  
significantly	  different	  from	  those	  in	  ethanol-­‐treated	  cells	  (EtOH=1).	  























Gal4-­‐PPARα	  Gal4-­‐PPARγ	  	  	  	  	  	  	  *	  
	  	  	  *	   	  	  *	   	  *	  
	  	   105	  
 Discussion	  3.4
3.4.1 Determination	  of	  a	  suitable	  cell	  line	  
Two	  cell	  lines	  were	  transfected	  and	  used	  to	  assess	  the	  transfection	  efficiency	  of	  a	  cationic	  polymer,	  branched	  polythethylenimine	  (bPEI),	  previously	  shown	  to	  successfully	  transfect	  mammalian	  cells	  (Hsu	  and	  Uludağ,	  2012).	  Maximum	  transfection	  efficiency	  of	  40.5-­‐fold	  over	  control	  (mock	  transfected	  wells)	  was	  observed	   at	   bPEI	   to	   DNA	   ratio	   of	   2.5:1	   when	   Gal-­‐PPARα,	  pGL4.31[luc2P/Gal4UAS/hygro]	   and	   pGL4.75[hRluc/CMV]	   were	   co-­‐transfected	  into	  AS	  cells	  (Figure	  3-­‐4)	  compared	  to	  when	  the	  polyplex	  solution	  was	  transfected	  to	  CHSE-­‐214	  cells	  that	  has	  the	  transfection	  efficiency	  of	  4.8-­‐fold	  over	  the	  control	  at	  1.25:1,	  bPEI	  to	  DNA	  ratio.	  The	  AS	  cell	  line	  was	  initially	  concluded	  suitable	  for	  future	  transfections	  as	  results	  have	  shown	  that	  highest	  firefly	  luciferase	  signal	  with	  9.4-­‐fold	  increase	  over	  the	  ethanol	  control	  vehicle	  observed	  when	   the	   transfected	   cells	  were	   treated	  with	   the	   PPARα	   agonist,	  WY-­‐14,643	  (Figure	  3-­‐5),	  suggesting	  Gal4-­‐PPARα	  activates	  transcription	  from	  the	   promoter	   of	   the	   Gal4UAS-­‐containing	   firefly	   luciferase	   reporter	   gene	  construct	  pGL4.31[luc2P/Gal4UAS/hygro]	  in	  response	  to	  PPARα	  ligand.	  This	  transfection	   efficiency,	   however,	   decreased	   drastically	   in	   subsequent	  experiments,	   which	   may	   have	   been	   the	   result	   of	   changes	   in	   the	  characteristics	  of	  the	  cell	  line	  at	  increased	  passage	  number	  (Figure	  3-­‐6).	  The	  AS	   cell	   line	   was	   initially	   examined	   at	   low	   passage	   number	   of	   99	   and	   was	  examined	   in	   the	   later	   stages	   at	   a	   higher	   passage	   number	   of	   121	   to	   ensure	  reproducibility	  and	  reliable	  experimental	  results.	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According	  to	  Jacobsen	  and	  Hughes	  (2007),	  passage	  number	  is	  one	  of	  the	  main	  factors	   that	   may	   influence	   the	   transfection	   efficiency	   in	   cellular	  transactivation.	   Increased	   passages	   may	   have	   led	   to	   undesirable	  differentiation	   in	   the	  cells	   resulting	  changes	   in	  characteristics	  and	  modified	  growth	   rates,	   affecting	   protein	   expression,	   for	   example	   expression	   of	   co-­‐activator	   proteins,	   and	   causing	   the	   cells	   to	   respond	  differently	   to	   the	   same	  transfection	  conditions.	  The	  decrease	  in	  transfection	  efficiency	  in	  AS	  cells	  can	  be	   seen	   in	   Figure	   3-­‐7	   when	   the	   AS	   cells	   were	   transfected	   with	   pEGFP	   at	  various	   bPEI	   to	   DNA	   ratio	   indicated	   by	   the	   presence	   of	   very	   few	   green	  fluorescent	  cells.	  The	  use	  of	  the	  enhanced	  green	  fluorescent	  protein	  plasmid	  (pEGFP)	   to	   evaluate	   the	   effectiveness	   of	   gene	   delivery	   using	   bPEI	   by	  examining	  the	  expression	  of	  the	  plasmid	  in	  both	  AS	  and	  CHSE-­‐214	  cell	  lines,	  indicated	  by	  the	  number	  of	  green	  cells	  (Zhang	  et	  al.,	  1996).	  When	  CHSE-­‐214	  cells	  were	  transfected	  with	  pEGFP	  with	  the	  same	  bPEI	  to	  DNA	  ratios,	  double	  the	  amount	  of	  bPEI	  to	  DNA	  2.5:1	  ratio	  (2	  x	  2.5:1),	  showed	  the	  highest	  number	  of	   green	   fluorescent	   cells	   and	   this	   corresponded	   to	   the	   maximum	  transfection	   efficiency	   observed	   when	   Gal-­‐PPARα,	  pGL4.31[luc2P/Gal4UAS/hygro]	   and	   pGL4.75[hRluc/CMV]	   were	   co-­‐transfected	  into	  CHSE-­‐214	  cells	  (Figure	  3-­‐8	  and	  Figure	  3-­‐9).	  	  Although	  there	  has	  not	  been	  a	  direct	  method	  in	  determining	  the	  effect	  of	  passage	  number	  of	  a	  cell	  line,	  passage-­‐related	  effects	  in	  cell	  lines	  have	  been	  demonstrated	  to	  be	  heavily	   dependent	   on	   the	   type	   of	   cell	   line	   (Hayes,	   2010).	   Cited	   by	   Hayes	  (2010),	   based	   on	   an	   unpublished	   data,	   high	   passage	   Caco-­‐2	   cell	   lines	   had	  shown	  an	  increase	  in	  GFP	  expression	  levels	  following	  transfection,	  whilst	  the	  expression	  of	  GFP	  levels	  decreased	  in	  MCF7	  cells	  with	  high	  passage	  number.	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While	  CHSE-­‐214	  cell	   line	  was	  confirmed	  suitable	   for	   future	   transfections	  as	  this	  cell	  line	  has	  proven	  to	  give	  more	  reliable	  experimental	  results	  in	  terms	  of	  reproducibility,	   it	   was	   made	   sure	   that	   experiments	   were	   consistently	  performed	   within	   a	   minimum	   range	   of	   passage	   number	   following	   the	  optimization	  experiment,	   to	  prevent	  any	  passage-­‐related	  effects	  above	  from	  influencing	  the	  transfections,	  thus,	  maintaining	  consistent	  cell	  performance.	  
3.4.2 Ratio	  of	  bPEI:DNA	  and	  transfection	  efficiency	  	  
Because	   each	   cell	   type	   respond	   differently	   to	   a	   transfection	   reagent,	  optimisation	   was	   necessary	   to	   obtain	   maximum	   results.	   It	   is	   generally	  understood	   that	   higher	   DNA	   concentration	   transfected	   into	   the	   cells,	   the	  higher	  the	  transfection	  efficiency.	  However,	  as	  far	  as	  the	  amount	  of	  bPEI	  was	  concerned,	  the	  amount	  of	  DNA	  that	  can	  be	  transfected	  depended	  on	  the	  final	  concentration	   on	   bPEI	   and	   the	   bPEI	   to	   DNA	   ratio.	   Thus,	   because	   each	   cell	  type	   responds	   differently	   to	   a	   transfection	   reagent,	   it	   was	   important	   to	  determine	   the	   optimal	   bPEI	   to	   DNA	   ratio	   to	   ensure	   the	   occurrence	   of	   full	  binding	  and	  full	  condensation	  (Hsu	  and	  Uludağ,	  2012).	  	  
Doubling	   the	   recommended	   bPEI	   to	   DNA	   ratio,	   2.5:1,	   exhibited	   relatively	  higher	   Renilla	   luciferase	   signals	   in	   the	   transfected	   CHSE-­‐214	   cells	   (Figure	  3-­‐9)	   compared	   to	   when	   the	   bPEI	   to	   DNA	   ratio	   of	   1:1	   was	   doubled.	   In	  solutions	   where	   the	   amount	   of	   bPEI	   was	   higher	   than	   the	   amount	   of	   DNA,	  would	  mean	  that	  the	  solution	  would	  have	  excess	  of	   free	  bPEI	  polymers	  and	  this	   would	   often	   be	   considered	   an	   advantage	   towards	   obtaining	   high	  transfection	   efficiency.	   These	   free,	   unbound,	   positive	   bPEI	   polymers	   had	  been	   documented	   essential	   for	   intracellular	   trafficking	   and	   for	   overcoming	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the	  inhibitory	  effect	  of	  the	  polyanionic	  glycosaminoglycans	  (GAGs)	  (Ruponen	  
et	  al.,	  2004;	  Hanzlíková	  et	  al.,	  2011;	  Hsu	  and	  Uludağ,	  2012).	  GAGs	  are	  found	  highly	   abundant	   in	   the	   extracellular	   space	   and	  because	   they	   are	   negatively	  charged	   in	   nature,	   they	   become	   potential	   inhibitors	   of	   non-­‐viral	   gene	  transfer.	  Thus,	  at	  the	  optimal	  of	  twice	  the	  amount	  of	  2.5:1,	  bPEI	  to	  DNA	  ratio,	  the	   interactions	   between	   free	   positively	   charged	   bPEI	   polymers	   with	  negatively	  charged	  GAGs	  had	  possibly	  decrease	  the	  inhibitory	  effect	  of	  GAGs	  and	   therefore,	   enabling	   bPEI-­‐DNA	   complexes	   to	   efficiently	   bind	   on	   the	   cell	  membrane,	   subsequently	   increase	   in	  cellular	  uptake,	  and	  as	  a	  consequence,	  exhibited	   the	  highest	   transfection	  efficiency.	  However,	  when	   the	  amount	  of	  bPEI	   was	   very	   high	   in	   relative	   to	   the	   amount	   of	   DNA,	   4:1,	   even	   when	   the	  amounts	   were	   doubled,	   the	   transfection	   efficiencies	   decreased	   drastically	  and	   this	   may	   have	   been	   the	   result	   of	   cell	   toxicity	   from	   the	   presence	   of	  excessive	   unbound	   bPEI	   polymers,	   thus,	   reducing	   the	   overall	   cell	   viability	  (Hsu	   and	   Uludağ,	   2012).	   Therefore,	   it	   can	   be	   concluded	   that	   double	   the	  amount	   of	   2.5:1	   bPEI	   to	   DNA	   ratio	   should	   be	   used	   to	   ensure	   efficient	  transfection	  of	  DNA	  in	  future	  experiments.	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3.4.3 Response	  of	  Gal4-­‐PPARs	  to	  PPAR	  agonists	  
There	   was	   an	   increase	   in	   normalised	   luciferase	   activity	   when	   the	   Gal4-­‐PPARα-­‐transfected	   CHSE-­‐214	   cells	   (Figure	   3-­‐10)	   were	   treated	   with	   WY-­‐14,643,	  indicating	  PPARα-­‐dependent	  transcription	  as	  reported	  for	  other	  fish	  cell	   lines.	   (Colliar	   et	  al.,	   2011).	   In	   another	   study	   described	   by	   Leaver	   et	  al.	  (2005),	  when	  a	   full-­‐length	  native	  PPARα	  was	   isolated	   from	  two	  marine	   fish	  species,	   the	   plaice	   (Pleuronectes	   platessa)	   and	   gilthead	   seabream	   (Sparus	  
aurata),	  PPARα	  receptor	  was	  tested	  in	  a	  cell-­‐based	  transactivation	  assay	  and	  it	   was	   observed	   that	   the	   expression	   of	   chloramphenicol	   acetyltransferase	  (CAT)	   reporter,	   under	   the	   control	   of	   promoter	   containing	   peroxisome	  proliferator-­‐response	   element	   (PPRE),	   increased	  when	   the	   transfected	   fish	  cells	  were	  treated	  with	  WY-­‐14,643,	   indicating	  that	  this	  compound	  is	  PPARα	  agonist.	   This	   activation	   was	   not	   only	   seen	   in	   fish	   PPARα,	   but	   also	   in	  mammalian	   PPARα	   in	   an	   in	   vivo	   experiment	   conducted	   using	   mPPARα-­‐deficient	   mice.	   It	   was	   previously	   reported	   that	   mouse	   liver	   peroxisomes,	  when	  exposed	  to	  WY-­‐14,643,	  increased	  in	  numbers	  significantly	  as	  a	  result	  of	  peroxisome	   proliferation	   (Moody	   and	   Reddy,	   1978).	   However,	   in	   mice	  lacking	  PPARα,	  no	  proliferation	  was	  observed	  when	  there	  were	  fed	  with	  the	  compound,	  indicating	  that	  this	  receptor	  mediates	  peroxisome	  proliferation	  in	  the	  presence	  of	  WY-­‐14,643	   (Lee	  et	  al.,	   1995).	  These	   studies	  have	   therefore	  concluded	   that	   Gal4-­‐PPARα	   construct	   behaves	   similarly	   to	   native	   PPARα.	  These	  results	  confirmed	  that	  the	  transfection	  system	  of	  the	  plasmid	  construct	  in	  CHSE-­‐214	  cells	  was	  performing	  as	  expected	  and	  required	  in	  terms	  of	  Gal4-­‐PPAR	  fusion	  protein	  and	  luciferase	  expression,	  and	  in	  subsequent	  luciferase	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assays.	  Thus,	   in	   this	  project,	  Gal4-­‐PPARα	  and	   its	   activating	   compound,	  Wy-­‐14,643	  were	  used	  as	  a	  positive	  control	  in	  cell-­‐transactivation	  experiments.	  
Plaice	  Gal4-­‐PPARγ,	   on	   the	   other	   hand,	  was	   observed	   to	   be	   unresponsive	   to	  rosiglitazone,	  a	  member	  of	  the	  thiazolidinedione	  class	  of	  compounds,	  which	  had	  been	   identified	   as	   a	   known	  high	   affinity	   ligand	   for	   PPARγ	   in	  mammals	  (Lehmann	   et	   al.,	   1995).	   Previously	   isolated	   PPARγ	   from	   the	   plaice	   and	  gilthead	   seabream	   (Sparus	   aurata)	   (Leaver	   et	   al.,	   2005),	   	   and	   from	   olive	  flounder	   (Paralichthys	   olivaceus)	   (Cho	   et	   al.,	   2009)	   showed	   significant	   but	  weak	   transactivation	   when	   exposed	   to	   rosiglitazone,	   indicating	   that	   these	  receptors	   may	   have	   structural	   differences	   contributing	   to	   this	   sensitivity.	  Whilst	   PPARα	   within	   fish	   species,	   including	   plaice,	   sea	   bream,	   Atlantic	  salmon	  (Salmon	  salar)	  and	  Fugu	  (Andersen	  et	  al.,	  2000;	  Maglich	  et	  al.,	  2003;	  Leaver	   et	  al.,	   2005),	   have	   identical	   key	   conserved	   residues	   to	   their	   human	  counterparts	  within	  the	  ligand-­‐binding	  domain,	  suggesting	  similar	  structure	  and	  functions,	  PPARγ	  has	  only	  one	  equivalent	  residue	  (H449)	  to	  one	  of	  three	  conserved	   residues	   (H323,	   H449	   and	   Y473)	   in	   all	   mammalian,	   avian	   and	  amphibian	   PPARγ	   proteins,	   identified	   to	   be	   critical	   for	   forming	   hydrogen	  bonds	  with	   the	   acidic	   head-­‐group	  of	   PPAR	   ligands.	   The	   two	   residues	  H323	  and	  Y473	  were	  replaced	  by	  isoleucine	  and	  methionine	  (Maglich	  et	  al.,	  2003;	  Leaver	   et	   al.,	   2005).	   These	   residue	   substitutions	   may	   have	   altered	   the	  structure	   of	   peptide	   regions	  within	   the	   ligand-­‐binding	   domain,	  which	   have	  consequently	   contributed	   to	   the	   sensitivity,	   affecting	   the	   binding	   of	  rosiglitazone	   or	   other	   ligands.	   It	   is	   possible	   that	   there	   are	   specific	   co-­‐activator	   proteins	   required	   for	   PPARγ	   activation	   that	   are	   not	   present	   in	  CHSE-­‐214,	   or	   other	   previously	   tested	   fish	   cell	   lines.	   However,	   given	   that	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PPARα	  is	  robustly	  activated	  in	  these	  cells,	  and	  that	  PPARγ	  and	  PPARα	  share	  some	   co-­‐activator	   proteins	   (Viswakarma	  et	  al.,	   2010),	   this	   is	   unlikely	   to	   be	  the	  cause	  of	  non-­‐activation	  of	  plaice	  PPARγ.	  	  
3.4.4 Response	  of	  Gal4-­‐PPARs	  to	  fatty	  acids	  
All	   of	   the	   three	   fatty	   acids	   tested	   induced	   transactivation	   of	   plaice	   Gal4-­‐PPARα,	   similar	   to	   the	   observations	   reported	   by	   Colliar	   et	   al.	   (2011).	   The	  highest	   signal	   observed	   in	   this	   study	  was	   the	   activation	   of	   Gal4-­‐PPARα	   by	  OEA,	   a	   fatty	   acid	   identified	   as	   a	   potent	   agonist	   of	   mammalian	   PPARα,	  responsible	   in	   controlling	   feeding	   and	   fat-­‐induced	   satiety	   (Scwartz	   et	   al.,	  2008,	   Dipasquale	   et	   al.,	   2010),	   suggesting	   that	   this	   fatty	   acid	   may	   have	   a	  similar	   function	   in	   both	  mammals	   and	   fish.	   In	   the	   contrary,	   the	   fatty	   acids	  tested	  failed	  to	  activate	  plaice	  Gal4-­‐PPARγ.	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3.4.5 Use	  of	  non-­‐commercial	  dual	  luciferase	  assay	  system	  
An	   alternative	   to	   the	   commercial	   assay	   system,	   a	   dual	   luciferase	   reporter	  assay	  was	   used	   to	   analyse	   the	   expression	   of	   reporter	   genes,	   by	   combining	  “homemade”	  buffers	  of	  both	  firefly	  (Photinus	  pyralis)	   luciferase	  enzyme	  and	  
Renilla	  (Renilla	  reniformis)	  luciferase	  enzyme	  within	  the	  same	  reaction	  tube,	  sequentially.	   The	   development	   of	   luciferase-­‐based	   protocols	   have	   been	  modified	  from	  Dyer	  et	  al.	  (2001)	  and	  these	  high	  throughput	  assays	  had	  been	  previously	  used	  in	  successful	  cell-­‐transactivation	  experiments	  conducted	  by	  Colliar	  et	  al.	  (2011).	  	  
In	  the	  firefly	  luciferase	  buffer,	   luciferin	  was	  used	  as	  a	  substrate	  in	  the	  assay	  system	   as	   the	   firefly	   luciferase	   enzyme,	   in	   the	   presence	   of	   ATP,	   molecular	  oxygen	   and	   magnesium	   ions,	   catalyses	   luciferin	   to	   produce	   oxy-­‐luciferin	  emitting	   light	   energy	   (bioluminescence).	   Sustaining	   the	   light	   intensity	   had	  previously	  become	  a	  major	  issue,	  there	  was	  a	  rapid	  increase	  in	  light	  intensity,	  characterised	  by	  a	  “flash”	  of	  light	  when	  substrates	  were	  added	  to	  the	  enzyme,	  which	   tend	   to	   decay	   rapidly	   to	   a	   constant	   low-­‐level	   luminescence.	   This	  problem	   of	   the	   kinetics	   of	   the	   luciferase-­‐luciferin	   reaction	   would	   have	  considerably	  reduced	  the	  time	  window	  in	  which	  a	  signal	  could	  be	  detected.	  The	  addition	  of	  the	  cofactor	  coenzyme	  A	  (CoA)	  in	  the	  firefly	  luciferase	  buffer	  had	   been	   reported	   to	   stabilise	   the	   luminescence	   signal	   and	   prolong	   light	  production	   at	   a	   higher	   level	   for	   a	   time	  period	  depending	  on	   the	   amount	   of	  CoA	   added,	   without	   having	   the	   initial	   peak	   of	   light	   intensity	   affected	   (van	  Lune	   and	   Bruggeman,	   2006).	   Combining	   the	   use	   of	   CoA	   and	   dithiothreitol	  (DTT)	  in	  the	  reaction	  mixture	  had	  proven	  to	  sustain	  the	  half-­‐life	  of	  the	  light	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signal	   longer	   up	   to	   300	   to	   500	   seconds.	   	   A	   further	   improvement	   had	   been	  made	  to	  the	  reaction	  mixture	  was	  the	  addition	  of	  ammonium	  and	  phosphate	  ions	   present	   in	   the	   tribasic	   potassium	   phosphate	   produced	   a	   strong	   light	  signal	  that	  had	  even	  longer	  stabilising	  effect	  ranging	  from	  30	  minutes	  up	  to	  8	  hours.	  
Within	   the	   assay	   system,	   Renilla	   buffer	   was	   added	   to	   the	   reaction	   well	   to	  examine	   adequacy	   and	   kinetics	   of	   quenching	   the	   firefly	   luciferase	   activity.	  The	   Renilla	   luciferase	   activities	   were	   therefore	   used	   to	   normalise	   for	  differences	  in	  transfection	  efficiencies	  between	  wells	  on	  an	  assay	  plate.	  In	  the	  
Renilla	   buffer,	   coelenterazine	   was	   used	   as	   a	   substrate,	   as	   the	   Renilla	  luciferase	   enzyme,	   in	   the	   presence	   of	   oxygen,	   catalyses	   coelenterazine	  oxidation	  leading	  to	  bioluminescence	  (Hori	  et	  al.,	  1973).	   	  It	  had	  been	  shown	  that	  non-­‐commercial	  Renilla	  buffer	  was	  able	   to	  quench	  the	   firefly	   luciferase	  activity	  as	  well	  as	  the	  commercial	  buffer,	  that	  the	  activity	  had	  exceeded	  99.9	  %	   (Dyer	   et	   al.,	   2000),	   indicating	   this	   buffer	   to	   be	   efficient	   in	   this	   assay	  system.	  	   	  
	  	   114	  
 Conclusions	  3.5
The	   determination	   of	   the	   most	   suitable	   cell	   line	   and	   its	   optimisation	   was	  imperative	   in	   the	   transfection	   experiments	   using	   the	   selected	   transfection	  reagent	   to	   maximise	   results	   and	   to	   ensure	   reproducibility	   and	   reliability.	  Because	   passage	   number	   may	   become	   an	   important	   factor	   for	   certain	   cell	  lines,	   they	   should	   be	   of	   relatively	   low	   and	   consistent	   passage	   number	   to	  avoid	   any	   changes	   or	  differentiation	   in	   cell	   structure	   or	  morphology	  which	  may	  in	  turn	  affect	  the	  overall	  performance.	  The	  health	  of	  the	  cell	  line	  and	  its	  maintenance	   should	   also	   be	   taken	   into	   consideration	   when	   it	   comes	   to	  transfection	  optimisation.	  	  CHSE-­‐214	  cell	  line	  has	  proven	  to	  be	  more	  reliable	  and	   robust	   compared	   to	   the	   AS	   cell	   line	   and	   that	   doubling	   the	   ratio	   to	   the	  amount	  of	  2.5:1	  bPEI	  (µl)	  to	  DNA	  (µg)	  ratio	  has	  shown	  to	  exhibit	  the	  highest	  transfection	   efficiency,	   which,	   therefore,	   being	   used	   as	   an	   optimal	   ratio	   in	  future	   transfection	   experiments.	   In	   the	   optimisation	   experiments,	   Gal4-­‐PPARα	  and	  Gal4-­‐PPARγ	  were	  tested	  in	  cellular-­‐transactivation	  in	  response	  to	  their	  activating	  compounds	  in	  fish	  to	  ensure	  the	  effectiveness	  of	  transfection	  using	  bPEI	  and	  the	  efficiency	  of	  the	  dual-­‐luciferase	  assay	  system	  using	  firefly	  luciferase	   and	   Renilla	   luciferase	   reagents.	   	   From	   the	   previous	   studies	   and	  from	   this	   study,	   because	   the	   full-­‐length	   piscine	   PPARγ	   and	   the	   Gal4-­‐PPARγ	  had	   been	   found	   to	   be	   unresponsive	   to	   fatty	   acids,	   PPARγ	   has	   become	   a	  subject	  of	   interest,	  thus,	  the	  Gal4-­‐PPARγ	  construct	  was	  developed	  for	  use	  in	  subsequent	  experiments	  in	  identifying	  its	  activating	  ligands.	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4 Lipid	  extraction	  and	  response	  of	  piscine	  PPARγ 	   to	  
lipid	  fractions	  
 Introduction	  4.1
A	   major	   paradox	   and	   constraint	   to	   aquaculture	   is	   that	   much	   finfish	  aquaculture	   is	   dependent	   on	   feeds	   manufactured	   from	   wild	   fish,	   utilising	  products	  such	  as	  fish	  meal	  and	  oil	  from	  industrial	  fisheries	  which	  have	  now	  reached	   their	   maximum	   sustainable	   limit.	   Because	   of	   the	   expanding	  aquaculture	  sector,	  pursuing	  alternatives	  to	  its	  current	  dependence	  on	  these	  materials	   is	  becoming	  crucial.	  Terrestrial	  plant	   seed	  meals	  and	  oils	  derived	  from	  processed	  soybean	  or	  rapeseed	  have	  been	  used	  to	  substitute	  fish	  meal	  and	  oil	   in	  farmed	  fish	  diets	  (Bell	  et	  al.,	  2001).	  However,	  the	  need	  to	  balance	  lipid	  storage	  and	  metabolism	  for	  growth,	  as	  well	  as	  ensuring	  health	  through	  the	  supply	  of	  essential	  nutrients	  such	  as	  polyunsaturated	  fatty	  acids	  must	  be	  addressed.	  Whilst	   the	  replacement	  of	   fish	  oil	  with	   terrestrial	  seed	  oils	   is	  an	  effective	  approach	   for	  some	   farmed	  species	  such	  as	  Atlantic	  Salmon,	  not	  all	  fish	  species	  tolerate	  such	  high	  levels	  of	  dietary	  seed	  oil	  inclusion	  (Bell	  et	  al.,	  2001).	  It	  is	  understood	  that	  mammals	  and	  fish	  share	  the	  same	  pathways	  for	  biosynthesis	  and	  catabolism	  of	  fatty	  acids	  and	  these	  pathways	  are	  controlled	  by	  the	  similar	  molecular	  mechanisms	  (Ruyter	  et	  al.,	  1997;	  Boukouvala	  et	  al.,	  2004).	   In	   mammals,	   peroxisome	   proliferator-­‐activated	   receptors	   (PPARs)	  have	  emerged	  as	  central	  factors	  in	  sensing	  fatty	  acid	  levels	  and	  in	  regulating	  fatty	   acid	   metabolism.	   Evidently,	   the	   PPARs	   in	   fish,	   generally,	   are	   the	  structural	  homologs	  of	  the	  mammalian	  PPARs,	  and	  are	  assumed	  to	  carry	  out	  similar	   functions.	  There	   is	   strong	  evidence	   that	  PPARs	  play	   critical	   roles	   in	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fish	  lipid	  homeostasis	  and	  that	  PPARα	  and	  PPARβ	  may	  have	  similar	  functions	  to	  those	  described	  in	  mammals	  for	  these	  receptors.	  This	   is	  based	  on	  having	  similar	   ligand	   activation	   profiles	   and	   tissue	   expression	   patterns	   as	   their	  mammalian	  counterparts	  (Leaver	  et	  al.,	  2005).	  However,	  the	  role	  of	  PPARγ	  in	  fish	   still	   remains	   unclear	   because	   piscine	   PPARγ	   is	   not	   activated	   by	  compounds	  which	  activate	  mammalian	  PPARγ	  (Maglich	  et	  al.,	  2003;	  Leaver	  et	  
al.,	   2005).	   Piscine	   PPARγ	   has	   some	   specific	   structural	   differences	   to	  mammalian	  proteins,	  particularly	  evident	  with	  regard	  to	  amino	  acid	  residues	  which	   are	   known	   to	   be	   critical	   for	   ligand	   binding	   in	  mammalian	   receptors	  (Ruyter	  et	  al.,	  1997;	  Andersen	  et	  al.,	  2000;	  Leaver	  et	  al.,	  2005).	  Despite	  this,	  the	  overall	  structural	  similarity	  of	  piscine	  PPARγ	  to	  all	  other	  PPARs	  strongly	  indicates	   that	   it	   is	   likely	   to	   be	   activated	   by	   a	   compound	   with	   structural	  similarities	  to	  the	  lipids	  and	  fatty	  acids	  which	  activate	  mammalian	  PPARγ	  and	  other	  PPAR	  forms.	  	  
Therefore,	  because	  mammalian	  PPARγ	  has	  a	  critical	  role	  in	  determining	  lipid	  uptake	  and	  storage,	  it	  is	  of	  particular	  interest	  in	  finfish	  aquaculture	  as	  farmed	  fish	   often	   accumulate	   excess	   visceral	   and	   hepatic	   fat	   especially	   when	   fed	  plant	  seed	  oil-­‐based	  diets.	  This	  can	  affect	  the	  health	  and	  welfare	  of	  the	  fish,	  and	  also	  represents	  an	  economic	  waste	  of	  valuable	  feed	  that	  might	  otherwise	  be	  channelled	  into	  growth.	  	  
Therefore,	   the	   aim	   of	   this	   chapter	   is	   to	   discover	   fish	   lipid	   fractions,	   thus,	  molecular	   components,	   which	   activate	   piscine	   PPARγ	   in	   cell	   transfection	  assays.	  An	  endogenous	  activator	  of	  fish	  PPARγ	  would	  shed	  light	  on	  the	  roles	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of	  this	  receptor,	  as	  well	  as	  providing	  tools	  for	  further	  function	  studies	  of	  lipid	  homeostasis	  in	  fish.	  
This	  chapter	  focuses	  on:	  
1) The	   extraction	   of	   total	   lipid	   from	   liver	   tissues	   of	   farmed	  Atlantic	  salmon	   (Salmon	   salar)	   and	   the	   determination	   of	   lipid	   classes	   by	  means	   of	   high-­‐performance	   thin-­‐layer	   chromatography	   (HPTLC)	  and	  lipid	  fractionation	  using	  thin-­‐layer	  chromatography	  (TLC).	  2) The	  discovery	  of	  the	  activating	  compounds	  of	  PPARγ	  from	  the	  lipid	  fractions	   through	   a	   high-­‐throughput	   cell-­‐based	   transactivation	  screen	   using	   the	   transient	   transfection	   assay	   developed	  previously.	  3) The	   identification	   of	   molecular	   components	   within	   the	   lipid	  fractions	   that	   activate	   PPARγ	   using	   gas	   chromatography-­‐flame	  ionisation	   detection	   (GC)	   and	   liquid	   chromatography-­‐mass	  spectrometry	  (LC-­‐MS).	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 Materials	  and	  methods	  4.2
4.2.1 Lipid	  and	  fatty	  acid	  analyses	  
4.2.1.1 Sampling	  of	  salmon	  livers	  
This	   experiment	   was	   subjected	   to	   ethical	   review	   and	   approved	   by	   the	  University	   of	   Stirling	   through	   Animal	   and	   Welfare	   Ethical	   Review	   Body	  (AWERB).	   Atlantic	   salmon	   (Salmon	   salar)	   pre-­‐smolts	   with	   weight	   range	   of	  400-­‐600	   g	   were	   obtained	   from	   the	   University	   of	   Stirling	   Buckieburn	   Field	  Station,	   Scotland.	   	   Fish	   were	   sacrificed	   with	   an	   overdose	   of	   tricaine	  methanesulfonate	   (MS222)	   and	   a	   sharp	   blow	   to	   the	   head.	   Liver	   tissues,	  weighing	  about	  1	  g	  each,	  were	  sampled	  from	  10	  fish	  and	  immediately	  placed	  in	   a	   sample	   bottle	   containing	   250	   ml	   of	   chloroform/methanol	   (C:M)	   (2:1,	  v/v)	  and	  stored	  in	  -­‐20	  °C	  before	  lipid	  extraction	  was	  performed	  the	  following	  day.	  
4.2.1.2 Total	  lipid	  extraction	  from	  salmon	  liver	  tissues	  
The	  procedure	  for	  the	  lipid	  extraction	  was	  based	  on	  Folch	  method	  (Folch	  et	  
al.,	  1957),	  a	  non-­‐destructive	  method	  for	  extracting	  total	  lipid	  from	  samples	  of	  animal	   tissues.	   In	   this	   project,	   liver	  was	   chosen	   because	   it	   contains	   all	   the	  important	  lipid	  classes	  and	  because	  of	  the	  central	  importance	  of	  this	  organ	  in	  lipid	  metabolism,	  and	  importantly	  because	  salmon	  and	  other	  fish	  PPARs	  are	  highly	   expressed	   in	   this	   tissue	   (Boukouvala	   et	  al.,	   2004;	   Ibabe	   et	  al.,	   2004;	  Ibabe	  et	  al.,	  2005;	  Leaver	  et	  al.,	  2005).	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Folch	   bulk	   extraction	   of	   total	   lipid	   was	   conducted	   by	   first	   homogenising	  (Ultra	  Turrax™	   rotating	  probe)	   tissue	   already	   collected	   in	  C:M	   (2:1,	   v/v).	  A	  quarter	   volume	   of	   0.88	  %	   (w/v)	   potassium	   chloride	   (KCl)	  was	   then	   added	  and	  mixed	  thoroughly,	  before	  transferring	  into	  a	  separating	  funnel	  and	  left	  to	  stand	  for	  one	  hour	  to	  allow	  the	  formation	  of	  two	  distinct	  layers.	  The	  bottom	  lipid	   layer	  was	   collected	   in	   a	   round-­‐bottomed	   flask,	   leaving	   behind	   the	   top	  (aqueous)	   layer.	   The	   lipid	   layer	   was	   then	   concentrated	   and	   dried	   under	  vacuum	  in	  a	  rotary	  evaporator,	  to	  evaporate	  remaining	  solvent.	  The	  resulting	  concentrated	   lipid	   was	   dissolved	   in	   a	   small	   amount	   of	   C:M	   (2:1)	   and	  transferred	  to	  a	  pre-­‐weighed	  test	  tube	  before	  the	  solvent	  was	  evaporated	  to	  dryness	  under	  a	  stream	  of	  oxygen-­‐free	  nitrogen	  (OFN).	  Tubes	  with	  total	  lipid	  were	   left	   to	  desiccate	   in	  vacuum	  overnight.	  The	   following	  day,	   total	   lipid	   in	  each	   tube	   was	   weighed	   and	   was	   re-­‐dissolved	   in	   C:M	   (2:1)	   +	   0.01%	   (w/v)	  butylated	  hydroxytoluene	  (BHT)	  at	  a	  concentration	  of	  10	  mg/ml	  and	  stored	  in	  glass	  vials	  under	  nitrogen	   in	  a	  spark	  proof	   freezer	  at	   -­‐18°C	  prior	   to	   lipid	  class	  and	  fatty	  acid	  analyses.	  
4.2.1.3 Determination	  of	  lipid	  class	  composition	  
Total	   lipid	   extracted	   was	   used	   to	   determine	   the	   lipid	   class	   compositions	  using	   single-­‐dimension,	   double-­‐development,	   high-­‐performance	   thin-­‐layer	  chromatography	   (HPTLC)	   and	   quantitative	   densitometry	   (Henderson	   and	  Tocher,	  1992).	  HPTLC	  plates	  (10	  cm	  x	  10	  cm	  x	  0.25	  mm,	  Merck,	  Darmstadt,	  Germany)	  were	   pre-­‐washed,	   in	   order	   to	   remove	   impurities	   from	   the	   layer,	  with	   the	   first	   developing	   solvent	   methyl	   acetate/propan-­‐2-­‐ol/	  chlororoform/methanol/0.25%	   aqueous	   KCl	   (25:25:25:10:9,	   by	   volume),	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before	   allowing	   the	   solvent	   to	   evaporate	   by	   air	   drying	   in	   a	   fume	   cupboard	  and	   leaving	   to	   desiccate	   under	   vacuum	   overnight.	   The	   washed	   plate	   was	  marked,	   by	   pencil,	   with	   six	   3	  mm	   origins	   at	   a	   distance	   of	   1.2	   cm	   between	  them.	  Four	  samples	  of	  10	  µg	  total	  lipid	  (i.e.	  1	  µl	  of	  10	  mg/ml),	  two	  lipid	  class	  standards	  (neutral	  lipid	  obtained	  from	  Sigma	  and	  cod	  roe	  total	  lipid	  and	  one	  blank	   were	   applied	   to	   each	   3	   mm	   origin	   using	   a	   10	   µl	   MicroliterTM	   glass	  syringe	  (Hamilton®,	  Bonaduz,	  Switzerland).	  In	  a	  development	  tank,	  the	  plate	  was	  developed	  to	  5.5	  cm	  in	  the	  first	  solvent	  mentioned	  above	  and	  this	  aimed	  to	   separate	   polar	   lipid	   classes.	   This	   was	   then	   removed	   and	   placed	   in	   the	  desiccator	   for	   at	   least	   20	   min	   to	   allow	   evaporation	   of	   excess	   solvent.	   The	  plate	  was	   then	  developed	   in	   the	  same	  direction	   in	   the	  second	  development	  containing	   iso-­‐hexane/diethyl	   ether/acetic	   acid	   (80:20:1,	   by	   volume)	   to	  separate	  the	  neutral	  lipid	  classes.	  Plate	  was	  again	  placed	  in	  the	  desiccator	  for	  at	  least	  5	  min	  to	  evaporate	  excess	  solvent,	  and	  then	  sprayed	  with	  3%	  cupric	  acetate	  in	  8%	  phosphoric	  acid	  staining	  solution.	  Excess	  solution	  was	  drained	  and	  the	  plate	  was	  charred	  at	  160°C	  for	  18	  min	  in	  an	  oven.	  Lipid	  classes	  on	  the	  plate	   were	   then	   examined	   by	   calibrated	   scanning	   densitometry	   using	   a	  Camag	  3	  TLC	  Scanner	  (Muttenz,	  Switzerland)	  and	  quantified	  using	  winCATS	  software.	  
4.2.1.4 Lipid	  fractionation	  into	  polar	  lipids	  and	  neutral	  lipids	  
Total	  lipid	  extracted	  in	  Section	  4.2.1.2	  was	  then	  fractionated	  into	  pure	  polar	  and	  neutral	  lipids	  using	  thin-­‐layer	  chromatography	  (TLC)	  on	  20	  cm	  x	  20	  cm	  x	  0.25	  mm	  plates	  (Merck,	  Darmstadt,	  Germany).	  The	  plates	  were	  first	  marked,	  by	  pencil,	  with	  a	  12	  cm	  origin	  starting	  at	  2	  cm	  from	  the	  side	  and	  1.5	  cm	  from	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the	   bottom	   of	   the	   plates,	   having	   the	   standards	  marked	   at	   1	   cm	   from	   both	  sides	  within	  the	  12	  cm	  origin.	  2	  ml	  of	  10	  mg/ml	  in	  C:M	  (2:1)	  +	  0.01	  %	  BHT	  of	  total	   lipid	  was	  evaporated	   to	  dryness	  under	  a	   stream	  of	  OFN	  on	  a	  nitrogen	  evaporator	  to	  obtain	  20	  mg	  of	  total	  lipid	  which	  was	  then	  reconstituted	  in	  150	  
µl	   C:M	   (2:1)	   (no	   BHT).	   This	   was	   applied	   to	   the	   origin	   using	   a	   50	   µl	  MicroliterTM	   glass	   syringe	   (Hamilton®,	   Bonaduz,	   Switzerland),	   drying	   the	  total	  lipid	  with	  OFN	  between	  every	  streak.	  The	  plates	  were	  developed	  to	  10.5	  cm	  in	  the	  first	  solvent	  system	  and	  were	  then	  placed	  in	  a	  vacuum	  desiccator	  for	   at	   least	   1	   hr	   with	   pump	   running	   to	   remove	   excess	   solvent.	   The	   plates	  were	  then	  fully	  developed	  in	  the	  second	  solvent	  system	  and	  were	  place	  in	  a	  vacuum	  desiccator	   for	   a	   further	   20	  min.	   The	   lipid	   bands	  were	   revealed	   by	  lightly	  spraying	  the	  standard	  lanes	  at	  the	  sides	  of	  the	  plates	  with	  1	  %	  iodine	  in	   chloroform.	   The	   position	   of	   the	   lipid	   bands	   were	   then	   identified	   and	  marked	   in	  pencil	  before	   the	  silica	  containing	   the	   lipid	  classes	  were	  scraped	  off	  and	  transferred	  into	  fresh	  medium	  stoppered	  test-­‐tubes.	  Each	  sample	  was	  dissolved	   in	   20	   ml	   C:M	   (2:1)	   and	   was	   placed	   overnight	   in	   a	   spark	   proof	  freezer	  at	  -­‐25	  °C.	  The	  following	  day,	  the	  silica	  samples	  were	  filtered	  through	  pre-­‐washed	  filter	  papers	  and	  into	  fresh	  test	  tubes.	  The	  solvent	  from	  each	  test	  tube	  was	  evaporated	  under	  a	  stream	  of	  OFN	  to	  approximately	  2	  ml	  and	  was	  transferred	   to	   labelled	   and	   pre-­‐weighed	   2	   ml	   glass	   vials.	   The	   remaining	  solvent	  was	  further	  evaporated	  and	  the	   lipid	  samples	  obtained	  were	  placed	  in	  the	  desiccator	  overnight	  to	  remove	  excess	  solvent.	  The	  next	  day,	  the	  glass	  vials	  were	  weighed	  again	  to	  measure	  the	  final	  amount	  of	  each	  lipid	  obtained,	  before	   they	   were	   reconstituted	   in	   the	   correct	   amount	   of	   C:M	   (2:1)	   to	   a	  concentration	  of	  10	  mg/ml.	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4.2.1.5 Purification	  check	  of	  lipid	  fractions	  on	  HPTLC	  
Prewashed	  10	  cm	  x	  20	  cm	  x	  0.2	  mm	  HPTLC	  plates,	  marked	  by	  pencil,	  with	  3	  mm	  origins	  at	  a	  distance	  of	  1.2	  cm	  between	   them,	  enough	   to	  accommodate	  the	   lipid	   samples	  obtained	  previously.	  To	  each	  origin,	  10	  µg	   (i.e.	   1	  µl	   of	  10	  mg/ml)	  of	  sample	  was	  applied	  and	  the	  plates	  were	  developed	  to	  5.5	  cm	  in	  the	  first	  solvent	  to	  identify	  and	  ensure	  separation	  of	  pure	  polar	  lipids.	  The	  plates	  were	  placed	  in	  a	  vacuum	  desiccator	  for	  at	  least	  20	  min	  with	  pump	  running	  to	  remove	   excess	   solvent	   vapour.	   The	   plates	   were	   again	   placed	   in	   the	   same	  direction	  in	  the	  second	  developing	  solvent	  to	  identify	  and	  ensure	  separation	  of	  neutral	  lipids	  before	  they	  were	  placed	  in	  the	  desiccator	  again	  for	  at	  least	  5	  min	   to	   remove	  all	   the	   solvent	   vapour.	  The	   entire	  plates	  were	   then	   sprayed	  with	  3	  %	  cupric	  acetate	  in	  8	  %	  phosphoric	  acid	  staining	  solution	  before	  the	  excess	  solution	  was	  drained	  and	  plates	  were	  charred	  at	  160	  °C	  for	  18	  min	  in	  an	  oven.	  
4.2.1.6 Preparation	  of	  lipid	  fractions	  in	  absolute	  ethanol	  	  
Before	   each	   lipid	   fraction	  was	   reconstituted	   in	   absolute	   ethanol,	   C:M	   (2:1)	  solvent	  from	  each	  vial	  was	  evaporated	  under	  a	  stream	  of	  OFN	  and	  they	  were	  placed	   in	   the	   desiccator	   overnight	   to	   remove	   excess	   solvent.	   The	   following	  day,	  each	  lipid	  sample	  was	  weighed	  to	  get	  the	  final	  amount	  and	  was	  dissolved	  in	  the	  correct	  amount	  of	  absolute	  ethanol	  to	  a	  concentration	  of	  5	  mg/ml.	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4.2.2 Treatment	  of	  transfected	  CHSE-­‐214	  cells	  with	  lipids	  
The	   Gal4-­‐PPARγ	   construct	   developed	   in	   Chapter	   3	   was	   used	   to	   test	   for	  agonistic	   effects	   of	   lipids	   obtained	   in	   cell-­‐based	   transactivation	   assays,	  making	  use	  of	  Gal4-­‐PPARα	   and	   its	   activating	   ligand,	  WY-­‐14,643	  as	  positive	  control.	  
4.2.2.1 Seeding	  and	  transfection	  of	  CHSE-­‐214	  cells	  
CHSE-­‐214	  were	  harvested	  from	  near-­‐confluent	  cell	  culture	  flasks	  and	  seeded	  at	  2	  x	  105	  cell	  per	  well	  of	  24	  well	  plates	  before	  transfection	  the	  following	  day	  with	  Gal4-­‐PPARα	   (treated	  with	  WY-­‐14,643	   tested	   for	  positive	  control	  only)	  and	  Gal4-­‐PPARγ	  as	  described	  in	  Sections	  3.2.2.3	  and	  3.2.2.4.	  
4.2.2.2 Treatment	  of	  transfected	  cells	  with	  polar	  lipids	  and	  neutral	  lipids	  
Following	  transfection	  of	  cells	  with	  Gal4-­‐PPARγ	  using	  the	  optimised	  bPEI	  to	  DNA	  ratio	  determined	  in	  the	  previous	  chapter,	  cells	  were	  treated	  with	  polar	  lipids	   and	   neutral	   lipids	   obtained,	   identified	   from	   the	   two	   lipid	   class	  standards	   used	   earlier.	   The	   polar	   lipids	   include	   lysophosphatidylcholine	  (LPC),	   sphingomyelin	   (SM),	   phosphatidylcholine	   (PC),	   phosphatidylserine	  (PS),	   phosphatidylinositol	   (PI),	   phosphatidylethanolamine	   (PE),	   unknown	  polar	  lipid	  (UNK1)	  and	  solvent	  front	  containing	  pigmented	  material	  (SF),	  and	  the	   neutral	   lipids	   identified	   are	   cholesterol	   (CHOL),	   free	   fatty	   acids	   (FFA),	  unknown	  neutral	  lipid	  (UNK2),	  triacylglycerols	  (TAG)	  and	  sterol	  esters	  (SE).	  	  
In	   bijoux	   tubes,	   each	   lipid	   with	   an	   initial	   concentration	   of	   5	   mg/ml	   was	  diluted	   into	   complete	   EMEM	   to	   give	   two	   final	   assay	   concentrations	   of	   25	  
	  	   124	  
µg/ml	  and	  50	  µg/ml,	  enough	  to	  produce	  quadruplicates	  with	  each	   lipid.	  An	  ethanol	  absolute	  was	  also	  prepared	  as	  a	  control	  treatment	  at	  a	  concentration	  of	  10	  µl	  ethanol	  absolute	  per	  ml	  of	  EMEM.	  The	  diluted	  treatment	  compounds	  were	  mixed	  thoroughly	  before	  1	  ml	  of	  each	  mixture	  was	  being	  added	  to	  the	  transfected	   cells.	   Cells	   were	   subsequently	   incubated	   with	   treatment	  compounds	   for	   24	   hours	   at	   22°C	   in	   an	   atmosphere	   of	   4	   %	   CO2	   before	  assaying	  for	  luciferase	  activity.	  
4.2.2.3 Luciferase	  activity,	  data	  normalisation	  and	  statistical	  analysis	  
Firefly	   and	  Renilla	   luciferase	   activities	   were	  measured	   using	   the	   luciferase	  assay	   buffers	   described	   in	   Chapter	   3.	   Twenty-­‐four	   hours	   post-­‐treatment,	  media	  containing	  treatment	  compounds	  was	  aspirated	  from	  assay	  plates	  and	  cells	  were	  washed	  twice	  with	  1x	  DPBS	  before	  they	  were	  lysed	  in	  1	  ml	  of	  1	  x	  passive	   lysis	  buffer	  (Promega)	  for	  10	  min,	  shaking.	  The	  cell	   lysate	  was	  then	  used	  in	  a	  dual	  luciferase	  assay	  system	  in	  which	  75	  µl	  of	  cell	  lysate	  form	  each	  well	  was	  transferred	  to	  a	  black	  96-­‐well	  plate	  (Corning).	  Into	  each	  well,	  equal	  volume	  of	   a	  2	   x	   concentrated	  volume	  of	   luciferase	  buffer	  was	   added	   to	   the	  wells.	  The	  contents	  of	  the	  wells	  were	  pipetted	  up	  and	  down	  to	  mix	  and	  was	  incubated	   for	   2	  min	   before	   luciferase	   activity	  was	  measured	   on	   the	  Wallac	  1420	  Victor	  2	  multilabel	  counter	  (Perkin	  Elmer).	  Following	  measurement	  of	  firefly	   luciferase,	   75	  µl	   volume	  of	  3	   x	   concentrated	  Renilla	   luciferase	  buffer	  was	   added	   and	   the	   contents	   were	   again	   pipetted	   up	   and	   down	   to	   mix,	  incubated	  for	  2	  min	  before	  Renilla	  luciferase	  activity	  was	  measured.	  	  
As	   previously	   described,	   Renilla	   luciferase	   values	   were	   used	   to	   normalise	  firefly	  activities	   for	  differences	   in	   transfection	  efficiency	  between	  wells.	  For	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each	   well,	   the	   firefly	   luciferase	   value	   was	   divided	   by	   the	   corresponding	  
Renilla	  luciferase	  value	  and	  the	  mean	  replicate	  wells	  was	  calculated.	  
Experiments	   were	   repeated	   independently	   twice	   (with	   different	   flasks	   of	  cells	  seeded	  on	  different	  days).	  Data	  is	  reported	  as	  the	  mean	  fold	  inductions	  in	  normalised	   luciferase	  activities	   compared	   to	  ethanol	   vehicle	   controls.	  To	  test	  for	  statistically	  significant	  differences	  between	  ethanol	  control	  treatment	  and	   treatment	   with	   lipid	   compounds,	   a	   one-­‐way	   ANOVA	   was	   carried	   out	  followed	   by	   Dunnet’s	   test	   on	  Minitab18	   software.	   Results	  were	   considered	  statistically	   significant	   when	   the	   probability	   value	   (P)	   was	   less	   than	   0.05	  (P<0.05).	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4.2.3 Identification	  of	  molecular	  components	  in	  lipid	  samples	  	  
4.2.3.1 Determination	  of	  fatty	  acids	  composition	  using	  GC	  
Lipid	   compounds	   that	   had	   significant	   luciferase	   activity	   with	   Gal4-­‐PPARγ	  transfected	  cells	  were	  further	  analysed	  to	  determine	  the	  fatty	  acid	  profile	  of	  lipid	   using	   fatty	   acid	  methyl	   esters	   (FAMEs)	   by	   gas	   chromatography-­‐flame	  ionisation	   detection	   (GC)	   (Christie,	   2003).	   The	   FAMEs	   were	   prepared	   by	  transmethylation.	   Following	   evaporation	   of	   ethanol,	  making	   sure	   that	   each	  sample	  contained	  0.2-­‐1	  mg	  of	  lipid,	  each	  sample	  was	  reconstituted	  in	  100	  µl	  C:M	  (2:1)	  before	  the	  samples	  were	  transferred	  into	  individual	  quick-­‐test	  tube	  and	  solvent	  evaporated	  under	  a	  stream	  of	  OFN.	  One	  ml	  of	  toluene	  and	  2	  ml	  of	  1	   %	   (v/v)	   sulphuric	   acid	   (H2SO4)	   in	   methanol	   were	   added	   to	   each	   lipid	  sample.	  Samples	  tubes	  were	  flushed	  with	  N2	  to	  prevent	  oxidation,	  sealed	  with	  glass	  stoppers	  and	  small	  piece	  of	  paper	  tissue	  before	  they	  were	  incubated	  in	  a	   hot	   block	   (Techne	  Dri-­‐block)	   at	   50	   °C	  overnight.	   The	   following	  day,	   after	  cooling,	   the	   FAMEs	   were	   extracted	   by	   adding	   2	   ml	   of	   2	   %	   potassium	  bicarbonate	  (KHCO3),	  followed	  by	  5	  ml	  of	  isohexane/diethyl	  ether	  (1:1,	  v/v)	  containing	   0.01	   %	   BHT.	   The	   contents	   were	   mixed	   by	   inverting	   the	   tubes	  followed	  by	  centrifugation	  at	  400	  gave	   for	  5	  min	  to	  separate	  the	  two	  phases.	  The	   organic	   upper	   layer	   was	   collected	   using	   a	   Pasteur	   pipette	   and	  transferred	  into	  a	  clean	  test	  tube.	  Further	  5	  ml	  isohexane/diethyl	  ether	  (1:1,	  v/v,	  without	  BHT)	  was	  added	  to	  the	  remaining	  lower	  layer	  and	  the	  extraction	  procedure	   repeated	   to	   ensure	   maximum	   recovery	   of	   FAMEs.	   Following	  mixing	   and	   centrifuging	   at	   400	   gave	  for	   5	  min,	   the	   organic	   upper	   layer	  was	  collected	   and	   transferred	   to	   the	   test	   tube	   before.	   The	   organic	   layers	   were	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placed	   under	   a	   stream	   of	   OFN	   to	   evaporate	   the	   solvent	   and	   the	   dry	   FAME	  extract	   re-­‐suspended	   in	  500	  µl	   of	   isohexane	   containing	  0.01	  %	  BHT	  before	  purified	  FAME	  extracts	  were	  transferred	  to	  chromacol	  vials	  and	  stored	  under	  N2	  at	  -­‐18	  °C	  (spark	  proof),	  ready	  for	  GC.	  Fame	  samples	  were	  analysed	  using	  a	  Fisons	  GC-­‐8160	  (thermo	  Fisher	  Scientific,	  UK)	  gas	  chromatograph	  equipped	  with	  a	  30	  m	  x	  0.25	  mm	  i.d.	  x	  0.25	  µm	  ZB-­‐wax	  column	  (Phenomenex,	  UK)	  and	  flame	  ionisation	  detector.	  	  
4.2.3.2 Determination	   of	   organic	   compounds	   using	   liquid	  
chromatography-­‐mass	  spectrometry	  (LC-­‐MS)	  
With	  the	  help	  of	  GC,	   fatty	  acid	  composition	   in	  each	   lipid	   fraction	  above	  was	  analysed	  and	  identified.	  However,	  because	  many	  compounds	  are	  sometimes	  impossible	  to	  analyse	  with	  GC,	  the	  same	  lipid	  fractions	  (about	  0.4	  to	  0.5	  mg)	  were	   analysed	   using	   high	   resolution	   LC-­‐MS	  with	   the	   help	   of	   experts	   in	   the	  Lipidomics	   Research	   Laboratory	   from	   the	   University	   of	   the	   Highlands	   and	  Islands	  in	  Inverness,	  Scotland.	  	  	  
Briefly,	   lipids	   were	   analysed	   by	   LC-­‐MS	   using	   a	   Thermo	   Orbitrap	   Exactive	  mass	   spectrometer	   (Thermo	   Scientific,	   Hemel	   Hempstead,	   UK),	   equipped	  with	  as	  heated	  electrospray	  ionization	  (HESI)	  probe	  and	  coupled	  to	  a	  Thermo	  Accela	  1250	  UHPLC	  system.	  All	  samples	  were	  analysed	  in	  both	  positive	  and	  negative	   ion	   mode	   over	   the	   mass	   to	   charge	   (m/z)	   range	   200-­‐2000.	   The	  samples	  were	  injected	  on	  to	  a	  Thermo	  Hypersil	  Gold	  C18	  column	  (2.1	  mm	  x	  100	   mm,	   1.9µm).	   Mobile	   phase	   A	   consisted	   of	   water	   containing	   10mM	  ammonium	  formate	  and	  0.1	  %	  (v/v)	  formic	  acid.	  Mobile	  phase	  B	  consisted	  of	  10:10	   isopropanol/acetonitrile	   containing	   10	   mM	   ammonium	   formate	   and	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0.1	   %	   (v/v)	   formic	   acid.	   The	   initial	   conditions	   for	   analysis	   were	  65%A/35%B.	   The	   percentage	   of	   mobile	   phase	   B	   was	   increased	   to	   100	   %	  over	  10	  minutes	  and	  held	  for	  7	  min	  before	  re-­‐equilibration	  with	  the	  starting	  conditions	   for	  4	  min.	  The	   raw	  LC-­‐MS	  data	  were	  processed	  with	  Progenesis	  CoMet	   v2.0	   software	   (Non-­‐linear	   Dynamics,	   Newcastle,	   UK)	   and	   searched	  against	  LIPID	  MAPS	  (www.lipimaps.org)	  for	  identification.	  
 Results	  4.3
4.3.1 Lipid	  content	  and	  lipid	  class	  composition	  of	  liver	  tissues	  
The	  lipid	  content	  and	  lipid	  class	  composition	  of	  the	  liver	  tissues	  are	  shown	  in	  Table	  4-­‐1.	  A	  total	  of	  26.15	  mg	  of	  total	  lipid	  was	  extracted	  from	  the	  tissues	  and	  a	   total	  of	  eight	  polar	   lipids	  and	   five	  neutral	   lipids	  were	  present	   in	   the	   total	  lipid	  extracted.	  The	  percentage	  composition	  of	   total	  polar	   lipids	  was	  almost	  double	   of	   the	   percentage	   of	   the	   total	   neutral	   lipids.	   The	   HPTLC	  chromatograms	   showing	   the	   lipid	   classes	   and	   the	   purified	   polar	   lipids	   and	  neutral	  lipids	  can	  also	  be	  seen	  in	  Figure	  4-­‐1	  and	  Figure	  4-­‐2.	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Table	  4-­‐1	  Lipid	  content	  and	  lipid	  class	  composition	  of	  liver	  tissues.	  
	  	   	  Lipid	  
Lipid	  content	  (mg)	   26.15	  ±	  0.5	  
Class	  composition	  (%)	   	  LPC	   0.8	  ±	  0.2	  SM	   3.6	  ±	  0.4	  PC	   24.4	  ±	  1.6	  PS	   6.3	  ±	  1.2	  PI	   8.0	  ±	  0.6	  PE	   12.7	  ±	  1.7	  UNK1	   7.0	  ±	  0.4	  SF	   2.5	  ±	  0.8	  
Total	  Polar	   65.3	  ±	  5.0	  CHOL	   10.9	  ±	  1.1	  FFA	   3.1	  ±	  0.8	  UNK2	   3.9	  ±	  0.7	  TAG	   16.4	  ±	  4.8	  SE	   0.3	  ±	  0.1	  
Total	  neutral	   34.7	  ±	  4.3	  	   	  Results	   are	   expressed	   as	  mean	   ±	   SD	   (n=4).	   Lipid	   class	   composition	   is	  
given	  as	  a	  percentage	  of	  the	  total	  lipid	  content.	  Abbreviations	  for	  polar	  
lipids:	   lysophosphatidylcholine	   (LPC),	   sphingomyelin	   (SM),	  
Phosphatidylcholine	   (PC),	   phosphatidylserine	   (PS),	  
phosphatidylinositol	   (PI),	   phosphatidylethanolamine	   (PE),	   unknown	  
polar	   lipid	   (UNK1)	   and	   solvent	   front	   containing	   pigmented	   material	  
(SF).	   Abbreviations	   for	   neutral	   lipids:	   the	  neutral	   lipids	   identified	   are	  
cholesterol	   (CHOL),	   free	   fatty	   acids	   (FFA),	   unknown	   neutral	   lipid	  
(UNK2),	  triacylglycerols	  (TAG)	  and	  sterol	  esters	  (SE).	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PC	  was	  found	  to	  be	  the	  most	  abundant	  phospholipids,	  about	  40	  %	  of	  the	  total	  polar	   lipids,	   followed	  by	  PE	  and	   then	  by	  PI	   and	  PS.	  PI,	   PS	   and	  SM	  contents	  were	  much	  lower	  (≤	  8.0	  %),	  and	  UNK1	  and	  SF	  were	  found	  to	  be	  7.0	  %	  and	  2.5	  %	   of	   the	   total	   lipid	   content,	   while	   LPC	   was	   present	   at	   relatively	   low	  concentration	   only.	   The	   separation	   of	   SM	   and	  PC	  using	   the	  TLC	  plates	  was	  challenging,	   therefore	   these	   two	   lipids	   were	   pulled	   together	   as	   one	   lipid	  sample	  labelled	  SM/PC	  (Figure	  4-­‐2).	  	  
The	  major	  component	  of	  the	  total	  neutral	  lipids	  was	  TAG,	  followed	  by	  CHOL,	  making	  up	  about	  50	  %	  and	  30	  %	  of	  the	  total	  neutral	  lipid,	  respectively.	  FFA,	  UNK2	  and	  SE	  were	  found	  to	  be	  lower	  than	  4.0	  %	  of	  the	  total	  lipid	  content.	  
	   	  









Figure	   4-­‐1	   HPTLC	   chromatogram	   of	   lipid	   class	   compositions	   in	   single	  
dimension,	  double	  development	  system	  of	  the	  total	  lipid	  extracted	  from	  
liver	   tissues,	   as	   described	   in	   text.	   Total	   lipid	   was	   run	   with	   two	   lipid	  
standards:	   cod	   roe	   total	   lipid	   (TL)	   and	   neutral	   lipids,	   to	   identify	   the	  
location	   of	   each	   lipid	   class.	   The	   plate	   was	   stained	   with	   3	   %	   cupric	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Figure	  4-­‐2	  HPTLC	  chromatogram	  of	  pure	  polar	  and	  neutral	  lipids	  in	  10	  
mg/ml	   C:M	   (2:1)	   prepared	   from	   TLC	   plates	   developed	   in	   single	  
dimension,	   double	   development	   system,	   as	   described	   in	   text,	   before	  
each	   lipid	   fraction	   was	   reconstituted	   in	   5	   mg/ml	   absolute	   ethanol.	  	  
Abbreviations	  refer	  to	  Table	  4-­‐1.	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4.3.2 Response	  of	  Gal4-­‐PPARγ 	  to	  polar	  and	  neutral	  lipids	  
Of	   the	   tested	   lipid	   fractions,	   the	   unknown	   polar	   and	   solvent	   front	   lipid	  fractions	  at	  50	  µg/ml	  were	  able	  to	  significantly	  induce	  transcriptional	  PPARγ	  activity	  with	  2.1-­‐fold	  and	  1.9-­‐fold	  increase	  over	  ethanol	  control	  (Figure	  4-­‐3).	  However,	   none	   of	   the	   lipids	   at	   the	   concentration	   of	   25	  µg/ml	  were	   able	   to	  induce	  PPARγ	  activity.	  
	  
Figure	   4-­‐3	   Response	   of	   PPARγ 	   to	   polar	   lipids	   and	   neutral	   lipids.	  
Transfected	  cells	  were	  treated	  with	  two	  lipid	  concentrations:	  25	  µg/ml	  
and	  50	  µg/ml.	  Data	  are	  the	  means	  ±	  SD	  of	  two	  independent	  experiments	  
(n=4	   for	   each	   experiment).	  Results	   are	   expressed	  as	   the	   fold	   increase	  
over	   ethanol	   control	   of	   normalised	   firefly	   luciferase	   activity.	   Asterisk	  
(*)	  represents	  statistically	  significant	  difference	  (P<0.05)	  to	  activities	  in	  
ethanol	  controls.	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4.3.3 Determination	  of	  molecular	  components	  in	  lipids	  
The	  two	  pure	  lipids	  fractions,	  the	  unknown	  polar	  lipid	  and	  solvent	  front,	  that	  were	   able	   to	   significantly	   induce	   PPARγ	   activity,	  were	   analysed	  with	   GC	   to	  identify	   the	   molecular	   weights	   of	   the	   fatty	   acid	   components	   and	   omit	  artefacts.	   It	  was	  revealed	  that	  the	  unknown	  polar	   lipid	   fraction	  consisted	  of	  more	  than	  50	  %	  long-­‐chain	  based	  saturated	  fatty	  acids,	  containing	  more	  than	  50	  %	  palmitic	  acid,	  16:0	  and	  about	  20	  %	  stearic	  acid,	  18:0	  (Table	  4-­‐2).	  The	  monoenoic	  (monosaturated)	  fatty	  acids	  were	  the	  second	  most	  abundant	  fatty	  acids	  in	  this	  lipid	  fraction,	  containing	  more	  than	  50	  %	  vaccenic	  acid,	  18:1n-­‐7.	  On	   the	   other	   hand,	   the	   solvent	   front	   fraction	   consisted	   of	  more	   than	   50	  %	  monoenoic	  fatty	  acids,	  comprising	  of	  almost	  40	  %	  oleic	  acid,	  18:1n-­‐9,	  and	  the	  second	   most	   abundant	   fatty	   acids	   in	   this	   lipid	   fraction	   was	   the	   n-­‐3	   poly	  unsaturated	   fatty	   acids	   (PUFA),	   consisting	   of	   high	   amounts	   of	   22:6	  docosahexaenoic	  acid	  (DHA).	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Table	  4-­‐2	  Fatty	  acid	  composition	  (%)	  of	  two	  pure	  lipid	  fractions	  UNK1	  
(unknown	   polar	   lipid)	   and	   SF	   (solvent	   front).	   Fatty	   acid	   is	   given	   as	   a	  
percentage	   of	   the	   total	   fatty	   acid	   content.	   Abbreviation:	  
polyunsaturated	  fatty	  acid	  (PUFA).	  
	  	   	  	   	  	   	  	   	  	   	   	  
Fatty	  acid	  
Percentage	  (%)	   	  	  
Fatty	  acid	  
Percentage	  (%)	  
UNK	   SF	   	  	   UNK	   SF	  14:0	   2.24	   1.39	   	   18:2n-­‐6	   2.70	   4.45	  15:0	   0.69	   0.22	   	   18:3n-­‐6	   0.16	   0.07	  16:0	   34.76	   6.93	   	   20:2n-­‐6	   0.61	   1.25	  18:0	   11.64	   2.71	   	   20:3n-­‐6	   0.22	   0.65	  19:0	   0.00	   0.00	   	   20:4n-­‐6	   0.34	   2.47	  20:0	   0.75	   0.21	   	   22:4n-­‐6	   0.08	   0.10	  22:0	   1.06	   0.30	   	   22:5n-­‐6	   0.27	   0.39	  24:0	   0.43	   0.00	   	   Total	  n-­‐6	  PUFA	   4.38	   9.38	  
Total	  saturated	   51.58	   11.76	   	   	   	   	  	   	   	   	   	   	   	  16:1n-­‐9	   0.80	   0.30	   	   18:3n-­‐3	   0.42	   0.86	  16:1n-­‐7	   1.87	   2.31	   	   18:4n-­‐3	   0.06	   0.18	  16:1n-­‐5	   0.00	   0.00	   	   20:3n-­‐3	   0.00	   0.23	  18:1n-­‐9	   17.62	   0.00	   	   20:4n-­‐3	   0.12	   0.14	  18:1n-­‐7	   2.45	   36.69	   	   20:5n-­‐3	   1.42	   2.18	  20:1n-­‐11	   0.77	   0.00	   	   21:5	   0.00	   0.00	  20:1n-­‐9	   4.91	   0.72	   	   22:5n-­‐3	   1.17	   2.54	  20:1n-­‐7	   0.55	   0.27	   	   22:6n-­‐3	   7.31	   20.55	  22:1n-­‐11	   2.25	   3.07	   	   Total	  n-­‐3	  PUFA	   10.51	   26.67	  22:1n-­‐9	   0.60	   0.65	   	   	   	   	  24:1n-­‐9	   1.39	   7.93	   	   	   	   	  
Total	  
monounsaturated	   33.23	   51.93	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Figure	  4-­‐4	  LC-­‐MS	  analyses	  of	   the	   (A)	  unknown	  polar	   lipid	   (UNK1)	  and	  
(B)	  solvent	  front	  (SF)	  previously	  selected	  as	  transfected	  CHSE-­‐214	  cells	  
treated	  with	  these	  two	  lipids	  fractions	  showed	  significantly	  high	  PPARγ 	  
activity.	  
The	   high	   resolution	   liquid	   chromatography-­‐mass	   spectrometry	   (LC-­‐MS)	  revealed	  that	  the	  major	   lipids	  found	  in	  the	  unknown	  lipid	  fraction	  were	  the	  molecular	   species	   of	   hexosylceramides	   and	   the	   predominant	   lipids	   in	   the	  solvent	  front	  fraction	  were	  ceramides	  (Figure	  4-­‐4).	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 Discussion	  4.4
4.4.1 Phospholipids	   (polar	   lipids)	   and	   neutral	   lipids	  
composition	  	  
Seven	  fractions	  of	  polar	  lipids	  were	  found	  and	  the	  principal	  phospholipids	  in	  the	   total	   lipid	   extracted	   from	   liver	   tissues	   were	   PC	   and	   PE.	   These	   were	  quantified	  by	  the	  densitometer,	  which	  can	  be	  seen	  in	  Table	  4-­‐1,	  and	  the	  dark	  stains	  on	  the	  HPTLC	  plate	   in	  Figure	  4-­‐1	  corresponded	  to	  the	  relatively	  high	  polar	  lipid	  concentrations.	  
From	  the	  results,	   it	  can	  be	  deduced	  that	  the	  phospholipid	  class	  composition	  of	   salmon	   liver	   corresponded	   to	   the	   content	   of	   phospholipid	   classes	   in	   the	  fish	   liver	  tissues	  observed	  in	  previous	  studies.	  For	  example,	   the	  polar	   lipids	  in	  liver	  tissues	  of	  two	  species	  of	  cottoid	  fish	  (Cottocomephorus	  grewingki	  and	  
C.	  inermis)	  (Kozlova,	  1998)	  and	  bogue	  (Boops	  boops)	  (Kapoulas	  and	  Miniadis-­‐Meimaroglou,	   1985)	   were	   found	   to	   consist	   about	   50	   %	   of	  phosphatidylcholine.	  While	   PC	  was	   the	  dominant	   phospholipid	   observed	   in	  liver	  tissues,	  this	  was	  also	  true	  for	  other	  fish	  tissues,	  such	  as	  in	  ovaries	  of	  the	  two	  species	  of	  cottoid	  fish	  containing	  about	  58-­‐78	  %	  of	  phosphatidylcholine,	  in	  ovaries	  of	  Atlantic	  salmon	  was	  94	  %	  (Cowey	  et	  al.,	  1985)	  and	  in	  ovaries	  of	  Atlantic	  herring	   (Clupea	  harengus)	  was	  about	  90	  %	  (Tocher	  et	  al.,	   1985).	   It	  was	  also	  observed	  that	  PC	  was	  the	  most	  abundant	  class	  in	  other	  tissues,	  such	  as	   in	   testes	   and	  muscles	   of	   the	   two	   species	   of	   cottoid	   fish	   (Kozlova,	   1998),	  and	  in	  head	  and	  skin	  of	  bogue	  (Kapoulas	  and	  Miniadis-­‐Meimaroglou,	  1985).	  PC	   is	   the	   most	   abundant	   phospholipid	   in	   animals	   and	   is	   the	   major	  phospholipid	   component	   of	   the	   plasma	   membrane	   bilayers.	   Moreover,	   the	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presence	  of	  this	  lipid	  in	  relatively	  high	  concentration	  in	  tissues	  is	  apparently	  essential	  to	  produce	  phosphatidic	  acid	  that	  is	  responsible	  in	  the	  activation	  of	  the	   main	   enzyme,	   phosphatidylinositol	   5-­‐phosphate	   5-­‐kinase,	   to	   generate	  polyphosphoinositides,	   responsible	   in	   the	   metabolism	   and	   signalling	  functions	  (Christie,	  2010).	  	  
PE,	  being	  the	  second	  most	  abundant	  phospholipid,	  amounted	  to	  about	  20	  %	  of	  liver	  phospholipids.	  Similar	  results	  were	  documented	  that	  the	  polar	  lipids	  consisted	  of	  about	  20-­‐30	  %	  of	  PE	  in	  liver	  tissues	  of	  two	  species	  of	  cottoid	  fish	  (Kozlova,	  1998)	  and	  bogue	  (Kapoulas	  and	  Miniadis-­‐Meimaroglou,	  1985),	  and	  this	  also	  agreed	  with	  the	  other	  tissues	  such	  as	  in	  ovaries,	  testes	  and	  muscles	  of	  the	  two	  species	  of	  cottoid	  fish,	  with	  a	  range	  of	  about	  20-­‐32	  %,	  25-­‐40	  %	  and	  25-­‐42	  %	  of	  PE,	  respectively.	  Although	  this	  lipid	  is	  sometimes	  associated	  with	  PC	  in	  biological	  systems,	  its	  chemical	  and	  physical	  properties	  are	  significantly	  different	   from	   that	   of	   PC,	   and	   therefore	   possess	   different	   functions	   in	  biochemical	   processes	   (Christie,	   2010).	   While	   both	   lipids	   are	   key	  components	   of	  membrane	   bilayers	  with	   equal	   importance	   to	  many	   cellular	  functions,	   PE	   interacts	   with	   other	   lipids	   in	   the	   bilayer	   and	   exerts	   a	   lateral	  pressure	   to	   maintain	   membrane	   curvature	   and	   stabilize	   the	   optimal	  conformations	  of	  membrane	  proteins.	  
Similar	  results	  were	  also	  observed	   for	   the	  other	  classes	  of	  phospholipids	   in	  liver	  tissues	  of	  the	  two	  species	  of	  cottoid	  fish	  (Kozlova,	  1998).	  In	  this	  study,	  the	  solvent	  front	  was	  obtained	  in	  small	  amounts	  and	  this	  lipid	  belongs	  to	  the	  more	  polar	  lipid	  class	  i.e.	  phospholipids.	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Five	   fractions	   of	   neutral	   lipids	   were	   quantified,	   TAGs	   being	   the	   most	  predominant	   in	   salmon	   liver	   tissues,	   a	   qualitative	   characteristic	   in	   most	  tissues,	   especially	   in	   the	   main	   lipid	   storage	   organ	   i.e.	   liver,	   in	   an	  overwhelming	  majority	  of	  fish	  (Lee	  et	  al.,	  1975;	  Henderson	  and	  Tocher,	  1987;	  Neighbors,	  1988;	  Eastman,	  1988;	  Kozlova,	  1998;	  Sargent	  et	  al.,	  2002).	  	  
FFA	  and	  LPC	  were	  found	  to	  be	  present	  only	  in	  small	  amounts,	  indicating	  that	  the	  lipids	  were	  extracted	  efficiently.	  Presence	  of	  high	  amounts	  of	  FFA	  in	  lipid	  extracts	  would	  have	  indicated	  tissue	  disruptions	  and	  consequently,	  affecting	  the	  overall	  amounts	  of	  the	  main	  lipid	  components	  (Christie	  and	  Han,	  2010).	  In	   the	  previous	   studies,	   it	  was	  observed	   that	   rapid	   freezing	   and	  pulverized	  animal	   tissues	   at	   -­‐70	   °C	   prior	   to	   extraction,	   yielded	   very	   low	   levels	   of	   free	  fatty	  acids	  in	  comparison	  to	  more	  conventional	  procedures,	  in	  which	  the	  lipid	  extracts	  were	  extracted	  from	  the	  animal	  tissues	  directly	  with	  a	  homogenizer	  of	  the	  rotating	  blade	  type	  at	  0	  °C	  (Kramer	  and	  Hulan,	  1978).	  Also,	  improper	  storage	   of	   tissue	   sample	   may	   cause	   lipases	   present	   in	   the	   tissues	   to	  breakdown	  of	   some	   lipids,	   causing	   artefactual	   formation	  of	   free	   fatty	   acids,	  even	   at	   -­‐20	   °C,	   and	   this	   activity	   will	   only	   accelerate	   during	   the	   thawing	  process,	  prior	  to	  extraction	  (Christie,	  2018),	  which	  may	  lead	  to	  the	  losses	  of	  essential	  unsaturated	  fatty	  acids	  and	  intact	  lipids	  (Christie	  and	  Han,	  2010).	  In	  this	   experiment,	   the	   artefactual	   hydrolysis	   of	   lipids	   in	   the	   liver	   tissues	  producing	  high	  amounts	  of	   free	   fatty	  acids	  was	   successfully	  avoided	  by	   the	  immediate	  transfer	  of	  the	  tissues	  into	  C:M	  (2:1)	  during	  sampling	  and	  stored	  in	  -­‐20	  °C	  before	  total	  lipid	  extraction	  was	  performed	  the	  following	  day.	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As	  seen	  in	  the	  results,	  this	  method	  is	  particularly	  very	  effective	  in	  extracting	  most	  of	  the	  lipids	  and	  substantially	  decreasing	  the	  losses	  of	  lipids	  incidental	  to	   freezing	   and	   thawing	   process.	   This	   also	   has	   led	   to	   the	   advantage	   of	  detecting	  various	  unidentified	  lipid	  classes	  (such	  as	  UNK1	  and	  UNK2)	  using	  lipid	  fractionation	  by	  TLC	  (Fuchs	  et	  al.,	  2011).	  
4.4.2 Activation	  of	  Gal4-­‐PPARγ 	  by	  polar	  lipids	  	  
Gal4-­‐PPARγ	   transfected	   cells	  were	   treated	  with	   two	   concentrations	   of	   lipid	  fractions	   dissolved	   in	   absolute	   ethanol,	   25	  µg/ml	   and	   50	  µg/ml,	   aiming	   to	  detect	  any	  PPARγ	   activity	  at	  both	   low	  and	  high	  concentrations.	  At	   low	   lipid	  concentration,	  none	  of	  the	  lipid	  fractions	  were	  able	  to	  activate	  PPARγ	  activity,	  suggesting	  that	  this	  concentration	  may	  have	  not	  been	  sufficient	  to	  produce	  an	  effect	   on	   the	   transcription	   of	   the	   firefly	   luciferase.	   When	   the	   lipid	  concentration	  was	  doubled,	   two	  of	   the	  polar	   lipid	   fractions,	  unknown	  polar	  and	   solvent	   front,	   were	   able	   to	   activate	   PPARγ	   activity,	   while	   no	   PPARγ	  activity	   was	   detected	   when	   the	   transfected	   cells	   were	   treated	   with	   the	  neutral	   lipid	   fractions.	   It	   can	   be	   suggested	   from	   this	   experiment	   that	   these	  lipids	  may	  contain	  molecular	  components	   that	  have	  the	  ability	   to	  bind	  with	  PPARγ	   ligand-­‐binding	  domain	  and	  activate	   transcription	  of	   firefly	   luciferase	  activity.	  	  
4.4.3 Identification	  of	  polar	  lipid	  fractions	  
Initially,	   these	   two	   lipids	   were	   analysed	   with	   gas	   chromatography-­‐flame	  ionisation	   detection	   (GC)	   to	   identify	   the	   fatty	   acid	   components	   in	   the	  fractions.	  The	  fatty	  acids	  identified	  to	  be	  present	  in	  the	  lipid	  fractions	  and	  in	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high	  amounts	  were	  palmitic	  acid,	  stearic	  acid,	  oleic	  acid	  and	  DHA.	  These	  fatty	  acids	   have	   been	   identified	   to	   activate	   mammalian	   PPARγ	   (Walkey	   and	  Spiegelman,	  2008)	  and	  have	  been	  tested	  on	  piscine	  PPARγ	  but	  none	  of	  these	  fatty	  acids	  were	  able	  to	  activate	  the	  receptor	  (Kondo	  et	  al.,	  2007;	  Colliar	  et	  al.,	  2011).	   The	   molecular	   components	   in	   the	   lipid	   fractions	   were	   further	  investigated	  using	  high	  resolution	  liquid	  chromatography-­‐mass	  spectrometry	  (LC-­‐MS)	  to	  identify	  individual	  molecular	  species	  of	  lipids	  that	  consisted	  of	  the	  previously	   identified	   fatty	   acid	   compositions	   (Table	   4-­‐2).	   Both	   of	   the	   lipid	  fractions	   consisted	   of	   mainly	   ceramide	   species	   in	   general.	   According	   to	  Christie	   and	   Han	   (2010),	   the	   nature	   of	   fatty	   acids	   and	   long-­‐chain	   bases	   in	  ceramides	  are	  commonly	  saturated	  and	  monoenoic	  (monosaturated)	  and	  this	  agrees	   with	   the	   high	   amounts	   of	   saturated	   fatty	   acids	   (mainly	   palmitate,	  16:0)	  in	  the	  unknown	  polar	  lipid	  fatty	  acid	  composition	  and	  the	  high	  amounts	  of	  monosaturated	   fatty	   acids	   (mainly	   vaccenic	   acid,	   18:1n-­‐7)	   in	   the	   solvent	  front	  fraction.	  These	  findings	  suggested	  that	  the	  individual	  fatty	  acids	  within	  the	  lipid	  fractions	  are	  not	  ligands	  or	  activators	  of	  piscine	  PPARγ	  due	  to	  their	  inability	   to	   activate	   the	   receptor,	   but	   it	   was	   the	   intact	   lipid	   structure	  comprising	  of	  these	  long-­‐chain	  bases	  fatty	  acids	  that	  may	  have	  been	  able	  to	  bind	   with	   the	   receptor	   and	   activate	   transcription	   of	   the	   firefly	   luciferase.	  However,	   it	  should	  be	  noted	  that	  the	  activation	  was	  weak,	  and	  it	   is	  possible	  that	   these	   compounds	   could	   be	   affecting	   the	   transcription	   of	   the	   reporter	  genes	   in	   a	   non-­‐PPAR	   dependent	   manner,	   or	   that	   low	   concentration	   of	  unidentified	  minor	  components	  of	  the	  fractions	  may	  be	  causing	  the	  observed	  effects.	  Nevertheless,	  these	  lipid	  fractions	  are	  one	  of	  the	  few,	  or	  possibly	  only	  examples	  showing	  activating	  effects	  on	  piscine	  PPARγ.	   It	  was	  also	  discussed	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in	   the	   previous	   chapter	   that	   alterations	   in	   the	   peptide	   regions	   within	   the	  ligand-­‐binding	  domain	  due	  to	  residue	  substitutions	  (Leaver	  et	  al.,	  2005)	  may	  have	  contributed	   to	   the	  ability	  of	   certain	  ceramide	  species	   to	  bind	  with	   the	  receptor	   of	   PPARγ.	   Thus,	   the	   ability	   of	   LC-­‐MS	   to	   detect	   the	   unknown	  compounds	   was	   very	   imperative	   in	   this	   project	   to	   further	   identify	   the	  potential	   organic	   compounds	   that	  may	  have	  binding	   specificity	  with	  PPARγ	  ligand-­‐binding	   domain	   and	   the	   possibility	   of	   activation	   of	   this	   receptor	   in	  particular.	  	  
 Conclusions	  4.5
Total	   lipid	   extraction	   from	   salmon	   liver	   and	   the	   efficient	   separation	   and	  detection	  of	  various	  lipid	  classes	  was	  achieved.	  This	  is,	  as	  far	  as	  can	  be	  found	  in	  the	  literature,	  the	  only	  example	  of	  preparative	  lipid	  fractionation	  from	  fish	  tissues.	  Potential	  activators	  of	  PPARγ	  in	  cell	  transfection	  assays	  were	  present	  in	   two	   unidentified	   lipid	   fractions.	   GC	   and	   LC-­‐MS	   showed	   that	   the	   major	  molecular	   species	   in	   these	   fractions	  were	   ceramides	   and	   hexosylceramides	  and	   this	   information	   was	   used	   as	   a	   prerequisite	   in	   conducting	   the	  experiments	  that	  followed	  in	  the	  next	  chapter.	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5 Response	  of	  fish	  PPARγ 	  to	  sphingolipids	  	  
 Introduction	  5.1
Sphingolipids,	  together	  with	  sterols	  and	  glycerolipids,	  are	  three	  major	  classes	  of	   lipids,	   recognised	  as	  essential	   components	   in	  eukaryotic	   cell	  membranes	  found	   in	   various	   species	   from	   fungi	   to	  mammals	   and	   in	   some	  bacteria	   and	  viruses	   (Merrill,	   2008).	   In	   addition	   to	   their	   well-­‐established	   roles	   as	  structural	  components	  of	  cell	  membranes,	  they	  have	  become	  a	  major	  topic	  of	  interest	   more	   recently	   since	   they	   have	   been	   recognized	   as	   signaling	  molecules	   (Hannun	   and	   Obeid,	   2008;	   Maceyka	   and	   Spiegal,	   2014)	   and	  essential	   components	   of	   ‘membrane-­‐rafts’	   (Simons	   and	   Gerl,	   2010).	  Sphingolipids	  are	   composed	  of	   characteristic	   long-­‐chain	  or	   sphingoid	  bases	  linked	   to	   a	   fatty	   acid	   via	   an	   amide	   bond	   (Christie	   and	   Han,	   2010).	  Sphingolipids	  may	   be	   divided	   into	   several	  major	   classes	   (Table	   5-­‐1,	   Figure	  5-­‐1)	  and	  these	  include:	  the	  sphingoid	  bases	  and	  their	  simple	  derivatives	  (e.g.	  the	  1-­‐phosphate),	   the	  sphingoid	  bases	  with	  an	  amide-­‐linked	  fatty	  acids	  (e.g.	  ceramides),	   and	   more	   complex	   sphingolipids	   with	   head	   groups	   via	  phosphodiester	   linkages	   (the	   phosphosphingolipids),	   via	   glycosidic	   bonds	  (the	   glycosphingolipids,	   and	   other	   groups	   e.g.	   phosphono-­‐	   and	   arseno-­‐sphingolipids	  (Fahy	  et	  al.,	  2005).	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Table	  5-­‐1	  Sphingolipids	  classes	  and	  subclasses.	  Adopted	  from	  Fahy	  et	  al.	  
(2005)	  
Sphingoid	  bases	   	   	   	  	   Sphing-­‐4-­‐enines	  (sphingosines)	   	  	   Sphinganines	   	   	   	  	   4-­‐Hydroxyphinganines	  (phytosphingosines)	  	   Sphingoid	  base	  homologs	  and	  variants	   	  	   Phingoid	  base	  1-­‐phosphates	   	  	   Lysophingomyelins	  and	  lysoglycophingolipids	  	   N-­‐Methylated	  phingoid	  bases	   	  	   Sphingoid	  base	  analogs	   	   	  Ceramides	   	   	   	  	   N-­‐Acylsphingosines	  (ceramides)	   	  	   N-­‐acylsphinganines	  (dihydroceramides)	   	  	   N-­‐Acyl-­‐4-­‐hydroxysphinganines	  (phytoceramides)	  	   Acylceramides	   	   	  	   Ceramide	  1-­‐phosphates	   	   	  Phosphosphingolipids	   	   	  	   Ceramide	  phosphocholines	  (sphingomyelins)	  	   Ceramides	  phosphoethanolamines	   	  	   Ceramide	  phosphoinositols	   	   	  Phosphonosphingolipids	   	   	  Neutral	  glycosphingolipids	   	   	  	   Simple	  Glc	  series	  (GlcCer,	  LacCer,	  etc)	   	  	   GalNAcβ1-­‐3Galα1-­‐4Galβ1-­‐4Glc-­‐	  (globo	  series)	  	   GalNAcβ1-­‐4Galβ1-­‐4Glc-­‐	  (ganglio	  series)	   	  	   Galβ1-­‐3GlcNAcβ1-­‐3Galβ1-­‐4Glc-­‐	  (lacto	  series)	  	   Galβ1-­‐4GlcNAcβ1-­‐3Galβ1-­‐4Glc-­‐	  (neolacto	  series)	  	   GalNAcβ1-­‐3Galα1-­‐3Galβ1-­‐4Glc-­‐	  (isoglobo	  series)	  	   GalNAcβ1-­‐2Manα1-­‐3Manβ1-­‐4Glc-­‐	  (mollu	  series)	  	   Galβ1-­‐4GlcNAcβ1-­‐3Manβ1-­‐4Glc-­‐	  (athro	  series)	  	   Gal-­‐	  (gala	  seires)	   	   	  	   Other	   	   	   	  Acidic	  glycosphingolipids	   	   	  	   Gangliosides	   	   	   	  	   Sulfoglycosphingolipids	  (sulfatides)	   	  	   Glucuronosphingolipids	   	   	  	   Phosphoglycosphingolipids	   	   	  	   Other	   	   	   	  Basic	  glycosphingolipids	   	   	  Amphoteric	  glycosphingolipids	   	   	  Arsenosphingolipids	   	   	  Other	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Figure	   5-­‐1	   Some	   representative	   structures	   for	   sphingolipids.	   Adopted	  
from	  Fahy	  et	  al.	  (2005).	  
	  	  	  (a)	  Sphinganines:	  sphinganine	  	  	  	  	  	  	  	  (b)	  Sphingoid	  base	  homologs	  and	  variants:	  hexadecasphinganine	  	  	  	  	  	  	  (c)	  Sphingoid	  base	  1-­‐phosphates:	  Sphing-­‐4-­‐enine-­‐1-­‐phosphate	  	  	  	  	  	  	  (d)	  N-­‐acylsphingosines	  (ceramides):	  N-­‐(tetradecanoyl)-­‐sphing-­‐4-­‐nine	  	  	  	  	  (e)	   Ceramide	   phosphocholines	   (sphingomyelins):	   N-­‐(octadecanoyl)-­‐sphing-­‐4-­‐enine-­‐1-­‐	  	  	  phosphocholine	  	  	  	  	  	  	  	  (f)	  Neutral	  Glycosphongolipids:	  Simple	  Glc	  series:	  Glcβ-­‐Cer(d18:1/12:0)	  	  	  	  	  	  	  (g)	  Acidic	  Glycosphingolipids:	  Sulfosphingolipids:	  (3’-­‐sulfo)Galβ-­‐Cer(d18:1/18:0)	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Sphingolipid	  metabolites,	  mainly	  ceramide,	  S1P	  and	  C1P,	  are	  important	  lipid	  mediators	   that	   function	   to	   regulate	   cellular	   activities	   including	   cell	   growth,	  survival,	  migration,	   immune	  cell	   trafficking,	  angiogenesis,	   inflammation	  and	  cancer	  (Hannun	  and	  Obeid,	  2002;	  Kihara	  et	  al.,	  2007;	  Tani	  et	  al.,	  2007;	  Bartke	  and	  Hannun,	  2009;	  Parham	  et	  al.,	  2015;	  Kleuser,	  2018).	  Ceramides	  are	  also	  known	   as	   key	   intermediates	   in	   the	   biosynthesis	   of	   the	   above	   complex	  sphingolipids	  in	  the	  sphingolipid	  metabolic	  pathways	  (Hait	  and	  Maiti,	  2017).	  Sphingolipid	   metabolism	   involves	   ceramide	   as	   the	   central	   sphingolipid	  molecule	   which	   may	   be	   produced	   via	   three	   major	   pathways:	   by	   de	   novo	  synthesis	  with	  a	  series	  of	  enzymatic	  reactions	  in	  the	  endoplasmic	  reticulum	  and	   mitochondria;	   by	   a	   salvage	   pathway	   in	   which	   ceramide	   is	   generated	  through	  the	  acylation	  of	  sphingosine;	  and	  by	  the	  hydrolysis	  of	  sphingomyelin	  through	  the	  action	  of	  sphingomyelinase	  (Figure	  5-­‐2).	  	  
The	  de	  novo	  synthesis	  of	  sphingolipid	  commences	  with	  the	  condensation	  of	  serine	   and	   palmitoyl-­‐CoA,	   catalysed	   by	   serine	   palmitoyl	   transferase	   to	  produce	  3-­‐keto	  sphingosine,	  which	  is	  subsequently	  reduced	  by	  a	  reductase	  to	  form	   sphinganine	   (dihydrosphingosine).	   Sphinganine	   is	   N-­‐acylated	   by	  (dh)ceramide	   synthases	   to	   form	  dihydroceramide	  or	   ceramide.	  Ceramide	   is	  converted	   to	   sphingomyelin	   by	   sphingomyeline	   synthase	   and	   this	   reaction	  can	  be	  reversed	  by	  sphingomyelinase	  to	  regenerate	  ceramide.	  Ceramide	  can	  also	   be	   converted	   to	   a	   hexosylceramide,	   usually	   glucosylceramide	   (GlcCer),	  by	  glucosylceramide	  synthase,	   to	   sphingosine	  by	  ceramidase	  and	   to	  C1P	  by	  ceramide	  kinase.	  Sphingosine	  can	  be	  converted	  to	  S1P	  by	  sphingosine	  kinase	  enymes,	  S1P	  can	  be	  converted	  back	  to	  sphingosine	  by	  S1P	  phosphatase	  and	  S1P	   lyase	   irreversibly	   degrades	   S1P.	   	   C1P	   can	   also	   be	   converted	   back	   to	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Figure	   5-­‐2	   Sphingolipid	   metabolic	   pathways.	   Adopted	   from	   Halt	   and	  
Maiti	  (2017)	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Based	  on	  the	  results	  from	  LC-­‐MS	  analysis	  (in	  Chapter	  4),	  lipid	  fractions	  which	  increased	  reporter	  activity	  on	  Gal4-­‐PPARγ	  transfected	  cells	  contain	  as	  major	  components,	   ceramides	   and	   hexosylceramides.	   These	   compounds,	   together	  with	   other	   metabolites	   involved	   in	   the	   reversible	   metabolic	   pathways	   in	  Figure	  5-­‐2,	  were	  tested	  on	  transfected	  cells	  in	  the	  subsequent	  experiments.	  	  
This	   chapter,	   therefore,	   focuses	   on	   the	   application	   of	   pure	   sphingolipid	  compounds	   above	   to	   test	   the	   response	   of	   Gal4-­‐PPARγ	   construct	   using	   the	  transient	  transfection	  assay	  developed	  previously.	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 Materials	  and	  methods	  5.2
Six	   pure	   sphingolipid	   compounds	   were	   tested	   on	   Gal4-­‐PPARγ	   transfected	  CHSE-­‐214	   cells	   for	   luciferase	   enzyme	   activity:	   ceramide,	   sphingosine,	  glucosylceramide	   (GlcCer),	   sphingosine-­‐1-­‐phosphate	   (S1P),	   ceramide-­‐1-­‐phosphate	   (C1P)	   and	   sphingomyelin	   (SM).	   Pure	   compounds	  of	   SM	  and	   S1P	  were	  purchased	  from	  Sigma,	  C24:	  Ceramide	  (d18:1/24:1(15z)	  and	  C24:	  C1P	  (d18:1/24:0)	   from	   Stratech,	   and	   N-­‐Hexanoyl-­‐glucosyl	   ceramide	   and	   D-­‐erytho-­‐C17-­‐Sphingosine	  were	  obtained	  from	  Universal	  Biologicals.	  
The	   stock	   solutions	   of	   these	   compounds	   were	   prepared	   in	   three	   different	  concentrations	  in	  absolute	  ethanol:	  5	  µM,	  10	  µM	  and	  500	  µM,	  and	  were	  used	  to	  dilute	  complete	  media	  EMEM	  to	  give	  final	  concentrations	  per	  ml:	  5	  nM,	  10	  nM,	   50	   nM,	   100	   nM,	   1	   µM,	   5	   µM,	   10	   µM	   and	   20	   µM,	   to	   be	   tested	   on	  transfected	  CHSE-­‐214	  cells.	  
5.2.1 Seeding	  and	  transfection	  of	  CHSE-­‐214	  cells	  
CHSE-­‐214	  were	  harvested	  from	  near-­‐confluent	  cell	  culture	  flasks	  and	  seeded	  at	  2	  x	  105	  cell	  per	  well	  of	  24	  well	  plates	  before	  transfection	  the	  following	  day	  with	  Gal4-­‐PPARα	   (treated	  with	  WY-­‐14,643	   tested	   for	  positive	  control	  only)	  and	  Gal4-­‐PPARγ	  as	  described	  in	  Sections	  3.2.2.3	  and	  3.2.2.4.	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5.2.2 Treatment	   of	   transfected	   cells	   with	   sphingolipids	   and	  
their	  metabolites	  
Following	  transfection,	  cells	  were	  treated	  with	  the	  above	  compounds	  to	  test	  for	  their	  ability	  to	  interact	  with	  the	  PPARγ-­‐ligand	  binding	  domain	  as	  receptor	  agonists,	   i.e.	   molecules	   capable	   of	   increasing	   transcriptional	   activity	   of	  PPARγ.	  Media	  was	  aspirated	  from	  the	  assay	  plate	  and	  cells	  were	  washed	  once	  with	   1	   x	   DPBS	   (Invitrogen)	   before	   the	   addition	   of	   the	   diluted	   treatment	  compounds	   prepared	   previously.	   Each	   treatment	   was	   run	   in	   triplicates	  within	  each	  experiment	  with	  an	  ethanol	  absolute	  as	  a	  control	  treatment	  at	  a	  concentration	   of	   10	   µl	   ethanol	   absolute	   per	   ml	   of	   EMEM.	   Cells	   were	  incubated	  with	   treatment	   compounds	   for	   a	   further	   24	   hours	   at	   22°C	   in	   an	  atmosphere	  of	  4%	  CO2	  before	  being	  assayed	  for	  luciferase	  activity.	  
5.2.3 Luciferase	   activity,	   data	   normalisation	   and	   statistical	  
analysis	  
Firefly	  and	  Renilla	  luciferase	  activities	  were	  measured	  using	  luciferase	  assay	  buffers	   described	   in	   Chapter	   3.	   Twenty-­‐four	   hours	   post-­‐treatment,	   media	  containing	   treatment	   compounds	  was	  aspirated	   from	  assay	  plates	  and	  cells	  were	   washed	   twice	   with	   1x	   DPBS	   before	   they	   were	   lysed	   in	   1	   ml	   of	   1	   x	  passive	   lysis	  buffer	  (Promega)	  for	  10	  min,	  shaking.	  The	  cell	   lysate	  was	  then	  used	  in	  a	  dual	  luciferase	  assay	  system	  described	  in	  Chapter	  3.	  
As	   previously	   described,	   Renilla	   luciferase	   values	   were	   used	   to	   normalise	  firefly	  activities	   for	  differences	   in	   transfection	  efficiency	  between	  wells.	  For	  
	  	   151	  
each	   well,	   the	   firefly	   luciferase	   value	   was	   divided	   by	   the	   corresponding	  
Renilla	  luciferase	  value	  and	  the	  mean	  replicate	  wells	  was	  calculated.	  
Experiments	  were	  repeated	  independently	  three	  times	  (with	  different	  flasks	  of	   cells	   seeded	   on	   different	   days).	   Data	   is	   reported	   as	   the	   mean	   fold	  inductions	   in	   normalised	   luciferase	   activities	   compared	   to	   ethanol	   vehicle	  controls.	   To	   test	   for	   statistically	   significant	   differences	   between	   ethanol	  control	   treatment	   and	   treatment	  with	   lipid	   compounds,	   a	   one-­‐way	   ANOVA	  was	   carried	   out	   followed	   by	   Dunnet’s	   test	   on	   Minitab18	   software.	   Results	  were	  considered	  statistically	  significant	  when	   the	  probability	  value	   (P)	  was	  less	  than	  0.05	  (P<0.05).	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 Results	  5.3
Of	   all	   the	   sphingolipids	   incubated	   with	   Gal4-­‐PPARγ,	   only	   one	   compound,	  GlcCer	  at	  a	  treatment	  concentration	  of	  5	  µM,	  was	  able	  to	  increase	  expression	  of	   firefly	   luciferase	   over	   that	   observed	   with	   ethanol	   to	   a	   statistically	  significant	   level	   of	   P<0.05,	   although	   this	   increase	   was	   small	   at	   1.91-­‐fold	  (Figure	  5-­‐3).	  Pure	  sphingomyelin	  compound	  caused	  no	  increase	  in	  luciferase	  activity,	   and	   this	   agrees	   with	   the	   observation	   previously	   documented	   in	  Chapter	   4	   in	   which	   the	   lipid	   fraction	   sphingomyelin/phosphatodylcholine	  (SM/PC)	   (and	   its	   molecular	   components)	   also	   failed	   to	   increase	   luciferase	  activity,	  therefore	  confirming	  that	  this	  compound	  does	  not	  act	  as	  an	  activator	  of	   PPARγ.	   As	   for	   the	   other	   sphingolipids	   tested,	   sphingosine	   (at	   20	   µM),	  ceramide	  (at	  100	  nM	  and	  1	  µM),	  S1P	  (at	  5,	  10,	  20	  µM)	  and	  C1P	  (at	  20	  µM)	  were	  observed	  to	  significantly	  suppress	  the	  PPARγ	  activity.	  
When	  the	  cells	  transfected	  with	  empty	  pBIND	  only	  were	  treated	  with	  5	  µM	  of	  the	   sphingolipids	   being	   tested	   above,	   there	   was	   no	   significant	   increase	   in	  luciferase	  activity	  over	  ethanol	  (Figure	  5-­‐4).	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Figure	   5-­‐3	   Response	   of	   PPARγ 	   to	   sphingolipids	   at	   different	  
concentrations.	   Data	   are	   the	   means	   ±	   SD	   of	   three	   independent	  
experiments.	   Results	   are	   expressed	   as	   the	   fold	   increase	   over	   ethanol	  
control	   of	   normalised	   firefly	   luciferase	   activity.	   Two	   asterisks	   (**)	  
represent	   statistically	   significant	  difference	   (P<0.01)	   and	  one	  asterisk	  
(*)	  represents	  statistically	  significant	  difference	  (P<0.05)	  to	  activities	  in	  
ethanol	  controls.	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Figure	  5-­‐4	  Response	  of	  empty	  pBIND	  to	  sphingolipids	  at	  5	  µM.	  Data	  are	  
the	   means	   ±	   SD	   and	   results	   are	   expressed	   as	   the	   fold	   increase	   over	  
ethanol	  control	  of	  normalised	  firefly	  luciferase	  activity.	  	  
 Discussion	  5.4
Sphingolipids	   are	   bioactive	   lipids	   that	   are	   important	   in	   signal	   transduction	  (Mathias	  et	  al.,1998;	  Pyne	  and	  Pyne,	  2000;	  Chalfant	  and	  Spiegel,	  2005,	  Kihara	  
et	  al.,	  2007).	  Ceramide	  is	  one	  of	  the	  main	  sphingolipid	  metabolites	  and,	  along	  with	   S1P	   and	   C1P,	   are	   lipid	   mediators	   that	   function	   to	   regulate	   cellular	  activities	   including	   cell	   growth,	   survival,	  migration,	   immune	  cell	   trafficking,	  angiogenesis,	   inflammation	  and	  cancer	  (Hannun	  and	  Obeid,	  2002;	  Kihara	  et	  
al.,	   2007;	   Tani	   et	  al.,	   2007;	   Bartke	   and	  Hannun,	   2009;	   Parham	   et	  al.,	   2015;	  Kleuser,	   2018).	   Because	   ceramide	   is	   the	   central	   sphingolipid	   molecule	   in	  sphingolipid	   metabolism	   and	   the	   key	   intermediate	   in	   the	   biosynthesis	   of	  complex	  sphingolipids,	  and	  because	  of	  its	  essential	  role	  in	  differentiation	  and	  in	   apoptosis	   (Futerman	   and	   Hannun,	   2004;	   Hannun	   and	   Obeid,	   2008),	  ceramide	   has	   emerged	   to	   become	   the	   most	   well-­‐studied	   class	   of	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sphingolipids.	   Reports	   on	   the	   relationship	   between	  mammalian	   PPARγ	   and	  sphingolipids	   are	   very	   limited,	   and	   to	   date,	   there	   are	   no	   published	  information	  that	  links	  PPARγ	  in	  fish	  and	  sphingolipids.	  The	  present	  study,	  for	  the	   first	   time,	   suggested	   a	   potential	   activating	   ligand	   of	   piscine	   PPARγ	   by	  indicating	  the	  involvement	  of	  sphingolipid	  metabolites.	  
5.4.1 Ceramide	  and	  its	  precursors	  
In	  mammals,	  ceramide	  has	  been	  reported	  to	  induce	  apoptosis	  in	  cancer	  cells,	  which	  required	  the	  activation	  of	  PPARγ	  pathway.	  Furthermore,	  ceramide	  was	  able	  to	  activate	  PPARγ	  in	  a	  dose	  dependent	  manner	  (Wang	  et	  al.,	  2006).	  This	  activation,	   however,	   is	   contradictory	   to	   the	   results	   observed	   in	   this	   study	  when	  Gal4-­‐PPARγ	  transfected	  CHSE-­‐214	  cells	  were	  treated	  with	  ceramide.	  In	  fact,	   ceramide	   suppressed	   piscine	   PPARγ	   activity.	   	   These	   results	   are	   more	  consistent	  with	  a	  previous	  report	  showing	  that	  PPARγ	  expression	  in	  cultured	  mouse	  preadipocytes	  (3T3-­‐L1)	  was	  downregulated	  by	  ceramide,	  resulting	  in	  the	  inhibition	  of	  adipogenesis	  (Sprott,	  et	  al.,	  2002).	  Similarly,	  sphingomyelin	  downregulated	   mammalian	   PPARγ	   expression	   in	   cultured	   preadipocytes	  (3T3-­‐F442A)	   in	   vitro	   (Al-­‐Makdissy	   et	   al.,	   2001)	   and	   adipocytes	   in	   vivo	  (Zeghari	   et	   al.,	   2000).	   This	   down-­‐regulation	   of	   PPARγ	   expression	   was	  evidently	   dependent	   on	   the	   length	   of	   the	   acyl	   chain	   of	   sphingomyelin	   such	  that	   longer	   acyl	   chains	   down-­‐regulated	   PPARγ	   to	   a	   greater	   extent	   (Al-­‐Makdissy	  et	  al.,	  2001).	  In	  this	  study,	  sphingomyelin	  failed	  to	  activate	  piscine	  PPARγ	   activity	   at	   various	   concentrations.	   Nevertheless,	   being	   the	   most	  abundant	   sphingolipid,	   sphingomyelin	   together	   with	   the	   enzyme	  sphingomyelinase	  provide	  the	  greatest	  contribution	  to	  ceramide	  production	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(Kihara	   et	   al.,	   2007)	   and	   thus,	   the	   production	   of	   other	   important	  sphingolipids	  metabolites.	  
Similar	   to	   ceramide	   treatment	   of	   Gal4-­‐PPARγ	   transfected	   cells,	   other	  precursors	   of	   ceramide,	   sphingosine,	   S1P	   and	   C1P,	   also	   suppressed	   the	  activity	   of	   piscine	   PPARγ	   in	   a	   dose	   dependent	   manner,	   although	   it	   is	   not	  possible	   to	   rule	   out	   toxic	   effects.	   Though	   the	   context	   of	   PPARγ	   signaling	   in	  fish	   remains	   unknown,	   the	   role	   of	   piscine	   PPARγ	   in	   fish	   lipid	   metabolism	  could	   be	   affected	   by	   these	   sphingolipid	  metabolites.	   This	   appears	   to	   be	   in	  contrast	  to	  the	  role	  of	  S1P	  with	  regard	  to	  PPARγ	   in	  mammals.	  S1P	  is	  known	  to	   be	   a	   bioactive	   lipid	   mediator	   important	   in	   various	   physiological	   and	  pathological	   cellular	   processes	   (Hla,	   2004)	   and	   its	   functions	   include	  regulating	   cell	   survival,	   proliferation,	  migration,	   signaling	   and	   angiogenesis	  (Hannun	  and	  Obeid,	  2008).	  Levels	  of	  S1P	  are	  affected	  by	  the	  amount	  of	  S1P	  lyase	  present	   in	   liver	  cells	  as	  this	  enzyme	  is	  responsible	  for	  the	  irreversible	  degradation	  of	   S1P	   (Bektas	  et	  al.,	   2010).	   In	  murine	   liver	   tissues	  where	  S1P	  lyase	  was	  deficient,	  PPARγ	  expression	  was	  observed	  to	  be	  upregulated.	  And	  S1P	   lyase	  deficiency	  affected	  the	   levels	  of	  multiple	  sphingolipid	  metabolites	  including	   sphingosine,	   ceramide,	   sphingomyelin	   and	   C1P	   (Bektas	   et	   al.,	  2010),	  suggesting	  this	  enzyme	  is	  central	  to	  the	  regulation	  of	  the	  sphingolipid	  metabolic	   pathway	   (Serra	   and	   Saba,	   2010).	   Moreover,	   overexpression	   of	  sphingosine	   kinase,	   an	   enzyme	   responsible	   in	   the	   production	   of	   S1P	   from	  sphingosine,	   increased	   lipid	   accumulation	   in	   mouse	   liver	   and	   PPARγ	  expression,	  similarly	  to	  treatment	  with	  S1P	  (Chen	  et	  al.,	  2016).	  These	  studies	  suggest	  that	  because	  ceramide	  and	  its	  metabolites	  are	  mutually	  convertible,	  it	   is	   desirable	   for	   cells	   to	   regulate	   the	   total	   amount	   of	   each	   metabolite	   in	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order	  to	  maintain	  the	  overall	  balance	   in	  cellular	   levels	  (Kihara	  et	  al.,	  2007).	  More	   recently	   and	   in	   complete	   contrast	   to	   the	   piscine	   results	   reported	  herein,	   S1P	   has	   been	   identified	   as	   a	   ligand	   of	   mammalian	   PPARγ	   in	   the	  regulation	   of	   neoangeogenesis	   (Parham	   et	   al.,	   2015).	   The	   interaction	  between	   S1P	   and	  mammalian	   PPARγ	   was	   predicted	   to	   have	   occurred	  with	  the	   formation	  of	  hydrogen	  bonds	  between	   the	  phosphate	  group	  of	  S1P	  and	  H323	   and	   H449	   of	   Helix	   12	   within	   PPARγLBD.	   However,	   as	   previously	  discussed	   in	   Chapter	   3,	   one	   of	   these	   amino	   acids	   in	   piscine	   PPARγLBD,	   i.e.	  H323,	  has	  been	  replaced	  by	  isoleucine	  in	  the	  PPARγLBD,	  while	  H449	  remains	  equivalent	   with	   PPARγLBD	   in	   mammals	   (Leaver	   et	   al.,	   2005).	   This	   again	  confirms	  that	  the	  alteration	  in	  the	  structure	  of	  the	  peptide	  regions	  within	  the	  LBD	  in	  fish,	  may	  be	  responsible	  for	  the	  differences	  between	  mammalian	  and	  piscine	  ligand	  specificity.	  	  	  
5.4.2 Glucosylceramide	  as	  a	  potential	  activating	  compound	  of	  
PPARγ 	  
While	   none	   of	   the	   sphingolipids	   tested	   above	   had	   the	   ability	   to	   activate	  PPARγ	   in	   fish,	   treatment	   of	   Gal4-­‐PPARγ	   transfected	   cells	   with	  glucosylceramide	   (GlcCer),	   one	   of	   the	   metabolites	   of	   ceramide	   in	   the	  synthesis	   of	   more	   complex	   membrane	   glycosphingolipids,	   resulted	   in	  significant	   increase	   in	   luciferase	   activities.	   Glucosylceramides	   are	  glucosylated	   lipids	  with	   simple	   structures	   and	   functions	   critical	   for	   cellular	  homeostasis	   and	   cellular	   activities	   (Ishibashi	   et	   al.,	   2013).	   Recent	   studies	  evidently	   suggested	   that	   GlcCer	   functions	   in	   fat	   metabolism	   in	   Drosophila	  (Kohyama-­‐Koganeya	   et	   al.,	   2011).	   The	   Drosophila	   fat	   body	   is	   an	   organ	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previously	  shown	  to	  be	  equivalent	  to	  both	  liver	  and	  white	  adipose	  tissue	  in	  mammals	   (Kohyama-­‐Koganeya	   et	   al.,	   2004;	   van	   Eijk	   et	   al.,	   2009).	   As	  previously	  mentioned	   and	   shown	   in	   Figure	   5-­‐2,	   glucosylceramide	   synthase	  (GlcT-­‐1)	   is	   the	   enzyme	   responsible	   for	   the	   production	   of	   GlcCer	   from	  ceramide.	   A	   recent	   study	   documented	   that	   there	   was	   an	   improvement	   in	  insulin	  sensitivity	  and	  normalization	  of	  adipogenesis	  in	  obese	  mice	  with	  the	  inhibition	  of	  GlcCer	  synthesis	  by	  GlcT-­‐1-­‐specific	  inhibitor,	  N-­‐(5-­‐adamantane-­‐1-­‐yl-­‐methoxyl)-­‐pentyl-­‐1-­‐deoxynojirimycin	   (AMP-­‐DNM)	   (van	   Eijk	   et	   al.,	  2009).	   The	   normalization	   of	   adipocytes	   was	   associated	   with	   an	   increase	  expression	   of	   a	   number	   of	   genes	   including	   PPARγ,	   suggesting	   that	   reduced	  amounts	   of	   GlcCer	   in	   the	   adipose	   tissue,	   improved	   lipid	   metabolism	   in	  dyslipidemic	  mammalian	  models.	  Overexpression	  of	  GlcT-­‐1	  in	  the	  Drosophila	  fat	   body,	   increased	   fat	   storage,	   and	   the	   reduction	   of	   GlcT-­‐1	   decreased	  storage,	  suggesting	  that	  GlcCer	  has	  an	  important	  role	  in	  energy	  storage	  in	  this	  species	   (Kohyama-­‐Koganeya	   et	   al.,	   2011).	   However,	   the	   molecular	  mechanism	  that	  links	  GlcCer	  with	  the	  regulation	  of	  energy	  metabolism	  is	  still	  not	   clearly	   understood	   in	  Drosophila	   and	   given	   that	   insects	   do	   not	   possess	  PPAR	  genes,	  and	  the	  exact	  relevance	  to	  vertebrates	   is	  not	  clear.	   It	  has	  been	  noted	   that	   relatively	   small	   amounts	   of	   dietary	   GlcCer	   can	   vastly	   improve	  human	   skin	   conditions,	   and	   this	   may	   be	   due	   to	   PPARγ	   activation,	   but	  involving	   GlcCer	   metabolites,	   4-­‐8-­‐sphingadienine	   and	   4-­‐hydroxy-­‐8-­‐sphingenine	  (Shirakura	  et	  al.,	  2012).	  	  
Application	  of	  GlcCer	  to	  transfected	  cells	  indicated	  a	  clear	  activation	  effect	  at	  5	  µM	   as	  was	   observed	  with	   lipid	   fractions	  whose	  major	   constituents	  were	  GlcCer	  compounds	  (Chapter	  4).	  However,	  at	  10	  µM	  and	  above,	  GlcCer	  did	  not	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have	  a	  significant	  effect.	  Whilst	  this	  might	  suggest	  random	  effects	  that	  do	  not	  represent	  bona	  fide	  activation,	  it	  is	  notable	  that	  this	  was	  the	  only	  compound	  tested	   that	   showed	   significant	   activation,	   and	   was	   also	   one	   of	   the	   major	  components	   of	   the	   only	   lipid	   fractions	   that	   showed	   effects.	   Therefore,	   the	  possibility	   of	   GlcCer	   interaction	   with	   piscine	   PPARγ	   is	   worthy	   of	   further	  investigation.	  However,	   it	   should	   also	   be	  noted	   that	   in	   the	   cell	   transfection	  assays	  herein,	  it	  is	  not	  possible	  to	  conclude	  whether	  GlcCer	  or	  one	  of	  more	  of	  its	   metabolites,	   as	   suggested	   for	   mammalian	   PPAR	   interactions	   described	  above,	   was	   able	   to	   activate	   piscine	   PPARγ.	   It	   is	   also	   possible	   that	   piscine	  PPARγ	   is	   not	   ligand	  activated,	   but	   acts	   as	   a	   repressor	  of	   gene	   transcription	  when	  bound	   to	   its	   cognate	  promoter,	   in	  which	   case	   target	   gene	   expression	  would	   be	   controlled	   by	   expression	   levels	   of	   PPARγ.	   This	   hypothesis	   and	  ligand	   activation	   hypothesis	   will	   only	   become	   testable	   after	   genuine	   gene	  targets	   for	   PPARγ	   are	   identified	   in	   fish.	   This	   presents	   a	   conundrum,	   as	   the	  mechanism	   of	   PPARγ	   may	   have	   to	   be	   determined	   before	   experiments	   can	  performed	  to	  identify	  target	  genes	  in	  fish.	  Nevertheless,	  the	  lack	  of	  response	  of	   piscine	   PPARγ	   to	   fatty	   acids	   observed	   previously	   in	   the	   experiments	  reported	   in	   Chapter	   3	   and	   from	   the	   previous	   studies	   (Leaver	   et	   al.,	   2005;	  Colliar	   et	   al.,	   2011),	   and	   the	   ability	   of	   a	   more	   complex	   sphingoid	   lipid	  structures	  in	  the	  activation	  of	  the	  receptor	  in	  both	  mammals	  and	  fish,	  suggest	  there	   may	   be	   common	   endogenous	   activators	   of	   mammalian	   and	   piscine	  PPARγ.	  	  	   	  
	  	   160	  
 Conclusions	  5.5
Piscine	  PPARγ	  is	  annotated	  based	  on	  its	  structurally	  close	  similarity	  to	  PPARγ	  in	  mammals.	  Despite	  this	  similarity,	  piscine	  PPARγ	  is	  not	  activated	  by	  typical	  lipid	  or	  synthetic	   ligands	  of	  mammalian	  PPARγ.	  This	  may	  be	  due	   to	  a	  small	  number	  of	  critical	  and	  phylogenetically	  invariable	  amino	  acid	  substitutions	  in	  the	   ligand	   binding	   domain	   of	   piscine	   PPARγ.	   However,	   both	   ceramide	   and	  GlcCer	   were	   identified	   as	   major	   components	   of	   lipid	   fractions	   that	   were	  capable	  of	  activating	  piscine	  PPARγ	  in	  cellular	  transactivation	  assays.	  Here,	  it	  is	  shown	  that	  of	  these	  two	  pure	  sphingolipids,	  only	  GlcCer	  showed	  activation	  of	  piscine	  PPARγ.	  Other	   sphingolipids,	   sphingosine,	   ceramide,	   S1P	  and	  C1P,	  which	  may	  have	  been	  present	   at	   lower	   levels	   in	   these	   lipid	   fractions,	  were	  not	  activators	  and	  in	  some	  cases	  appeared	  to	  inhibit	  PPARγ.	  There	  is	  a	  limited	  wider	  literature	  on	  sphingolipid	  interactions	  with	  PPARs	  and	  to	  date,	  there	  is	  evidence	  that	  GlcCer	  metabolites	  might	  activate	  mammalian	  PPARγ,	  but	  this	  does	  suggest	  that	  these	  metabolites	  should	  be	  tested	  on	  piscine	  PPARγ.	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6 Phylogeny	   and	   tissue	   distribution	   of	   peroxisome	  
proliferator-­‐activated	   receptors	   (PPARs)	   in	  
Atlantic	  salmon	  (Salmon	  salar)	  
 Introduction	  6.1
Peroxisome	   proliferator-­‐activated	   receptors	   (PPARs)	   are	   ligand-­‐inducible	  transcription	   factors	   that	   belong	   to	   the	   nuclear	   hormone	   receptor	  superfamily.	  Since	  their	  initial	  discovery	  as	  transcription	  factors,	  PPARs	  have	  been	   intensively	   studied	   and	   the	   three	   PPAR	   isotypes,	   PPARα,	   PPARγ	   and	  PPARβ	   (or	   δ)	   have	   been	   identified	   and	   functionally	   characterised	   in	  mammals	  (Kliewer	  et	  al.,	  1992;	  Issemann	  et	  al.,	  1993),	  amphibians	  (Dreyer	  et	  
al.,	  1992)	  and	  birds	  (Diot	  and	  Douaire,	  1999).	  Each	   isotype	   is	  encoded	  by	  a	  single	  gene	  and	  each	  has	  different	  functions,	  reflected	  by	  distinct	  patterns	  of	  tissue	  distribution	   (Desvergne	  and	  Wahli,	   1999;	  Escher	  et	  al.,	   2001;	  Hihi	  et	  
al.,	  2002;	  Boukouvala	  et	  al.,	  2004;	  Leaver	  et	  al.,	  2005).	  
PPARα	   functions	   in	   fatty	   acid	   oxidation	   in	  mitochondria	   and	   peroxisomes,	  thus,	  is	  highly	  expressed	  in	  tissues	  with	  high	  rates	  of	  β-­‐oxidation	  such	  as	  the	  liver,	   heart,	   muscle	   and	   kidney.	   The	   role	   of	   PPARα	   is	   conserved	   in	   both	  mammalian	   (Braissant	   et	   al.,	   1996)	   and	   fish	   species.	   Although	   only	   one	  PPARα	  has	  been	  identified	  in	  mammals,	  most	  fish	  investigated	  so	  far	  express	  two	   PPARα	   subtype	   genes,	   termed	   PPARα1	   and	   PPARα2,	   (Maglich	   et	   al.,	  2003;	  Leaver	  et	  al.,	  2005).	  
Like	   its	   mammalian	   homolog,	   piscine	   PPARβ	   being	   the	   most	   ubiquitous	  isotype,	  showed	  the	  strongest	  overall	  expression	  and	  is	  present	  in	  almost	  all	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tissues,	  thus,	  the	  physiological	  role	  of	  PPARβ	  is	  less	  well	  established	  than	  for	  other	   PPARs.	  While	   there	   is	   only	   a	   single	   gene	   that	   encodes	   for	   PPARβ	   in	  mammals,	   the	  numbers	  of	  PPARβ	   subtypes	  varies	   in	   fish	  species.	  Similar	   to	  mammals,	   pufferfishes	   exhibit	   only	   one	   PPARβ	   gene	   (Maglich	   et	   al.,	   2003)	  and	  this	  is	  also	  evidently	  true	  for	  plaice	  and	  sea	  bream	  (Leaver	  et	  al.,	  2005).	  However,	  it	  has	  previously	  been	  reported	  that	  more	  than	  one	  gene	  for	  PPARβ	  may	  be	  present	  in	  zebrafish	  (Robinson-­‐Rechavi	  et	  al.,	  2001).	  Multiple	  PPARβ	  genes	   have	   been	   have	   also	   been	   identified	   in	   Atlantic	   salmon,	   termed	  ssPPARβ1A,	   ssPPARβ1B,	   ssPPARβ2A	  and	   ssPPARβ2B,	   at	   least	   two	  of	  which	  appear	  to	  be	  functional	  (Leaver	  et	  al.,	  2007).	  	  
Mammals	  have	  a	  single	  gene	  encoding	  PPARγ	  that	  is	  alternatively	  spliced	  to	  give	   rise	   to	   two	   proteins,	   PPARγ1	   and	   PPARγ2,	   each	   carrying	   different	   N-­‐terminal	  sequence	  (Tontonoz	  et	  al.,	  1994).	  PPARγ1	  is	  highly	  expressed	  in	  gut	  where	   as	   PPARγ2	   is	   abundant	   in	   adipose	   tissues	   compared	   to	   the	   other	  tissues	   (Escher	   et	   al.,	   2001).	   From	   the	   available	   genome	   information	   of	  zebrafish,	   stickleback,	  medaka,	  pufferfish,	   sea	  bream,	  sea	  bass	  and	  plaice,	   it	  was	  observed	  that	  fish	  also	  possess	  a	  single	  PPARγ	  gene	  with	  no	  indications	  of	  alternatively	  spliced	  PPARγ	  proteins	  (Maglich	  et	  al.,	  2003;	  Boukouvala	  et	  
al.,	  2004;	  Leaver	  et	  al.,	  2005).	  
The	  differences	   in	   the	  number	   of	   genes	   in	   different	   fish	  may	  have	   resulted	  from	  the	  occurrence	  of	  ancestral	  genome	  duplications	  after	  the	  split	  between	  mammalian	   and	   teleost	   lines.	   These	   genes	  may	   have	   been	   lost	   or	   retained	  during	  the	  divergence	  of	  different	  lineages	  of	  fish	  (Woods	  et	  al.,	  2005).	  Whilst	  the	   previous	   genome	   duplication	   may	   have	   occurred	   in	   early	   evolution	   of	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ray-­‐finned	  fishes	  (Taylor	  et	  al.,	  2003),	  the	  presence	  of	  multiple	  PPARβ	  genes	  in	  Atlantic	  salmon	  supports	  the	  theory	  that	  salmonids	  may	  be	  derived	  from	  a	  relatively	  recent	  autotetraploidization	  event	  (Allendorf	  and	  Thorgaard,	  1984;	  Alexandrou	   et	   al.,	   2013).	   The	   recent	   availability	   of	   the	   salmon	   genome	  sequence	   (Lien	   et	   al.,	   2010)	   now	   enables	   the	   identification	   of	   the	   full	  complement	  of	  PPAR	  genes	  in	  this	  species.	  
This	  study	  aimed:	  
(1) To	   assess	   the	   phylogenetic	   relationship	   of	   Atlantic	   salmon	   PPAR	  genes	  and	  the	  PPAR	  genes	  in	  other	  fish	  species	  and	  other	  vertebrates,	  	  (2) To	   determine	   the	   PPAR	   distribution	   in	   various	   tissues	   of	   Atlantic	  salmon	   through	   the	   investigation	   of	   the	   gene	   expression	   of	   the	  different	  isoforms	  of	  PPAR.	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 Materials	  and	  methods	  6.2
6.2.1 Sampling	  
This	   experiment	   was	   subjected	   to	   ethical	   review	   and	   approved	   by	   the	  University	   of	   Stirling	   through	   Animal	   and	   Welfare	   Ethical	   Review	   Body	  (AWERB).	   Five	   juvenile	   pre-­‐smolt	   specimens	   of	   Atlantic	   salmon	   (Salmon	  
salar)	   with	   weight	   range	   of	   about	   300-­‐400	   g	   were	   obtained	   from	   the	  University	  of	  Stirling	  Buckieburn	  Field	  Station,	  Scotland.	  Fish	  were	  sacrificed	  with	  an	  overdose	  of	  tricaine	  methanesulfonate	  (MS222)	  and	  a	  sharp	  blow	  to	  the	   head.	   Approximately	   50-­‐100	   mg	   of	   different	   tissue	   samples	   including	  heart,	   brain,	   spleen,	   intestine,	   kidney,	   ovary,	   liver,	   gill	   and	   muscle	   were	  collected	   from	   five	   female	   fish.	   The	   samples	   were	   preserved	   overnight	   in	  RNA	   later	   (stabilisation	   buffer)	   at	   4	   °C	   and	   subsequently	   stored	   in	   -­‐70	   °C	  freezers	  till	  required.	  
6.2.2 RNA	  extraction	  
Total	  RNA	  was	  extracted	  following	  the	  RNA	  tri	  Reagent	  (Sigma-­‐Aldrich,	  USA)	  extraction	   protocol.	   About	   50	   mg	   tissue	   samples	   fixed	   in	   RNAlater	   were	  homogenised	  in	  1	  ml	  TRI	  Reagent	  in	  2	  ml	  screw	  cap	  microtubes	  using	  a	  Mini-­‐Beadbeater	  (Bio	  Spec	  Products	  Inc.,	  Bartlesville,	  USA).	  Homogenised	  samples	  were	  incubated	  at	  room	  temperature	  for	  5	  min	  before	  they	  were	  centrifuged	  at	   14,000	   x	   g	   in	   a	   microcentrifuge	   for	   5	   min.	   In	   the	   fumehood,	   the	  supernatants	  were	  transferred	  into	  fresh	  Eppendorf	  tubes	  and	  1/10	  volume	  of	  1-­‐bromo-­‐3-­‐chloropropane	  (BCP)	  was	  added.	  The	  contents	  were	  mixed	  by	  vortex	   before	   they	   were	   incubated	   at	   room	   temperature	   for	   15	   min	   and	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centrifuged	   at	   14,000x	   g	   for	   10	   min.	   The	   clear,	   upper	   aqueous	   phase	   was	  carefully	   transferred	   to	   fresh	   Eppendorf	   tubes	   in	   200	  µl	   aliquots.	   Half	   the	  volume	   (per	   aqueous	  phase	  volume)	  of	   isopropanol	   and	  half	   the	  volume	  of	  RNA	  precipitation	   solution,	   consisting	  of	   1.2	  M	   sodium	  chloride	   (NaCl)	   and	  0.8	   M	   sodium	   citrate	   sesquihydrate	   (C6H6Na2O7	   -­‐1.5H2O),	   were	   added	   to	  precipitate	   the	   RNA.	   The	   mixtures	   were	   subsequently	   mixed	   thoroughly	  before	   the	   tubes	   were	   centrifuged	   at	   14,000	   x	   g	   for	   15	   min.	   The	   RNA	  precipitate	   formed	   gel-­‐like	   pellets	   on	   the	   bottom	   of	   the	   tubes.	   The	  supernatant	  was	  removed	  carefully	  by	  pipetting	  and	  pellet	  was	  washed	  with	  1	  ml	  of	  75	  %	  ethanol	   in	  MilliQ	  water	  (v/v).	  The	  pellets	  were	  lifted	  from	  the	  bottom	  of	   the	   tube	  by	   flicking	  and	   inverting	   the	   tubes	  a	   few	   times	   to	  make	  sure	  the	  entire	  surface	  of	  the	  pellets	  was	  properly	  washed	  before	  they	  were	  incubated	  at	  room	  temperature	  for	  an	  hour	  for	  the	  pellets	  to	  become	  clearly	  visible.	   The	   tubes	   were	   then	   centrifuged	   at	   14,000	   x	   g	   for	   5	   min	   and	   the	  ethanol	  was	  carefully	  removed	  and	  discarded.	  The	  RNA	  pellets	  were	  air	  dried	  at	   room	   temperature	   until	   all	   visible	   traces	   of	   ethanol	   were	   gone.	  Subsequently,	  RNA	  pellets	  were	   re-­‐suspended	   in	   an	   appropriate	   amount	   of	  MilliQ	   water	   of	   40-­‐400	   µl	   depending	   on	   the	   size	   of	   the	   RNA	   pellet.	   RNA	  solutions	   were	   incubated	   at	   room	   temperature	   for	   30-­‐60	   min	   with	   gentle	  flicking	  of	  the	  tubes	  every	  15	  min	  to	  aid	  resuspension.	  The	  concentration	  and	  quality	  of	  RNA	  were	  assessed	  spectrophotometrically	  using	  the	  NanoDrop®	  (Labtech	   International	   ND-­‐1000	   spectrophotometer).	   The	   quality	   and	  integrity	   of	  RNA	   samples	  were	   further	   assessed	  by	   electrophoresis	   on	  1	  %	  agarose	  gel,	  as	  described	  in	  Section	  2.2.4.	  The	  RNA	  solution	  were	  then	  stored	  at	  -­‐70	  °C	  until	  further	  analysis.	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6.2.3 Cloning	  of	  Atlantic	  Salmon	  PPARγL	  cDNA	  
RNA	  was	  extracted	  (as	  describe	  in	  6.2.2)	  from	  a	  whole	  Atlantic	  salmon	  alevin.	  Synthesis	  of	  cDNA	  was	  carried	  out	  with	  2	  µg	  of	  total	  RNA,	  and	  a	  Nanoscript2	  synthesis	   kit	   (Primer	  Design,	   UK),	   using	   the	   oligo	   dT	   primer	   supplied	  with	  the	  kit.	  The	  database	  entry	   for	  mRNA	  sequence	   for	  Atlantic	  salmon	  PPARγL	  (XM_014168483)	  is	  a	  prediction	  based	  on	  the	  genome	  sequence	  and	  during	  alignment	   with	   other	   salmon	   PPARs	   sequences	   the	   deduced	   amino	   acid	  sequence	   showed	   some	   unlikely	   irregularities.	   Therefore,	   primers	   were	  designed	   (GGACCTGGCAGAGATGGACAAC,	   CCCACTACTCTAGTACAGGTCCCT)	  to	  regions	  encompassing	  the	  predicted	  start	  and	  stop	  codons	  and	  applied	  to	  the	   salmon	   alevin	   cDNA	   sample	   in	   a	   PCR	   reaction	   containing	   10	   µl	   2	   x	  MyTaqHS	  mastaermix	  (Bioline,	  UK),	  200	  nM	  each	  primer,	  and	  1	  µl	  of	   cDNA	  synthesis	  reaction.	  Cycling	  parameters	  were	  95	  °C	  for	  20	  s,	  60	  °C	  for	  20	  s,	  and	  72	   °C	   for	   30	   s.	   PCR	   products	   were	   purified	   from	   reactions	   using	   silica	  membrane-­‐based	   spin	   columns	   (Qiagen),	   and	   ligated	   to	   pGEMTeasy	   PCR	  product	   cloning	   vector	   (Promega),	   according	   to	   the	   manufacturer’s	  instructions.	   Plasmids	   containing	   cDNA	   inserts	   were	   sequenced	  commercially	  (GATC	  Biotech).	  
6.2.4 Complementary	  DNA	  (cDNA)	  synthesis	  
Complementary	   DNA	   (cDNA)	   was	   synthesised	   using	   the	   Precision	  nanoScriptTM2	  Reverse	  Transcription	  Kit	  (Primer	  Design	  Ltd,	  UK),	   following	  manufacturer’s	  instructions.	  The	  reverse	  transcription	  kits	  and	  the	  RNA	  were	  allowed	  to	  thaw	  on	  ice.	  A	  total	  of	  10	  µl	  of	  RNA	  solution	  containing	  1	  µg	  RNA	  and	  1	  µl	  reverse	  transcriptase	  oligo	  dT	  primers	  in	  MilliQ	  water	  was	  prepared	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in	  0.2	  ml	  PCR	  tubes.	  These	  were	  heated	  in	  a	  Biometra	  thermocycler	  for	  5	  min	  at	  65	  °C	  to	  denature	  RNA	  and	  placed	  on	   ice	  at	  4	  °C	  immediately	  to	  cool	   the	  tubes.	  The	  cDNA	  reverse	  transcriptase	  master	  mix	  was	  prepared	  according	  to	  manufacturer’s	   instructions,	  multiplied	  by	  the	  number	  of	  samples	  available.	  A	   volume	   of	   10	   µl	   of	   the	   cDNA	   reverse	   transcriptase	   mix	   containing	   5	   µl	  nanoScript2	  4x	  buffer,	  1	  µl	  dNTP	  mix	  10	  mM,	  1	  µl	  nanoScript2	  enzyme	  and	  3	  
µl	   nuclease-­‐free	  water	  was	   added	   to	   the	   10	  µl	   solution	   of	   denatured	   RNA,	  mixed	  briefly	  by	  vortexing	  followed	  by	  a	  pulse	  spin.	  These	  tubes	  were	  put	  in	  a	  thermocycler	  set	  at	  25	  °C	  for	  5	  min,	  42	  °C	  for	  20	  min,	  75	  °C	  for	  15	  min	  and	  4	  
°C	  for	  4	  min,	  after	  which	  the	  cDNA	  samples	  were	  diluted	  to	  80	  µl	  total	  volume	  (1:4)	  with	  MilliQ	  water	   and	   stored	  at	   -­‐20	   °C	  until	   required	   for	  quantitative	  polymerase	  chain	  reaction	  (qPCR).	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6.2.5 Quantitative	  polymerase	  chain	  reaction	  (qPCR)	  primers	  	  
Atlantic	   salmon	   PPAR	   mRNA	   sequences	   (Table	   6-­‐1)	   were	   identified	   by	   a	  combination	  of	  text	  searches	  of	  current	  annotations	  of	  the	  salmon	  genome	  on	  NCBI,	   and	   BLAST	   searches	   of	   the	   salmon	   genome	   using	   previously	  characterised	  fish	  PPAR	  sequences.	  This	  resulted	  in	  the	  identification	  of	  eight	  (8)	   genes,	   and	   corresponding	   cDNAs	   with	   high	   similarity	   to	   PPARs	   across	  vertebrates.	   As	   these	   salmon	   mRNAs	   are	   to	   some	   extent	   the	   result	   of	  computer	  predictions	  based	  on	  genomic	  sequence,	  they	  were	  also	  compared	  to	  previously	  deposited	  salmon	  sequences	  and	  inspected	  for	  possible	  errors	  or	   ambiguities	   in	   order	   to	   exclude	   regions	   of	   ambiguity	   when	   designing	  amplification	  primers.	   In	   the	  case	  of	  PPARγL,	  substantial	  problems	  with	  the	  database	  mRNA	   sequence	   prediction	   necessitated	   cDNA	   cloning	   (described	  above	   in	   Section	   6.2.2).	   Primers	   were	   derived	   using	   PrimerBLAST	  	  (www.ncbi.nlm.nih.gov),	  setting	  requirements	  for	  amplicon	  lengths	  between	  150	  and	  250	  base	  pairs,	  and	  primer	  melting	  temperatures	  (Tm)	  between	  59	  and	   61	   °C.	   Primers	   were	   checked	   for	   specificity	   against	   all	   other	   Atlantic	  salmon	  sequence	  deposited	  on	  Genbank_nr.	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Table	  6-­‐1	  Nucleotide	  sequences	  of	  primers	  used	   for	  PCR	  amplification	  
of	  cDNA	  fragments	  encoding	  ssPPARs	  
Name	  of	  Sequencing	  Primer	   Forward	  Primer	  sequence	  (5’	  to	  3’)	   Reverse	  Primer	  sequence	  (5’	  to	  3’)	   Amplicon	  size	  (base	  pairs)	  
ssPPARα	   GGCGTCTACGAGGCACTGTT	   GCGAACTGAAACTTGGGCTC	   152	  
ssPPARαL	   CAGTCGAGTAACGGCTCTGG	   GGCGAAAGAAACCCTTGCAG	   214	  
ssPPARβ1A	   GCCAACCACACTGACTCAAAG	   CTCCCAATCCCAGAAACCAGG	   234	  
ssPPARβ1B	   TCACATTACCTCTTCCCCAAGC	   ACTCACAGGAGTGAGTGAACAG	   223	  
ssPPARβ2A	   CAAACTTTCCACATCCCCTGAA	   TTCCATGATACCCTTGAGATGGG	   175	  
ssPPARβ2B	   CCCTTGCTGTCAGAGCAGTT	   GCTCTCTCACAGCGCTCATA	   188	  
ssPPARγ	   TCATCCTCAGTGGAGACCGT	   CTGCTTCTTGAGCAGGTGGA	   206	  
ssPPARγL	   GCACATTGGACCTGGCAGAGA	   GGACTGTTGAGGCTGTGCTCT	   112	  
18S	  rRNA	   ACCACATCCAAGGAAGGCAG	   CACCAGACTTGCCCTCCAAT	   159	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6.2.6 Tissue	  expression	  analysis	  
The	  expression	  of	  each	  target	  gene	  mentioned	  in	  Section	  6.2.5	  was	  measured	  by	   real	   time	   quantitative	   PCR	   (qPCR)	   using	   Eppendorf	   Mastercycler®	   ep	  
realplex	   (Germany).	  The	  qPCR	  reactions	  were	  prepared	   in	  10	  µl	  volumes	   in	  MilliQ	  water	   using,	   per	   reaction,	   2	  µl	   cDNA,	   prepared	   in	   Section	   6.2.4,	   5	  µl	  SensiFAST™	  SYBR®	  No-­‐ROX	  mix	   (Bioline)	   and	  0.2	  µl	   (10	  µM)	   forward	   and	  reverse	   primer	   each.	   The	   qPCR	   reaction	   for	   the	   reference	   gene,	   18S	   rRNA,	  was	   also	  prepared	   in	   the	   same	  way.	   	   Each	  plate	   included	  negative	   controls	  (no	  template	  control,	  NTC)	  containing	  no	  cDNA	  to	  ensure	  contamination	  has	  not	   occurred.	   A	   cDNA	   reference	   pool	   dilution	   series	   was	   also	   included	   on	  each	   plate	   to	   calculate	   the	   efficiency	   of	   the	   PCR	   reaction.	   Each	   cDNA	   (4	  µl	  each)	  from	  all	  the	  tissues	  of	  sampled	  fish	  were	  pooled	  and	  was	  diluted	  to	  give	  cDNA	  dilutions	  of	  1	  in	  2,	  1	  in	  5,	  1	  in	  10,	  1	  in	  50	  and	  1	  in	  100	  in	  MilliQ	  water.	  The	  undiluted	  cDNA	  reference	  pool	  was	  prepared	  in	  aliquots	  and	  stored	  at	  -­‐20	   °C	   and	   dilutions	   were	   freshly	   prepared	   on	   the	   day	   of	   use.	   The	   cDNA	  samples	   were	   run	   in	   duplicates,	   and	   the	   controls	   and	   pooled-­‐dilutions	   in	  triplicates	   on	   each	   plate.	   Plates	   were	   sealed	   using	   Clear	   Seal	   lids	  (KBiosciences)	  and	  briefly	  centrifuged	  to	  collect	  reactions	  in	  bottom	  of	  plate	  wells.	   Reactions	   were	   run	   at	   95	   °C	   for	   2	   min	   to	   activate	   the	   polymerase	  enzyme	  followed	  by	  40	  cycles	  of	  denaturation	  at	  95	  °C	  for	  5	  seconds,	  primer	  annealing	  at	  60	  °C	  for	  10	  seconds	  and	  extension	  at	  72	  °C	  for	  30	  seconds.	  After	  amplification,	   the	   temperature	  was	   increased	   from	  60	   °C	   to	  95	   °C	   in	  0.5	   °C	  increments	   every	   15	   seconds	   to	   produce	   a	   dissociation	   curve,	   used	   to	  confirm	  a	  single	  product	  in	  each	  reaction.	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6.2.7 Data	  normalisation	  and	  statistical	  analysis	  
Relative	   expression	   ratios	   (R)	   of	   each	   PPAR	   was	   calculated	   using	   a	  mathematical	   ‘delta-­‐delta’	   method	   (Pfaffl,	   2001)	   where	   by	   the	   relative	  expression	  of	  a	  target	  gene	  is	  calculated	  based	  on	  the	  amplification	  efficiency	  (E)	   and	   the	   crossing	   point	   (CP)	   deviation	   of	   an	   unknown	   sample	   versus	   a	  control	  	  and	  expressed	  in	  comparison	  to	  a	  reference	  gene,	  using	  the	  equation	  below:	  
𝑅 =    (𝐸!"#$%!)∆!"#$%&'#(!"#$%"&!!"#$%&)(𝐸!"#)∆!"#$%(!"#$%"&!!"#$%&)  
The	   relative	   expression	   of	   each	   PPAR	   target	  was	   calculated	   for	   each	   tissue	  from	   the	  best	   four	  of	   five	   fish	  using	   the	   reference	   gene,	   18S	   rRNA,	   and	   the	  expression	  of	  each	  PPAR	  was	  normalised	   to	  PPAR	  expression	   in	  muscle.	  To	  test	  for	  statistically	  significant	  differences,	  for	  each	  receptor,	  expression	  was	  compared	   across	   tissues	   using	   one-­‐way	   ANOVA,	   followed	   by	   post-­‐hoc	  comparisons	   using	   Tukey’s	   test	   at	   a	   significance	   level	   of	   P<0.05,	   using	  Minitab	  18	  software.	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6.2.8 Phylogenetic	  analysis	  
Amino	   acid	   sequences	   of	   PPAR	   receptors	   from	   Atlantic	   salmon	   and	   other	  vertebrates	   obtained	   from	   the	   NCBI/EMBL/UNIPROT	   databases	   were	  aligned	   using	  Mega	   7	   software.	   Phylogenetic	   analysis	  was	   done	   on	   the	   full	  receptors	   and	   ligand-­‐binding	   domains.	   The	   PPARs	   of	   Atlantic	   salmon	  were	  compared	  to	  those	  of	  other	  mammalian	  (human),	  bird	  (chicken),	  amphibian	  (frog)	   and	   fish	   (Northern	   pike,	   gilthead	   seabream,	   European	   plaice	   and	  zebrafish)	   vertebrates.	   The	   phylogenetic	   analyses,	   using	   Mega	   7	   Software,	  utilised	   the	   maximum	   likelihood	   method	   (Zuckerkandl	   and	   Pauling,	   1965)	  and	   the	   reliability	   of	   the	   nodes	   of	   the	   tree	   tested	   the	   bootstrap	   test	   with	  1,000	  replicates.	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 Results	  6.3
6.3.1 PPARγL	  mRNA	  sequence	  
The	  results	  of	  cDNA	  cloning	  and	  sequencing	  of	  products	  for	  PPARγL	  indicated	  subatantial	  differences	   from	  the	  predicted	  mRNA	  on	  GenBank,	  but	   included	  an	   open	   reading	   encoding	   a	   protein	   with	   a	   sequence	   much	   more	   closely	  similar	   to	   salmon	   PPARγ	   (Figure	   6-­‐1).	   This	   enabled	   design	   of	   primers	   for	  tissue	  expression	  analysis	  as	  in	  Figures	  6-­‐4	  to	  6-­‐8.	  
6.3.2 Phylogenetic	  analysis	  
The	  phylogenetic	  analyses	  of	   full-­‐length	  and	  LBD	  of	  PPARs	  were	  performed	  by	  constructing	  trees	  comparing	  the	  different	  PPAR	  isoforms	  from	  a	  variety	  of	   vertebrate	   species.	  The	   topology	  of	   the	   trees	   from	  both	  analysis	   showed	  similar	  results	  with	  two	  clades:	  one	  consisting	  of	  PPARα	  and	  PPARβ	  and	  the	  other	   consisting	  of	  PPARγ	   (Figure	  6-­‐2	  and	  Figure	  6-­‐3).	  The	  PPARγ	   proteins	  themselves	  were	  separated	  into	  two	  clusters,	  one	  group	  consisting	  of	   fishes	  whereas	   the	  other	   consisted	  of	  PPARγ	   of	   the	  higher	  vertebrates	   i.e.	  human,	  frog	  and	  chicken.	  Similar	  observations	  were	  seen	  for	  PPARα	  and	  PPARβ.	  The	  level	   of	   statistical	   support	   in	   the	   full-­‐length	  PPAR	  phylogeny	  was	   relatively	  higher	  (92%)	  in	  the	  way	  PPARα	  isoforms	  of	  the	  teleost	  group	  are	  positioned	  compared	   to	   level	   of	   confidence	   in	   the	   PPAR	  LBD	  phylogeny	   (75%).	   In	   the	  phylogeny	   tree	   for	   full-­‐length	   PPAR,	   all	   teleost	   PPARβ	   strongly	   clustered	  (99%)	   separately	   from	   the	   higher	   vertebrates	   (chicken	   and	   human)	  whilst	  the	  level	  of	  confidence	  for	  teleost	  PPAR	  LBD	  was	  relatively	  lower	  i.e.	  83%.	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Figure	  6-­‐1	  Alignment	  of	  deduced	  amino	  acid	  sequences	  of	  salmon	  and	  
human	  PPARs.	  Ligand-­‐binding	  domains	  are	  shown.	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Four	   PPARβ	   genes	   and	   corresponding	   cDNAs	   were	   identified	   in	   Atlantic	  salmon.	  Within	  the	  PPARβ	  phylogeny	  based	  on	  full-­‐length	  protein	  sequences	  (Figure	   6-­‐2),	   the	   four	   sequences	  were	   grouped	   in	   two	   branches	   containing	  two	  PPARs	  each.	  Each	  of	  these	  two	  branches	  was	  mostly	  closely	  attached	  to	  two	  PPARs	  present	  in	  Northern	  Pike.	  Thus,	  these	  salmon	  PPARβ	  forms	  have	  been	   provisionally	   denoted	   as	   ssPPARβ1A,	   ssPPARβ1B,	   ssPPARβ2A	   and	  ssPPARβ2B.	  It	  is	  also	  notable	  that	  although	  the	  zebrafish	  possess	  two	  PPARβ	  subtypes,	   they	   do	   not	   resolve	   in	   the	   same	   branches	   as	   the	  Atlantic	   salmon	  and	  Northern	  pike	  isoforms.	  Nevertheless,	  the	  two	  zebrafish	  PPARβ	  subtypes	  seemed	   to	  be	  more	   closely	   related	   to	   the	  Atlantic	   salmon	  PPARβ1s	   than	   to	  the	  PPARβ2s	  and	  PPARβ	  of	  plaice	  and	  sea	  bream.	  
Within	  the	  teleost	  group	  of	  PPARα,	  zebrafish,	  sea	  bream	  and	  Northern	  pike	  seemed	  to	  possess	  two	  PPARα	  lineages.	  These	  have	  been	  denoted	  as	  PPARα1	  and	  PPARα2.	  Whilst	  Atlantic	   salmon	   also	  has	   two	  PPARα	   genes,	   it	   appears	  that	   both	   of	   these	   belong	   to	   the	   PPARα1	   subgroup	   as	   they	   resolve	   in	   the	  same	  branch	   as	   the	  Northern	  pike	   PPARα1,	   although	   their	   positions	   in	   the	  LBD	  phylogeny	  are	  not	  well	  supported	  (29%).	  Salmon	  do	  not	  seem	  to	  possess	  PPARα2	  form	  present	  in	  many	  other	  teleost	  species.	  	  
The	  Northern	  pike	  PPARγ	  was	  observed	  to	  possess	  two	  PPARγ	  forms,	  which	  is	   in	  contrast	  to	  other	  teleost	  species	  examined	  so	  far,	  which	  only	  contain	  a	  single	   gene.	   Atlantic	   salmon	   also	   possess	   to	   PPARγ	   genes	   with	   one	   form	  strongly	   clustered	   (100	  %)	  with	   one	   of	   the	   pike	   forms	   and	   the	   other	   form	  strongly	   clustered	   (95	  %)	  with	   the	   other	   PPARγ	   form	   of	   pike	   and	   of	   other	  teleost	  species.	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Figure	   6-­‐2	   Phylogenetic	   tree	   for	   the	   full-­‐length	   PPARs	   from	   diverse	  
species,	   generated	   using	  MEGA	   7	   software	   using	  maximum	   likelihood	  
method.	  Bootstrapping,	  using	  1000	  replicates,	  assessed	  the	  reliability	  of	  
the	   tree	   with	   figures	   representing	   the	   bootstrap	   value	   in	   percentage	  
(%).	  Receptor	  sequences	  used	  were:	  (1)	  Gallus	  gallus	   (chicken)	  PPARa	  
(NP_001001464),	   PPARb	   (NP_990059),	   PPARg	   (NP_001001460);	   (2)	  
Homo	   sapiens	   (human)	   PPARa	   (NP_005027),	   PPARb	   (NP_006229),	  
PPARg	   (NP_005028);	   (3)	   Xenopus	   laevis	   (African	   clawed	   frog)	   PPARa	  
(P37232),	   PPARb	   (NP_001081310),	   PPARg	   (XP_018095920)	   (4)	   Esox	  
Lucius	   (Northern	   pike)	   PPARa1	   (XP_010882200),	   PPARa2	  
(XP_010885449),	   PPARba	   (XP_010891645),	   PPARbb	   (XP_012993730),	  
PPARga	   (XP_010872599),	   PPARgb	   (XP_010900626);	   (5)	  Sparus	  aurata	  
(gilthead	   seabream)	   PPARa1	   (not	   submitted	   to	   database),	   PPARa2	  
(AAT85613),	  PPARb	  (AAT85615),	  PPARg	  (AAT85618);	  (6)	  Pleuronectes	  
platessa	   (European	   plaice)	   PPARa2	   (CAD62447),	   PPARb	   (CAD62448),	  
PPARg	   (CAB51618);	   (7)	   Danio	   rerio	   (zebrafish)	   PPARaa	  
(NP_001154805),	   PPARab	   (NP_001096037),	   PPARba	   (XP_699900),	  
PPARbb	   (NP_571543),	   PPARg	   (NP_571542);	   (8)	   Salmon	  salar	  (Atlantic	  
salmon)	   PPARa1a	   (PPARa,	   NP_001117032),	   PPARa1b	   (PPARaL,	  
XP_014025332),	  PPARb1a	  (Q1XE69_SALSA),	  PPARb1b	  (Q1XE68_SALSA),	  
PPARb2a	   (NP_001117031),	   PPARb2b	   (XP_014002724),	   PPARg	  
(XP_014000887),	  PPARgL	  (not	  submitted	  to	  database).	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Figure	   6-­‐3	   Phylogenetic	   tree	   for	   the	   ligand-­‐binding	   domain	   (LBD)	   of	  
PPARs	   from	   diverse	   species,	   generated	   using	   MEGA	   7	   software	   using	  
maximum	   likelihood	   method.	   Bootstrapping,	   using	   1000	   replicates,	  
assessed	   the	   reliability	   of	   the	   tree	   with	   figures	   representing	   the	  
bootstrap	  value	  in	  percentage	  (%).	  Receptor	  sequences	  used	  were:	  (1)	  
Gallus	   gallus	   (chicken)	   PPARa	   (NP_001001464),	   PPARb	   (NP_990059),	  
PPARg	   (NP_001001460);	   (2)	   Homo	   sapiens	   (human)	   PPARa	  
(NP_005027),	   PPARb	   (NP_006229),	   PPARg	   (NP_005028);	   (3)	   Xenopus	  
laevis	   (African	  clawed	  frog)	  PPARa	  (P37232),	  PPARb	  (NP_001081310),	  
PPARg	   (XP_018095920)	   (4)	   Esox	   Lucius	   (Northern	   pike)	   PPARa1	  
(XP_010882200),	   PPARa2	   (XP_010885449),	   PPARba	   (XP_010891645),	  
PPARbb	   (XP_012993730),	   PPARga	   (XP_010872599),	   PPARgb	  
(XP_010900626);	   (5)	   Sparus	  aurata	   (gilthead	   seabream)	   PPARa1	   (not	  
submitted	   to	   database),	   PPARa2	   (AAT85613),	   PPARb	   (AAT85615),	  
PPARg	   (AAT85618);	   (6)	   Pleuronectes	   platessa	   (European	   plaice)	  
PPARa2	   (CAD62447),	   PPARb	   (CAD62448),	   PPARg	   (CAB51618);	   (7)	  
Danio	   rerio	   (zebrafish)	   PPARaa	   (NP_001154805),	   PPARab	  
(NP_001096037),	   PPARba	   (XP_699900),	   PPARbb	   (NP_571543),	   PPARg	  
(NP_571542);	   (8)	   Salmon	   salar	   (Atlantic	   salmon)	   PPARa1a	   (PPARa,	  
NP_001117032),	   PPARa1b	   (PPARaL,	   XP_014025332),	   PPARb1a	  
(Q1XE69_SALSA),	   PPARb1b	   (Q1XE68_SALSA),	   PPARb2a	  
(NP_001117031),	   PPARb2b	   (XP_014002724),	   PPARg	   (XP_014000887),	  
PPARgL	  (not	  submitted	  to	  database).	  
	  
	  	   	  
	  	   180	  
6.3.3 Distribution	  patterns	  of	  Atlantic	  salmon	  PPARs	  




	  	   181	  
	  
Figure	  6-­‐4	  Tissue	  expression	  profile	  of	   female	  Atlantic	   salmon	  PPARα 	  
isotypes.	   Relative	   expression	   of	   each	   PPAR	   was	   normalised	   to	   PPAR	  
expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  
individual	  salmon	  fish.	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Figure	   6-­‐5	   Tissue	   expression	   profile	   of	   female	   Atlantic	   salmon	  PPARγ 	  
isotypes.	   Relative	   expression	   of	   each	   PPAR	   was	   normalised	   to	   PPAR	  
expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  
individual	  salmon	  fish.	  
	  	   183	  
	  
Figure	  6-­‐6	  Tissue	  expression	  profile	  of	  female	  Atlantic	  salmon	  PPARβ1	  
isotypes.	   Relative	   expression	   of	   each	   PPAR	   was	   normalised	   to	   PPAR	  
expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  
individual	  salmon	  fish.	  Asterisk	  (*)	  represents	  PPAR	  expression	  value,	  
which	  differs	  significantly	  from	  muscle	  (P<0.05).	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Figure	  6-­‐7	  Tissue	  expression	  profile	  of	  female	  Atlantic	  salmon	  PPARβ2	  
isotypes.	   Relative	   expression	   of	   each	   PPAR	   was	   normalised	   to	   PPAR	  
expression	   in	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  
individual	  salmon	  fish.	  Asterisk	  (*)	  represents	  PPAR	  expression	  value,	  
which	  differs	  significantly	  from	  muscle	  (P<0.05).	  
	   	  




Figure	  6-­‐8	  Gene	   expression	  of	  PPARs	   in	   each	   tissue	  where	   the	  data	   is	  
normalised	   to	   muscle.	   Data	   are	   the	   means	   ±	   SD	   of	   results	   from	   four	  
individual	  salmon	  fish.	  Asterisk	  (*)	  represents	  PPAR	  expression	  value,	  
which	  differs	  significantly	  from	  muscle	  (P<0.05).	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 Discussion	  6.4
PPARs	  have	  been	  previously	  identified	  and	  characterized	  in	  various	  tissues	  of	  several	   fish	   species	   including	   zebrafish	   (Danio	   rerio)	   (Escriva	   et	   al.,	   1997;	  Ibabe	   et	   al.,	   2005),	   Atlantic	   salmon	   (Salmo	   salar)	   (Ruyter	   et	   al.,	   1997;	  Andersen	   et	   al.,	   2000;	   Robinson-­‐Rechavi	   et	   al.,	   2001),	   plaice	   (Pleuronectes	  
platessa)	  (Leaver	  et	  al.,	  1998,	  2005),	  gilthead	  sea	  bream	  (Leaver	  et	  al.,	  2005),	  	  liver	   of	   gray	   mullet	   (Mugil	   cephalus)	   (Ibabe	   et	   al.,	   2004),	   sea	   bass	  (Dicentrarchus	   labrax)	   (Boukouvala	   et	   al.,	   2004),	   turbot	   (Scophthalmus	  
maximus)	   (Robinson-­‐Rechavi	   et	   al.,	   2001),	   Japanese	   pufferfish	   (Fugu	  
rubripes)	   (Maglich	  et	  al.,	   2003),	  brown	   trout	   (Salmo	  trutta	  f.	   fario)	   (Batista-­‐Pinto	  et	  al.,	  2005,	  2009),	  	  thicklip	  grey	  mullet	  (Chelon	  labrosus)	  (Raingeard	  et	  
al.,	   2009)	   and	   red	   sea	   bream	   (Pagrus	   major)	   (Oku	   and	   Umino,	   2008).	  Although	  PPARs	  are	  present	  in	  all	  fish	  species,	  their	  expression	  levels	  vary	  in	  different	   tissues	   and	   it	   is	   assumed	   that	   the	   expression	   patterns	   of	   PPARs	  reflect	  their	  different	  physiological	  functions.	  	  
PPAR	  sequences	  have	  been	  previously	  applied	  to	  model	  the	  functional	  role	  of	  genome	   duplications	   (Escrivá	   García	   et	   al.,	   2003),	   and	   because	   these	  receptors	  are	  dispersed	  in	  the	  genome,	  they	  are	  strong	  phylogenetic	  markers	  (Laudet	   et	  al.,	   1992)	   due	   to	   the	   highly	   conserved	  DNA-­‐	   and	   ligand-­‐binding	  domains	   consisting	   of	   large	   numbers	   of	   amino-­‐acid	   sites	   that	   can	   be	  compared,	  to	  allow	  robust	  phylogenetic	  construction	  (Escrivá	  García,	  Laudet	  and	  Robinson-­‐Rechavi,	  2003).	  	  
Because	   gene	   and	   genome	   duplication	   are	   believed	   to	   have	   become	   the	  driving	   force	   in	   shaping	   the	   evolution	   of	   organisms	   (Ohno,	   1970),	   the	   in-­‐
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depth	   study	   of	   gene	   families	   can	   be	   illuminating	   in	   linking	   duplications	   to	  functional	   adaptations.	   Therefore,	   in	   this	   study,	   the	   full	   receptors	   and	   the	  ligand-­‐binding	   domains	   of	   PPARs	   of	   various	   vertebrates	   were	   used	   to	  construct	   phylogenetic	   trees,	   with	   the	   aim	   of	   determining	   the	   origin	   of	  Atlantic	  salmon	  PPARs,	  to	  identify	  genetic	  divergence	  of	  these	  receptors	  and	  possibly	  infer	  functional	  adaptations.	  	  The	  availability	  of	  genome	  information	  of	   fish	   such	   as	   Northern	   pike,	   zebrafish,	   plaice,	   sea	   bream	   and	   other	  vertebrates	   including	   human,	   chicken	   and	   frog,	   has	   shown	   that	   similar	  isoforms	  clustered	  together	  which	  is	  in	  consistent	  with	  studies	  reporting	  that	  fish	   PPARs	   share	   high	   degrees	   of	   sequence	   similarities	   to	   their	   higher	  vertebrates	   counterparts.	  For	  example,	  Atlantic	   salmon	  PPAR	  has	   shown	   to	  share	  44-­‐49	  %	  overall	   sequence	   identity	  with	  PPARα	   and	  PPARβ	   of	   higher	  vertebrates,	   and	   56	   and	   47	   %	   identity	   with	   PPARγ	   of	   human	   and	   frog,	  respectively	  (Ruyter	  et	  al.,	  1997).	  Moreover,	  PPARs	  of	  sea	  bream	  and	  plaice	  also	  share	  the	  sequence	  identity	  of	  more	  than	  70	  %	  in	  the	  DNA-­‐binding	  and	  ligand-­‐binding	   domains	   of	   their	   higher	   vertebrates	   counterparts	   (Leaver	  et	  
al.,	   2005).	   In	   addition,	   sea	   bass	   shares	   more	   than	   90	   %	   PPAR	   sequence	  identity	  to	  their	  human	  counterparts	  in	  the	  DNA-­‐binding	  domain	  and	  that	  67,	  78	  and	  66%	  common	  residues	  in	  the	  ligand-­‐binding	  domain	  of	  the	  α,	  β	  and	  γ	  isoforms	  (Boukouvala	  et	  al.,	  2004).	  	  
The	  PPAR	  phylogeny	  supports	  the	  teleost	  fish	  as	  a	  separate	  group	  within	  the	  vertebrates,	   with	   very	   high	   support,	   and	   also	   indicates	   the	   divergence	   of	  PPARs	  from	  an	  ancestral	  gene	  before	  the	  evolutionary	  divergence	  of	  fish	  and	  higher	  vertebrates	  about	  500	  million	  years	  ago	  (Laudet	  et	  al.,	  1992;	  Taylor	  et	  
al.,	  2003).	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The	   presence	   and	   phylogenetic	   pattern	   of	   four	   PPARβ	   genes	   in	   Atlantic	  salmon	  supports	  the	  theory	  that	  salmonids	  may	  be	  derived	  from	  a	  relatively	  recent	   autotetraploidization	   event	   (Allendorf	   and	   Thorgaard,	   1984;	  Alexandrou	  et	  al.,	   2013)	   and	   that	   a	   previous	   genome	  duplication	  may	  have	  occurred	   in	   early	   evolution	  of	   ray-­‐finned	   fishes	   (Taylor	  et	  al.,	   2003).	   In	   the	  phylogeny	  trees,	  Northern	  pike	  PPARβb	  formed	  a	  group	  with	  ssPPARβ1A	  and	  ssPPARβ1B	   with	   very	   high	   support,	   and	   similarly,	   the	   other	   β	   form	   of	  Northern	   pike,	   PPARβa,	   is	   more	   closely	   related	   to	   ssPPARβ2A	   and	  ssPPARβ2B.	  The	  four	  PPARβ	  genes	  grouped	  into	  two	  subfamilies	  as	  a	  result	  of	   duplication	   of	   two	   PPARβ	   subtypes	   from	   an	   ancestral	   diploid	   salmonid,	  with	  high	   support	   in	  both	  phylogeny	   trees.	  This	  has	  previously	  been	  noted	  and	  was	  suggested	  to	  have	  enabled	  some	  functional	  divergence	  (Leaver	  et	  al.,	  2007).	   However,	   the	   tissue	   expression	   results	   for	   salmon	   PPARβ	   forms	  argues	  against	  a	  major	  functional	  difference	  as	  it	  indicates	  a	  broadly	  similar	  pattern	   amongst	   all	   four	   forms,	   with	   the	   exception	   of	   heart,	   where	   the	  PPARβ2	   forms	  are	   relatively	  higher	   than	  PPARβ1	  expression.	  These	   results	  differ	   from	   a	   previous	   study,	   which	   concluded	   that	   ssPPARβ1A	   and	  ssPPARβ2A	  have	  distinct	   tissue	  expression	  profiles,	  based	  on	  differences	   in	  expression	   liver	  and	  gill	   (Leaver	  et	  al.,	   2007).	   It	   should	  be	  noted	   that	   these	  differences	   are	   also	   evident	   in	   the	   results	   presented	   here,	   but	   across	   the	  broader	   range	   of	   tissues	   and	   PPARβ	   subtypes	   in	   this	   study,	   it	   is	   clear	   that	  there	  is	  more	  similarity	  than	  difference	  in	  overall	  PPARβ	  expression	  profile.	  	  
However,	   the	   origin	   of	   the	   salmon	   PPARβ	   genes,	   consistent	   with	   genome	  duplication	  hypotheses,	  may	  not	  be	  the	  case	  for	  Atlantic	  salmon	  PPARα	  and	  PPARγ.	   Many	   widely	   diverged	   fish	   species	   possess	   two	   forms	   of	   PPARα,	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apparently	   diverging	   early	   and	   subsequently	   conserved	   sufficiently	   to	  demonstrate	   a	   strong	   phylogenetic	   signal.	   Although	   Atlantic	   salmon	  possesses	  two	  PPARα	  genes,	  they	  are	  clearly	  the	  result	  of	  a	  salmonid-­‐specific	  duplication	   of	   only	   one	   of	   the	   piscine	   forms,	   denoted	   PPARα1.	   	   Since	   the	  Northern	   pike,	   possess	   the	   two	  piscine	   PPARα	   forms,	   it	  would	   appear	   that	  salmonids	   have	   lost	   the	   second	   gene	   following	   their	   emergence	   and	   more	  recent	   salmonid-­‐specific	   genome	   duplication	   event.	   Despite	   this	   recent	  PPARα1	  duplication	  in	  salmonids,	  the	  two	  Atlantic	  salmon	  genes	  show	  some	  differences	  in	  tissue	  expression	  pattern,	  with	  PPARαL	  being	  relatively	  more	  highly	  expressed	  in	  ovary	  and	  liver	  than	  PPARα.	  This	  could	  represent	  some	  sub-­‐functionalization	   at	   least	   at	   the	   level	   of	   gene	   regulation.	   PPARγ	   of	   the	  Atlantic	   salmon	   shows	   similar	   pattern	   to	   PPARα,	   with	   duplication	   of	   one	  ancestral	   gene	   clearly	   represented	   in	  Northern	  pike.	  However,	   it	   is	   notable	  that,	  unlike	  any	  other	  fish,	  Northern	  pike	  possess	  two	  distinct	  PPARγ	  genes,	  only	   one	   which	   is	   present	   as	   a	   duplicate	   in	   Atlantic	   salmon.	   The	   Atlantic	  salmon	   have	   presumably	   lost	   the	   other	   PPARγ	   gene,	   but	   notably	   the	   gene	  retained	   and	   duplicated	   in	   the	   same	   lineage	   as	   the	   novel	   PPARγ,	   one	   also	  existing	   in	   the	   Northern	   pike.	   The	   two	   salmon	   PPARγ	   forms	   have	   quite	  distinct	   tissue	   expression	   patterns.	   ssPPARγL	   had	   a	   tendency	   for	   increased	  expressions	   in	   the	  heart	  and	  ovary	  and	   its	  expression	   in	  other	   tissues	  were	  relatively	   very	   low.	   On	   the	   other	   hand,	   ssPPARγ	   had	   very	   high	   expression	  levels	  in	  most	  tissues	  including	  liver,	  intestine,	  gills,	  kidney	  and	  ovary.	  Thus,	  salmon	   PPARγ	   is	   highly	   unusual	   and	   it	   is	   not	   known	   whether	   the	   unique	  PPARγ	   represented	   in	   the	   Atlantic	   salmon	   and	   the	   Northern	   pike	   is	  functionally	  different	  from	  other	  PPARγ,	  or	  indeed	  whether	  the	  duplicates	  of	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this	   gene	   in	   salmon	  have	   functionally	   diverged	   by	   their	   distinct	   expression	  patterns.	  
Clearly	  PPAR	  biology	   is	  complex	   in	  vertebrates,	  and	  particularly	  complex	   in	  Atlantic	  salmon	  and	  probably	  salmonids	  generally.	  Salmonids	  appear	  to	  have	  gained	   genes	   for	   PPARβ	   and	   PPARγ	   and	   both	   gained	   and	   have	   lost	   a	   pan-­‐vertebrate	  PPARα	  subtype,	  but	  duplicated	  a	  teleost	  specific	  PPARα.	  Whilst	  it	  is	  not	  possible	  at	  the	  moment	  to	  definitively	  conclude	  that	  this	  has	  functional	  consequences	   for	   lipid	  and	  energy	  homeostasis	   in	   salmonids,	   there	   is	   some	  evidence	   here	   that	   PPARα	   and	   PPARγ	   duplicates	   in	   Atlantic	   salmon	   have	  diverged	   in	   terms	   of	   expression	   profile.	   It	   should	   be	   noted	   that	   tissue	  expression	  was	  only	  measured	  in	  pre-­‐smolts	  in	  freshwater	  and	  a	  full	  analysis	  of	   tissue	   expression	   would	   require	   measurement	   at	   various	   development	  stages	  and	   life	  history	   transitions	   in	  salmon.	  Functionally	   the	  consequences	  of	  duplicated	  PPAR	  genes	  in	  salmon	  must	  await	  the	  discovery	  of	  gene-­‐specific	  activation	   compounds,	   or	   genetic	   knock-­‐out/knock-­‐in	   studies,	  which	  would	  enable	  the	  genes	  these	  proteins	  regulate	  to	  be	  identified	  in	  a	  tissue,	  stage	  and	  nutrition-­‐specific	  manner.	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 Conclusion	  6.5
Several	   fish	   species	   from	   which	   PPARs	   have	   been	   isolated	   have	   shown	   to	  differ	  from	  other	  vertebrates	  in	  terms	  of	  the	  number	  functional	  PPARs	  they	  contain.	   Phylogenetic	   analyses	   deduced	   that	   sequences	   of	   Atlantic	   salmon	  PPARs	   corresponding	   to	   that	   of	   other	   fish	   species	   and	   higher	   vertebrates	  reveals	  that	  the	  Atlantic	  salmon	  PPARs	  are	  more	  similar	  to	  those	  of	  other	  fish	  species	  than	  to	  mammalian,	  bird	  or	  amphibian	  species,	  as	  expected.	  From	  the	  phylogenetic	  evidence,	  whilst	  the	  four	  PPARβs	  in	  Atlantic	  salmon	  may	  be	  the	  result	  of	  autotetraploidization	  in	  the	  salmonid	  lineage,	  to	  the	  distribution	  of	  duplicated	   PPARα	   and	   PPARγ	   genes	   cannot	   be	   simply	   explained	   by	   this	  genome	   duplication	   model.	   Tissue	   expression	   evidence	   suggests	   that	  duplicated	  salmon	  PPARα	  and	  PPARγ	  have	  functionally	  diverged	  to	  a	  greater	  extent	   that	   the	  PPARβ	   forms,	   and	   the	   potential	   identification	   of	   ligands	   for	  the	  receptors	  will	  enable	  the	  physiological	  relevance	  of	  this	  divergence	  to	  be	  investigated.	  Given	  the	  unique	  complement	  of	  PPAR	  genes	  in	  Atlantic	  salmon	  and	  their	  presumed	  roles	  in	  lipid	  homeostasis,	  it	  is	  interesting	  to	  understand	  whether	  this	  extends	  to	  a	  unique	  energy	  and	  lipid	  metabolism	  in	  this	  species,	  especially	  in	  an	  aquaculture	  context.	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7 General	  discussion	  and	  conclusions	  
7.1 Introduction	  
Studies	   have	   proven	   that	   mammals	   and	   fish	   share	   the	   same	   pathways	   for	  biosynthesis	  and	  catabolism	  of	  fatty	  acids	  and	  these	  pathways	  are	  controlled	  by	   similar	   molecular	   mechanisms	   (Ruyter	   et	   al.,	   1997;	   Boukouvala	   et	   al.,	  2004).	   In	  mammals,	  PPARs	  have	  emerged	  as	  central	   factors	   in	  sensing	  fatty	  acid	   levels	   and	   in	   regulating	   fatty	  acid	  metabolism.	  Evidently,	   the	  PPARs	   in	  fish,	  generally,	  are	  structural	  homologs	  of	   the	  mammalian	  PPARs,	   therefore	  assumed	  to	  carry	  out	  similar	  functions.	  Thus,	  there	  is	  a	  reasonable	  evidence	  that	   PPARs	  play	   critical	   roles	   in	   fish	   lipid	   homeostasis	   and	  because	  PPARα	  and	   PPARβ	   have	   similar	   ligand	   activation	   profiles	   and	   tissue	   expression	  patterns	   as	   their	   mammalian	   counterparts	   (Leaver	   et	   al.,	   2005),	   these	  receptors	   may	   have	   similar	   functions	   to	   those	   described	   in	   mammals.	  However,	   because	   studies	   have	   reported	   that	   compounds	   that	   activate	  mammalian	   PPARγ	   do	   not	   activate	   piscine	   PPARγ	   (Maglich	   et	   al.,	   2003;	  Leaver	   et	  al.,	   2005),	   the	   role	   of	   PPARγ	   in	   fish	   still	   remains	   unclear.	   Piscine	  PPARγ	   has	   some	   specific	   structural	   differences	   to	   mammalian	   proteins,	  particularly	   evident	   with	   regard	   to	   amino	   acids,	   which	   are	   known	   to	   be	  critical	   for	   ligand	   binding	   in	   mammalian	   receptors	   (Ruyter	   et	   al.,	   1997;	  Andersen	  et	  al.,	  2000;	  Leaver	  et	  al.,	  2005).	  Despite	  this,	  the	  overall	  structural	  similarity	   of	   piscine	   PPARγ	   to	   all	   other	   PPARs	   strongly	   indicates	   that	   it	   is	  likely	  to	  be	  activated	  by	  a	  compound	  related	  to	  the	  lipids	  and	  fatty	  acids	  that	  activate	  mammalian	  PPARγ.	   For	   this	   reason,	   the	   critical	   role	   of	  mammalian	  PPARγ	   in	   determining	   lipid	   uptake	   and	   storage	   has	   led	   to	   this	   particular	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study	  with	  the	  aim	  of	  characterising	  PPAR	  distribution	  in	  fish	  and	  identifying	  the	  activating	  ligands	  of	  piscine	  PPARγ.	  
7.2 Suitable	  cell	  line	  for	  cellular	  transactivation	  assay	  
A	  cell-­‐based	  reporter	  gene	  assay	  system	  was	  developed	  and	  used	  to	  study	  the	  potential	   activating	   ligands	   of	   PPARγ	   in	   fish.	   To	   achieve	   this,	   PPARγ	   was	  cloned	   from	   European	   plaice	   and	  was	   used	   to	   develop	   a	   receptor	   plasmid	  construct.	   The	   ligand-­‐binding	  domain	   of	   PPARγ	  was	   ligated	  downstream	  of	  the	   DNA-­‐binding	   domain	   of	   yeast	   Gal4	   to	   produce	   Gal4-­‐PPARγLBD.	   The	  cationic	   polymer,	   branched	   polyethylenimine	   (bPEI),	   was	   successfully	  applied	  as	  a	  transfection	  reagent	  at	  an	  optimal	  of	  double	  the	  amount	  of	  bPEI	  to	  DNA	  ratio	  2.5:1	  (2x	  25:1)	  for	  CHSE-­‐214	  cell	   line.	  Notably,	  the	  AS	  cell	   line	  was	  optimally	  transfected	  at	  a	  ratio	  of	  2.5:1	  as	  well	  but	  at	  1	  x	  concentration.	  
Between	   the	  Atlantic	   salmon	  (AS)	  and	  Chinook	  salmon	  embryo	  214	  (CHSE-­‐214)	   cell	   lines	   tested,	   the	   AS	   cell	   line	   was	   initially	   concluded	   suitable	   for	  future	  transfections,	  however,	  this	  cell	  line	  failed	  to	  show	  reproducibility	  and	  reliability	   in	   the	   transfection	  experiments,	   indicated	  by	  significant	  decrease	  in	   firefly	   luciferase	   activity,	   which	   may	   have	   been	   due	   to	   undesirable	  differentiation	   in	   the	   cells	   at	   higher	   passage	   numbers,	   resulting	   changes	   in	  characteristics	   and	  modified	   growth	   rates,	   affecting	  protein	   expression	   and	  causing	  cells	   to	  respond	  differently	  to	  the	  same	  transfection	  conditions.	  For	  these	  reasons,	  therefore,	  the	  present	  study	  utilised	  the	  CHSE-­‐214	  cell	  line,	  as	  its	  cells	  are	  fast	  growing,	  easy	  to	  subculture	  and	  maintain	  and	  it	  has	  also	  been	  widely	   used	   in	   other	   studies	   (Jensen	   et	   al.,	   2002;	   Jørgensen	   et	   al.,	   2007;	  Herath	  et	  al.,	  2009).	  It	  was	  also	  ensured	  that	  transfection	  experiments	  were	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consistently	   performed	   within	   a	   minimum	   range	   of	   passage	   number	  following	   the	   optimization	   experiment,	   to	   prevent	   any	   passage-­‐related	  effects	   from	   influencing	   the	   transfections,	   thus,	   maintaining	   consistent	   cell	  performance.	  While	   mammalian	   studies	   have	   shown	   that	   certain	   cell	   lines	  are	  particularly	  useful	  for	  particular	  PPAR	  studies,	  the	  availability	  of	  fish	  cells	  is	  much	  more	   restricted.	   In	   this	   study,	   it	  was	   assumed	   that	   a	   salmonid	   cell	  line	  would	  be	  preferable	  to	  one	  from	  another	  group,	  because	  the	  presence	  of	  compatible	   co-­‐activators/repressors	   would	   be	   more	   likely.	   However,	   it	  would	  be	  potentially	  useful	  to	  screen	  a	  range	  of	  available	  salmonid	  and	  other	  cell	  lines	  for	  optimizing	  the	  transfection	  assays.	  
7.3 Lipid	  extraction	  from	  liver	  tissues	  	  
Salmon	  liver	  tissue	  was	  selected	  for	  total	  lipid	  extraction	  as	  it	  contains	  all	  the	  important	   lipid	   classes	   (Christie	   and	  Han,	   2010)	   and	   because	   of	   its	   central	  importance	  in	  lipid	  metabolism	  (De	  Silva	  and	  Anderson,	  1995),	  and	  also	  most	  importantly	  because	  PPARs	  are	  highly	  expressed	  in	  this	  tissue	  of	  salmon	  and	  other	   fish	   (Boukouvala	   et	   al.,	   2004;	   Ibabe	   et	   al.,	   2004;	   Ibabe	   et	   al.,	   2005;	  Leaver	  et	  al.,	  2005).	  	  
To	  avoid	  lipid	  degradation,	  as	  observed	  by	  the	  high	  free	  fatty	  acid	  content	  of	  extracts	   stored	   frozen,	   liver	   tissues	   samples	   were	   immediately	   transferred	  into	   chloroform/methanol	   solvent	   (2:1)	   after	   removal	   to	   allow	   maximum	  extraction	  of	  lipids	  present	  in	  the	  tissues	  with	  minimum	  breakdown	  of	  lipids	  by	   hydrolysis.	   This	   method	   yielded	   very	   low	   levels	   of	   free	   fatty	   acids	   in	  comparison	   to	   the	   initial	   procedure	   above.	   Also,	   this	   method	   facilitated	  separation	   of	   various	   lipid	   classes,	   including	   the	   unknown	   polar	   and	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unknown	  neutral	   lipids,	   in	   addition	   to	   the	   common	  polar	   and	   neutral	   lipid	  classes.	  While	  this	  method	  is	  applicable	  for	  maximum	  extraction	  of	  lipids,	  and	  when	   rapid	   extraction	   is	   not	   feasible,	   tissue	   samples	   can	   also	   be	   frozen	   as	  rapidly	   as	   possible	   with	   dry	   ice	   or	   liquid	   nitrogen,	   stored	   in	   sealed	   glass	  containers	  at	   -­‐20	   °C	   in	  an	  atmosphere	  of	  nitrogen	   (Natio	  and	  David,	  1984).	  The	  samples	  should	  then	  be	  homogenized	  and	  extracted	  with	  solvent	  at	  the	  lowest	  temperature	  practicable,	  without	  being	  allowed	  to	  thaw	  to	  avoid	  any	  breakdown	  of	  lipids	  by	  active	  enzymes.	  Storing	  tissue	  samples	  in	  bags,	  vials	  or	  other	  plastic	   containers	   should	  also	  be	  avoided	  as	  plasticizers	  will	   leach	  out	  and	  contaminate	  extracts.	  
7.4 Piscine	  PPARγ 	  and	  its	  potential	  ligand	  
In	  the	  optimisation	  experiments,	  Gal4-­‐PPARα	  was	  used	  as	  a	  positive	  control,	  tested	  in	  cellular	  transactivation	  in	  response	  to	  its	  known	  agonists	  in	  fish	  to	  ensure	  effectiveness	  of	  transfection	  using	  bPEI	  and	  the	  efficiency	  of	  the	  dual-­‐luciferase	   assay	   system	   using	   firefly	   luciferase	   and	   Renilla	   luciferase	  reagents.	   From	   the	   previous	   studies	   and	   from	   this	   study,	   because	   the	   full-­‐length	  piscine	  PPARγ	  and	  the	  Gal4-­‐PPARγ	  had	  been	  found	  to	  be	  unresponsive	  to	   fatty	   acids	   (Leaver	   et	   al.,	   2005;	   Kondo	   et	   al.,	   2007;	   Colliar	   et	   al.,	   2011),	  PPARγ	  has	  become	  a	  subject	  of	  interest,	  thus,	  the	  Gal4-­‐PPARγ	  construct	  was	  developed	  to	  identify	  its	  potential	  activating	  ligands.	  
Polar	   and	   neutral	   lipids	   fractionated	   from	   the	   total	   lipid	   extracted	   from	  salmon	  liver	  using	  thin-­‐layer	  chromatography	  (TLC),	  were	  tested	  in	  cellular	  transactivation	   assay.	   None	   of	   the	   neutral	   lipid	   fractions	   induced	   PPARγ	  activity	   while	   two	   polar	   lipid	   fractions,	   containing	   unknown	   polar	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compounds	   and	   unresolved	   compounds	   present	   at	   the	   solvent	   front	   were	  able	   to	   significantly	   increase	   PPARγ	   activity	   at	   50	   µg/ml,	   suggesting	   that	  these	  lipid	  fractions	  contain	  molecular	  components	  or	  metabolites	  that	  have	  the	   ability	   to	   bind	   with	   PPARγ	   ligand-­‐binding	   domain	   and	   activate	  transcription	  of	  firefly	  luciferase	  activity.	  It	  was	  deduced	  by	  LC-­‐MS	  that	  these	  lipid	  fractions	  mainly	  contain	  hexosylceramides	  and	  ceramides.	  According	  to	  Christie	   and	   Han	   (2010),	   the	   nature	   of	   fatty	   acids	   and	   long-­‐chain	   bases	   in	  ceramides	  are	  commonly	  saturated	  and	  monoenoic	  (monosaturated)	  and	  this	  agreed	   with	   the	   high	   amounts	   of	   saturated	   fatty	   acids	   (mainly	   palmitate,	  16:0)	  in	  the	  unknown	  polar	  lipid	  fatty	  acid	  composition	  and	  the	  high	  amounts	  of	  monosaturated	  fatty	  acids	  (mainly	  oleic	  acid,	  18:1n-­‐9)	  in	  the	  solvent	  front	  fraction.	   These	   fatty	   acids	   have	   been	   tested	   on	   piscine	   PPARγ	   but	   none	   of	  them	  were	   able	   to	   activate	   the	   receptor	   (Kondo	   et	   al.,	   2007;	   Colliar	   et	   al.,	  2011).	   These	   findings	   suggested	   that	   the	   individual	   fatty	   acids	   within	   the	  lipid	   fractions	   are	   not	   ligands	   or	   activators	   of	   piscine	   PPARγ	   due	   to	   their	  inability	   to	   activate	   the	   receptor,	   but	   it	   was	   the	   intact	   lipid	   structure	  containing	   esterified	   fatty	   acids	   that	   constitute	   the	   activating	   compound.	  These	   assays	   do	   not	   indicate	   whether	   such	   compounds	   bind	   with	   the	  receptor	  and	  activate	  transcription	  of	  the	  firefly	  luciferase.	  It	  is	  possible	  that	  they	   give	   rise,	   directly	   metabolism,	   or	   indirectly	   by	   the	   stimulation	   of	  endogenous	  ligand	  formation,	  to	  other	  true	  ligands.	  
When	   Gal4-­‐PPARγ	   transfected	   CHSE-­‐214	   cells	  were	   treated	  with	   ceramide,	  PPARγ	   activity	  was	   suppressed	   in	   a	   dose	  dependent	  manner.	   Precursors	   of	  ceramide	   which	   have	   been	   reported	   to	   activate	   mammalian	   PPARγ,	  sphingosine,	   S1P	   and	   C1P	   also	   suppressed	   luciferase	   output	   in	   Gal4-­‐
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transfected	   cells.	   It	   is	   not	   clear	  whether	   this	   suppression	   is	   physiologically	  relevant,	   or	   simply	   represents	   increasing	   cellular	   toxicity	   in	   the	   assay	   at	  higher	  treatment	  levels.	  	  
While	  none	  of	  the	  sphingolipids	  tested	  above	  has	  the	  ability	  to	  activate	  PPARγ	  in	   fish,	   treatment	   of	   Gal4-­‐PPARγ	   transfected	   cells	   with	   glucosylceramide	  (GlcCer),	  a	  major	  component	  of	  one	  of	  the	  activating	  lipid	  fractions,	  resulted	  in	   significant	   increase	   in	   luciferase	   activities.	   Glucosylceramides	   are	  glucosylated	   lipids	  with	   simple	   structures	   and	   functions	   critical	   for	   cellular	  homeostasis	  and	  cellular	  activities	  (Ishibashi	  et	  al.,	  2013).	  Glycosylceramide	  synthase	   (GlcT-­‐1)	   is	   the	   enzyme	   responsible	   for	   the	   production	   of	   GlcCer	  from	  ceramide.	   Interestingly,	   insulin	  activity	  and	  adipocyte	  profile	  has	  been	  shown	  to	  be	  improved	  in	  obese	  mice	  by	  the	  inhibition	  of	  GlcT-­‐1	  (van	  Eijk	  et	  
al.,	  2009).	  Moreover,	  dietary	  GlcCer	  has	  been	  shown	  to	  dramatically	  improve	  certain	   skin	   conditions	   in	   humans,	   and	   there	   is	   evidence	   that	   this	   effect	   is	  mediated	  by	  GlcCer	  metabolites	  through	  activation	  of	  PPARγ	  (Shirakura	  et	  al.,	  2012).	  As	  GlcCer	  did	  not	  have	  direct	  effect	  on	  PPARγ	  in	  this	  human	  study,	  it	  is	  possible	   that	   the	   effects	   observed	   with	   GlcCer	   on	   piscine	   PPARγ	  transactivation	  might	   also	   be	  mediated	   by	   GlcCer	  metabolites	   produced	   in	  the	  CHSE-­‐214	  cells,	  or	  which	  are	  present	  at	  low	  levels	  in	  the	  extracts.	  Future	  studies	  should	   focus	  on	  testing	   these	  metabolites	   if	   they	  can	  be	  obtained	   in	  pure	  form.	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7.5 Phylogeny	   and	   tissue	   expression	   patterns	   of	   Atlantic	  
salmon	  PPARs	  
From	   the	   phylogenetic	   evidence,	   it	   is	   clear	   that	   PPARs	   in	   vertebrates	   have	  diverged	  into	  three	  forms	  (α,	  β	  and	  γ)	  before	  the	  evolutionary	  divergence	  of	  fish	  and	  higher	  vertebrates	  about	  500	  million	  years	  ago	  (Laudet	  et	  al.,	  1992;	  Taylor	  et	  al.,	  2003).	  	  
In	  this	  study,	  the	  phylogeny	  of	  Atlantic	  salmon	  PPARs	  was	  examined,	  because	  salmon	  is	  an	  important	  aquaculture	  species	  and	  because	  they	  possess	  at	  least	  8	   intact	   PPAR	   genes,	   possibly	   due	   to	   the	   fact	   that	   they	   have	   a	   recently	  duplicated	   genome.	   It	   was	   clear	   that	   salmon	   have	   two	   PPARα	   genes,	   four	  PPARβ	   genes,	   and	   two	  PPARγ	   genes.	   The	   four	   PPARβ	   genes	   are	   clearly	   the	  result	   of	   the	   salmonid	   genome	   duplication,	   forming	   highly	   supported	  groupings	   with	   the	   two	   forms	   from	   Northern	   pike,	   the	   nearest	   relative	   of	  salmon	  with	  an	  unduplicated	  genome.	  However,	  it	  was	  observed	  that	  the	  two	  PPARα	   and	   PPARγ	   forms	   in	   salmon	   are	   not	   the	   direct	   result	   of	   salmonid	  genome	   duplication.	   Northern	   pike	   clearly	   have	   two	   PPARγ	   forms	   as	   well,	  which	   form	   clear	   groups	   with	   the	   salmon	   forms,	   indicating	   that	   the	   gene	  duplication	   event,	   which	   generated	   these	   two	   PPARs	   occurred	   before	   the	  salmon	  whole	  genome	  duplication.	  In	  all	  other	  fish	  examined	  so	  far,	  only	  one	  PPARγ	  form	  is	  present.	  Whilst	  other	  fish	  species,	  including	  pike	  possess	  two	  forms	  of	  PPARα,	  when	  compared	  again	  to	  pike,	  the	  Atlantic	  salmon	  appears	  to	   have	   duplicated	   only	   one	   form	   of	   PPARα,	   and	   appears	   to	   have	   lost	   the	  other	  completely.	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Tissue	   expression	   analysis	   revealed	   that	   the	   four	   β-­‐subtypes	   in	   Atlantic	  salmon	   generally	   have	   high	   expression	   levels	   in	   heart,	   ovary	   and	   gill,	   and	  overall	   the	  tissue	  expression	  profile	  of	  all	   four	   isotypes	   is	  similar.	  Similarly,	  both	   duplicated	   genes	   of	   PPARα	   in	   the	   Atlantic	   salmon	   exhibited	   a	   similar	  expression	   pattern,	   with	   PPARαL	   displaying	   a	   tendency	   for	   slightly	   higher	  expression	   in	   liver.	  However,	   the	   two	  PPARγ	   genes	  were	   clearly	  differently	  expressed	   across	   tissues,	   with	   the	   novel	   PPARγL	   form	   showing	   higher	  expression	  that	  PPARγ	  in	  heart	  and	  ovary.	  In	  all	  other	  tissues,	  PPARγ	  was	  the	  more	  highly	  expressed	  gene.	  Given	  the	  relatively	  early	  duplication	  of	  the	  gene	  in	  the	  Northern	  pike	   lineage,	   the	  conservation	  of	  both	  genes	   in	  salmon,	  and	  these	  distinct	  expression	  differences,	  this	  suggested	  that	  there	  may	  be	  some	  functional	   divergence	   with	   regard	   to	   function.	   It	   is	   notable	   that	   many	  salmonids	  have	  an	  unusual	  life	  history,	  with	  early	  life	  spent	  in	  nutrient-­‐poor	  freshwaters	  where	  growth	  can	  be	  slow,	  and	  later	  life	  spent	  at	  sea	  with	  much	  faster	  growth.	  This	  period	  is	  then	  followed	  by	  return	  to	  freshwater	  to	  spawn,	  during	  which	  time	  gonads	  mature	  and	  fish	  cease	  to	  eat,	  existing	  entirely	  on	  lipid	  and	  protein	  reserves.	  These	  switches	  in	  lifestyle	  and	  extreme	  changes	  in	  metabolism	   may	   have	   evolved	   in	   tandem	   with	   the	   enabling	   molecular	  regulatory	   mechanisms	   and	   could	   explain	   the	   retention	   and	   divergence	   of	  PPAR	  duplicate	  in	  salmonids.	  	  
However,	   in	   order	   to	   gain	   a	   further	   understanding	   of	   the	   different	   tissue	  expressions	  of	  PPARs,	  functional	  characterization	  of	  each	  of	  these	  subtypes	  is	  required	   to	   further	   determine	   if	   activating	   compounds	   differ,	   and	   also	   to	  determine	   if	   the	   expression	   differs	   in	   adipose	   tissue,	   which	   was	   not	  identifiable	  in	  the	  young	  fish	  sampled	  for	  this	  experiment.	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7.6 Conclusions	  
In	  summary,	  the	  results	  of	  the	  present	  study	  indicated	  that:	  
a) CHSE-­‐214	   cell	   line	   has	   proven	   to	   be	   more	   reliable	   and	   robust	  compared	   to	   the	   AS	   cell	   line	   and	   the	   use	   of	   bPEI	   as	   transfection	  reagent	   has	   proven	   to	   successfully	   transfect	   fish	   cell	   lines	   in	   this	  study.	  	  b) The	   CHSE-­‐214	   cell	   line,	   and	   Gal4-­‐PPAR	   luciferase	   transactivation	  system	  is	  suitable	  for	  the	  screening	  of	  potential	  activating	  compounds	  as	  well	  as	  cell	  extracts.	  c) Screening	   of	   cell	   lipid	   extracts	   demonstrated	   that	   it	  was	   possible	   to	  identify	   fractions	   with	   piscine	   PPARγ-­‐induce	   activity	   and	   LC-­‐MS	  confirmed	  that	  the	  predominant	  lipids	  present	  in	  these	  fractions	  were	  ceramides	  and	  glucosylceramides.	  d) Of	   all	   the	   ceramide	   precursors	   tested	   in	   the	   cellular	   transactivation	  assay,	   glucosylceramide	   increased	   transcriptional	   activity	   suggesting	  that	   this	   lipid	   molecule,	   or	   its	   metabolites	   could	   be	   a	   biologically	  relevant	  endogenous	  activator	  of	  piscine	  PPARγ.	  e) In	   the	   important	  aquaculture	   species,	  Atlantic	   salmon,	   there	  are	   two	  PPARγ	  genes,	  which	  have	  both	  been	  conserved	  since	  their	  duplication	  before	   the	   salmonid	  whole	   genome	   duplication.	   These	   PPARγ	   forms	  have	   different	   tissue	   distributions,	   which	   suggest	   some	   functional	  divergence	   that	   may	   be	   some	   relevance	   given	   the	   importance	   of	  dietary	  lipid	  quality	  and	  quantity	  and	  the	  issue	  of	  excessive	  adiposity	  in	  farmed	  fish.	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